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This study was designed for the development of novel methods for isothermal 
amplification of nucleic acids using phi29 and Bst DNA polymerases in the 
detection and characterization of pathogenic viruses of the respiratory tract. 
High Resolution Melting (HRM) analysis was used in this study for screening 
similar sequences to avoid unnecessary sequencing from genomic libraries and 
detection of common pathogenic viruses of the respiratory tract. 
 
Four different structures of DNA linear double stranded DNA (dsDNA, 48 kb), 
linear single stranded DNA (ssDNA, 3.6 kb), small circular dsDNA (2.6 kb) and 
a large circular dsDNA (8.6 kb) were used as representatives of different types 
of viral nucleic acids for the evaluation of phi29-amplification at limiting 
concentrations. Phi29-amplification of linear ds, large and small circular dsDNA 
could be amplified 10-100-fold but ssDNA could not be amplified at all. 
Alternative protocols were adapted for ligating ssDNA and dsDNA to construct 
large concatemers for efficient phi29-amplification. Phi29-amplification of 
ssDNA was found to increase >10-fold when it was ligated using T4 RNA ligase 
in the presence of a large excess of background ssDNA compared to that in the 
absence of background ssDNA. T4 DNA ligase-mediated phi29-amplification of 
double stranded cDNA (dscDNA) was found to increase >105-fold compared to 
non-ligated dscDNA. CircLigase II ssDNA ligase was used for circularization 
of ssDNA and aid phi29-amplification. CircLigase II ssDNA ligase-mediated 
phi29-amplification of ssDNA was found to increase >107-fold compared to 
non-ligated sscDNA. 
 
A method named RT-Bst was developed for simultaneous reverse transcription 
and Bst DNA polymerase amplification of cDNA in the same reaction. In a 
qualitative PCR assay, RT-Bst was found to be more efficient than the 
QuantiTect reverse transcription kit (QIAGEN, Crawley, UK). The RT-Bst 
method was used for amplification of cDNA in 70 nasopharyngeal samples for 
detection of a panel of 12 pathogenic viruses of the respiratory tract. The 
performance of multiplex RT-Bst PCR detection of pathogenic viruses was 
comparable to that of multiplex one-step RT-PCR (performed in this study) and 
more efficient than immunofluorescence (performed by a hospital diagnostic 
laboratory). The RT-Bst protocol was further modified using tailed random 
primers to develop another protocol for whole genome amplification designated 
RT-Bst Single Primer Amplification (RT-Bst SPA) as a cheaper alternative to 
sequence independent single primer amplification. 
 
HRM analysis was used in this study to demonstrate its application for low cost 
screening of similar sequences to avoid unnecessary sequencing task from 
whole genome libraries prepared from MS2 RNA and tissue culture media 
positive for influenza B and hRSV. HRM analysis was also used for rapid and 
low cost detection of common pathogenic viruses of the respiratory tract. 
 
It is proposed that RT-Bst and RT-Bst SPA have the potential for sequence 
independent amplification of RNA sequences for subsequent multiplex PCR 
detection, and other downstream applications. HRM analysis can be used for 
rapid and cost effective detection of pathogenic viruses of the respiratory tract. 
However, a more detailed study will be required for further optimization and 
validation of the developed protocols for appropriate commercialization as kits. 
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1.1 Respiratory tract infection 
The development of molecular methods has revolutionised not only the detection 
of unknown viruses but also the detection of divergent novel viruses of the 
respiratory tract. A number of previously unknown pathogenic viruses of the 
respiratory tract for example, human metapneumovirus (hMPV) (van den Hoogen 
et al., 2001), human coronavirus (hCoV) NL63 (van der Hoek et al., 2004) and 
HKU1 (Woo et al., 2005), human bocavirus (hBoV) (Allander et al., 2005) have 
been reported in the last two decades. Human viral infections may affect all age 
groups with a range of severity of infections which may depend on different 
environmental factors and clinical conditions (Weber, 2009).  Respiratory tract 
infections can be caused by a variety of microorganisms but the majority of such 
infections are caused by viruses (Makela, et al., 1998). Some of these viruses 
such as influenza A may cause severe disease and can lead to pandemic spread 
with high morbidity and mortality (Grasselli et al., 2011). Other viruses such as 
bocavirus may cause less severe infection leading to common cold symptoms 
(Lindner et al., 2008). The patterns of respiratory tract infections in common cold 
are complex due to the potential incidence of multiple viruses in respiratory tract 
infections in humans.  
 
Upper respiratory tract infections (URTI) can be caused by a wide variety of 
viruses, including rhinovirus, coronavirus, influenza A and B, parainfluenza, 
respiratory syncytial virus, adenovirus, metapneumovirus, and enterovirus; as well 
as by bacteria, including Chlamydia pneumoniae, Mycoplasma pneumoniae, 
Streptococcus pyogenes, Streptococcus pneumoniae, Bordetella pertussis, and 
Haemophilus influenzae (Costa et al., 2006; Louie et al., 2005; Makela et al., 
1998). The clinical symptoms of URTI are highly variable and cannot be used to 
identify the aetiological agents. Traditional methods for the identification of URTI 
pathogens, including culture and serology are effective for many viral pathogens 
but are laborious and time consuming. Serological tests, for example 
immunofluorescence, can be rapid but are often not sensitive or specific enough to 
detect all varieties of pathogenic viruses. In one study enzyme immunoassays 




(EIA) and direct immunofluorescence (DIF) assays showed sensitivities of 85% 
and 60-80%, respectively for detection of influenza virus (Cram et al., 1999). 
Although viral culture is generally accepted as the gold standard for diagnosis, 
PCR can be more sensitive (Templeton et al., 2004). In one study, culture 
detected 40% of rhinovirus infections in patients while PCR detected 51.5% 
(Makela et al., 1998). Similarly, an influenza virus surveillance study showed that 
18% of samples were positive by culture and 28% were positive by TaqMan-PCR 
(Schwieger et al., 2000). However, TaqMan-PCR is relatively expensive and is not 
regularly used for routine laboratory diagnosis of pathogenic viruses in developing 
countries. 
 
Respiratory tract viral infection can be self-limiting upper respiratory tract infections 
or more serious forms of lower respiratory tract infections. Rapid and accurate 
detection of pathogenic viruses of the respiratory tract can help the early diagnosis 
of pathogenic viral infection, decrease the duration of hospitalization and reduce 
management costs, as well as avoiding additional laboratory testing and 
unnecessary administration of antibiotics (Barenfanger et al., 2000; Woo et al., 
1997). 
 
1.2 Global picture of respiratory tract viral infections 
Respiratory tract infection is a major cause of disease burden compared to other 
causes of infection (Mizgerd, 2006). Respiratory tract infection is one of the 
leading causes of disease and resulting in mortality rate of 18% in children less 
than 5 years old in 2002. The next most common infections are diarrhoeal 
diseases (15%) and malaria (11%) around the world (WHO, 2005). Morbidity due 
to respiratory tract infection in this age group varies in different parts of the world. 
It was reported that 22% and 26.7% of all hospitalized patients had respiratory 
illness in the UK (Nicholson et al., 2006) and Belgium (Massin et al., 2006), 
respectively. Amongst all other viral infections in humans, influenza was found to 
be associated with approximately 250,000–500,000 deaths globally each year 
(World Health Organization, 2009). The actual mechanism for spread of influenza 




seasonally worldwide is not clearly understood but is found to be associated with a 
number of factors including environmental conditions and patient health (Cannell 
et al., 2006; Dowell, 2001; Lipsitch and Viboud, 2009; Lofgren et al., 2007). 
Influenza epidemics occur in the northern and southern hemispheres during their 
respective winters (Finkelman et al., 2007; Hope-Simpson, 1981) while increased 
influenza activity is found to be linked to the rainy season in several tropical 
populations (Chew et al., 1998; Chumkiew et al., 2007; de Mello et al., 2009; 
Dosseh et al., 2000; Moura et al., 2009; Rao and Banerjee, 1993). Other factors 
linked to influenza epidemics include cold temperatures (Davey and Reid, 1972), 
low indoor humidity (Hemmes et al., 1962), and minimal solar radiation (Hope-
Simpson, 1981). However, a detailed study needs to be done for comprehensive 
description of the global pattern of seasonal activity of influenza.  
 
1.3 Common pathogenic viruses associated with respiratory tract 
infections 
Respiratory tract infections are commonly associated with a range of pathogenic 
viruses and clinical manifestations. There are approximately 200 known respiratory 
tract viruses of the Adenoviridae, Parvoviridae, Orthomyxoviridae, 
Paramyxoviridae, Picornaviridae and Coronaviridae families associated with 
respiratory syndromes (Abed and Boivin, 2006). Only the common pathogenic 
viruses associated with respiratory tract infections are described in the following 
section. 
 
1.3.1 Influenza virus 
Human influenza viruses are enveloped, single-stranded, negative-strand, 
segmented RNA viruses that belong to the family Orthomyxoviridae. Influenza 
virus infections may lead to febrile respiratory illnesses and annual epidemics 
prevailing for about 3 to 8 weeks (Atmar, 2007; Harman, 1999). Influenza infection 
can spread globally in the pandemic form through the spread of novel virus types. 
These novel types of influenza viruses emerge following genetic reassortment of 




the haemagglutinin (HA) and neuraminidase (NA) genes (Stockman et al., 2006). 
Although three subtypes: H1N1, H2N2 and H3N2 were found to be associated with 
seasonal variations in the last 100 years, a new variant of H1N1 transferred from 
swine to humans was responsible for a pandemic (worldwide) outbreak in 2009 (Al 
Johani et al., 2011). In addition, the transfer of subtype H5N1 from birds to 
humans triggered the severe outbreak in Southeast Asia in 2003 and caused 
significant mortality and morbidity in humans (Adams and Sandrock, 2010). 
Although clinicians sometimes use laboratory diagnosis, they often diagnose 
patients solely based on the presence of influenza-like symptoms. Identification of 
influenza virus in a hospital environment is important for appropriate control of the 
spread of infection for example by droplet isolation. The spread of influenza 
infection in a hospital can be disastrous for immunocompromised patients for 
example, transplant recipients or cancer patients, and can cause serious 
complications leading to death. Transplant recipients may acquire viruses through 
the donor-derived infections, reactivation of endogenous latent viruses or from the 
community. Due to the immunocompromised states of these patients they are 
susceptible to infections from any opportunistic pathogens. Administration of 
specific antiviral agents for example, M2 channel inhibitors (amantadine and 
rimantidine) can be effective in controlling the spread of infections between 
patients. However, for effective treatment of patients M2 channel inhibitors need to 
be given within first 24 hours of infection. Therefore, a rapid and accurate 
laboratory diagnosis of influenza virus is of prime importance. 
 
Avian influenza virus (H5N1) was first detected in Hong Kong in 1997 (Gillim-Ross, 
2006) and resulted in death for 6 of 18 reported cases. A large number (1.5 
million) of infected chickens were culled in Hong Kong to limit the spread of the 
virus from the infected chickens. Millions of wild and domestic birds were infected 
by H5N1 in Southeast Asia in 2003. Subsequently, 229 people died out of 359 
people who became infected in 14 countries in 2008 (WHO, 2008).  
 
 




1.3.2 Human parainfluenzavirus (PIV) 
Human parainfluenzaviruses are enveloped single-stranded negative-sense RNA 
viruses grouped within the family of Paramyxoviridae.  There are four distinct 
serotypes of PIV associated with human infections (Beck and Henrickson, 2010; 
Henrickson, 2003). The mode of transmission and pathogenesis of PIVs are 
similar to those of influenza viruses. PIV1 and PIV2 are found to be the major 
cause of croup in children (Wright, 2005; Denny et al., 1983) and upper respiratory 
tract infection (URTI) in all other age groups (Mahony, 2008; Henrickson, 2003). 
PIV3 is more likely to be associated with severe lower respiratory tract infection 
(LRTI) in children. Infections caused by the PIV4 (Subtypes PIVa and PIVb) are 
less prevalent and less studied compared to the other common viruses of the 
respiratory tract (Beck and Henrickson, 2010). 
 
1.3.3 Human respiratory syncytial virus (hRSV) 
Human respiratory syncytial virus (hRSV) is a member of Paramyxoviridae and 
contains a single-stranded negative-sense RNA genome. RSV has been reported 
to be the major cause of bronchiolitis and pneumonia in children under the age of 
2 years (American Academy of Pediatrics, 2003). There are two subtypes (A and 
B) of hRSV found to be associated with infections caused by hRSV. There were 
over 100,000 hospitalization and 4,500 deaths associated with hRSV infection 
each year in the USA, with an estimated cost to the economy of $300 million (Hall 
et al., 2000). 
 
1.3.5 Adenovirus 
Adenoviruses are double-stranded DNA viruses of the Adenoviridae family and 
have more than 51 known serotypes which are categorized into six subgenera A to 
F. Adenoviruses can also cause other types of infections for example, 
conjunctivitis, keratoconjunctivitis, and acute gastroenteritis. Amongst the 51 
known serotypes the ones associated with the respiratory tract infections include 1 
to 5, 7, 14, 19 and 37. Adenoviruses generally spread through inhalation of droplet 
nuclei and infect children under the age of 10 years old (Fox et al., 1969). The 




incidence of adenovirus infections in haematopoietic stem cell transplant patients 
have been reported by different workers which range between 4.9% and 20.9% 
(Blanke et al., 1995; Wasserman et al., 1988; Shields et al., 1985; Munoz et al., 
1998).  
 
1.3.6 Rhinovirus (RV) 
Rhinoviruses are single-stranded positive-sense RNA viruses of the Picornaviridae 
family of which more than 200 serotypes have been identified. Rhinoviruses cause 
approximately two-third of cases of common cold in humans and have been found 
associated with asthma exacerbations in chronic lung disease (Kling et al., 2005; 
Gern, 2002; Douglas, 1970). Rhinoviruses and enteroviruses belong to the same 
family Picornaviridae and often detected using primers specific for the highly 
conserved 5’-noncoding region (NCR). However, designing a second set of 
primers targeting the VP1 or VP4 genes can be useful to differentiate between 
rhinoviruses and enteroviruses (Kiang et al., 2007). RT-PCR, nucleic acid 
sequence based amplification (NASBA) have been found to be more sensitive 
than conventional culture techniques for the detection of rhinoviruses (Blomqvist et 
al., 1999; Halonen et al., 1995; Hyypia¨ et al., 1998; Loens et al., 2006; Steininger 
et al., 2001; Vuorinen et al., 2003). 
 
1.3.7 Enterovirus and Parechovirus 
Enterovirus and Parechovirus are single-stranded positive-sense RNA viruses of 
the Picornaviridae family. The genus Enterovirus and Parechovirus have been 
shown to have 63 and 4 distinct members, respectively. Enteroviruses are 
prevalent worldwide infecting an estimated 1 billion people each year. These 
infections are common in infants and young children especially under the age of 1 
year (Benschop et al., 2006a and 2006b; Boivin et al., 2005). Enterovirus 
infections can cause a range of disease conditions starting from mild respiratory 
symptoms (Cherry, 2004) to serious forms such as poliomyelitis and aseptic 
meningitis. Although parechoviruses mainly cause respiratory tract and 
gastrointestinal infections (Benschop et al., 2006b; Kuypers et al., 2006) human 




parechoviruses can cause acute flaccid paralysis and severe encephalitis 
(Figueroa et al., 1989; Koskiniemi et al., 1989).  
 
1.3.8 Human metapneumovirus 
Human metapneumoviruses consist of two major groups (A and B) and four 
subgroups. Human metapneumovirus is an RNA virus of the Paramyxoviridae 
family which were discovered in 2001 (van den Hoogen et al., 2001). It can cause 
mild to severe respiratory tract infections with symptoms very similar to those 
caused by hRSV and can lead to the development of bronchiolitis and pneumonia 
(Konig et al., 2004; Van den Hoogen et al., 2003). Human metapneumovirus 
(hMPV) can cause sporadic infection throughout the year (Williams et al., 2004) 
with predominant outbreaks in the winter and spring months of temperate climates 
(Kaida et al., 2006; Robinson et al., 2005; Van den Hoogen et al., 2004). This virus 
can spread through aerosols, droplets or contaminated surfaces and infect people 
of all ages primarily infants (Tang et al., 2007; von Linstow et al., 2006). 
 
1.3.9 Coronavirus (CoV) 
Coronaviruses are single-stranded positive-sense RNA viruses belonging to the 
Coronaviridae family. Of the five types of coronaviruses reported so far, HCoV-
229E and NL-63 belong to group I whereas OC43, SARS-CoV and HKU1 belong 
to the group II CoVs. CoV OC43 and 229E have been found to be associated with 
respiratory tract infection in immunocompromised children and hospitalized elderly 
patients (Falsey et al., 2002; Pene et al., 2003). The worldwide outbreak of severe 
acute respiratory syndrome (SARS) from 2002 to 2003 was associated with 
SARS-CoV of group II CoV. 
  
1.3.10 Human bocavirus (hBoV) 
Human bocavirus is a single-stranded DNA virus of the Parvoviridae family. 
Human bocavirus was discovered by Allander et al. (2005) using a large-scale 
molecular viral screening and DNase Sequence Independent Single Primer 
Amplification (SISPA) technique. Based on several studies it was found that about 




2% to 19% of respiratory tract infections were caused by hBoV. Bocavirus 
infections are detected mainly by molecular techniques (Lu et al., 2006; Neske et 
al., 2007; Choi et al., 2008) as it is not yet possible to grow isolates in cell culture. 
 
1.3.11 Parvovirus Type 4 and 5 and Mimivirus 
Parvovirus type 4 and 5 were found in the serum or plasma samples of 70% of HIV 
infected patients (Manning et al., 2007). Parvoviruses were also found in 4% of 
manufactured plasma and in healthy blood donors (Fryer et al., 2007). These 
types of viruses are considered as potential pathogens of the respiratory tract as 
are two other parvoviruses, parvovirus B19 and HBoV that are associated with 
respiratory tract infections. 
Mimivirus is a large DNA virus considered as a potential pathogen of the 
respiratory tract. Antibodies to mimivirus could be detected in 9.7% of community-
acquired pneumonia cases compared to 2.3% of healthy controls (La Scola, et al., 
2005). Mimivirus DNA was also found in bronchoalveolar lavage specimens from 
intensive care unit patients (La Scola, et al., 2005). However, in another study 
mimivirus sequence could not be detected by real-time PCR in 496 pneumonia 
patients (Dare et al., 2007). Further research is necessary in order to establish the 
true pathogenicity of these viruses.   
 
1.4 Traditional diagnostic methods for viruses of the respiratory 
tract 
Serology has been used as the major diagnostic approach during the last two 
decades for the detection of respiratory tract pathogenic viruses.  The most 
common serological tests used for diagnosis of respiratory tract viral infections are 
the haemagglutination inhibition (HAI) test, complement fixation and enzyme 
immunoassay (EIA). HAI was used for determining the subtyping H1 and H3 of 
influenza and influenza A virus infections. Detection of cytopathic effect (CPE) by 
haemagglutinating viruses may be improved by haemadsorption with red blood 
cells.  The efficiency of cell culture was also improved in the early 1990s with the 




introduction of shell vial culture (SVC) with specific monoclonal antibodies. This 
approach reduced the cell culture time from 8-10 days to 1-2 days. Direct 
fluorescent antibody (DFA) staining of cells from nasopharyngeal swabs is another 
technique commonly used in many laboratories for rapid detection of viruses and 
takes around 3 hours to complete. Enzyme immunoassays (EIAs) were introduced 
in the 1980s and 1990s but were found to be less sensitive than molecular 
methods. Consequently, more sensitive molecular techniques such as PCR, 
nucleic acid sequence based amplification (NASBA), loop-mediated isothermal 
amplification (LAMP) were developed as more sensitive detection methods for 
pathogenic viruses of the respiratory tract. 
 
1.5 Molecular methods for detection of pathogenic viruses of the 
respiratory tract 
There are a number of molecular methods developed in the last two decades for 
the detection of pathogenic viruses of the respiratory tract. Only the most relevant 
methods have been described in the following sections. 
 
1.5.1 Important aspects of molecular detection of pathogenic 
viruses of the respiratory tract 
Interpretation of the results of molecular detection of pathogenic viruses of the 
respiratory tract is critical for accurate diagnosis of infections of the respiratory 
tract. Several important factors need to be considered for interpretation of the 
detection result such as, viral shedding, quantitation of virus concentration which is 
described in the following sections.   
   
1.5.1.1 Viral infection and shedding 
Collection of patient samples during the early stage of infection is a prerequisite for 
reliable diagnosis of the respiratory tract infection (Antonishyn and Levett, 2010). 
The incubation period, infection period and mode of transmission of respiratory 
tract viruses can vary for different viruses. In a recent multiplex-real-time detection 




study of fifteen respiratory tract viruses demonstrated that the detection of viruses 
is associated with the duration of symptoms (Brittain-Long et al., 2009). Detection 
rate of viruses was higher (51%) in patients having symptoms of six days or less 
and compared to 30%, p<0.01 for patients having symptoms of seven days or 
more. A similar decline in the detection of RSV has been reported by other 
workers (Gerna et al., 2008; Campanini et al., 2007). In another study using real-
time PCR it was found that the threshold cycle (CT) values increased with the 
duration of symptoms in case of the enveloped respiratory tract viruses (Brittain-
Long et al., 2010). Threshold cycle value is the cycle number at which 
fluorescence generated within a reaction crosses the background fluorescence. 
Background fluorescence is determined from the fluorescence produced by a no 
template control. The CT value is inversely proportional to the template 
concentrations in the quantitative real-time PCR reaction. These real-time PCR 
findings suggest that the concentrations of viruses decrease gradually after the 
onset of infection (Brittain-Long et al., 2010). In the same study it was found that 
concentration hRV declined slowly and could still be detected after 10 days of 
infection. In other studies hRV and hEV were found to shed from respiratory 
mucous for several weeks and bocaviruses were found to shed for several months 
(Von et al., 2008). 
 
1.5.1.2 Significance of a positive result in a molecular method 
Molecular diagnostic tests are highly sensitive compared to older techniques, such 
as culture and immunofluorescence (Antonishyn and Levett, 2010; Beck and 
Henrickson, 2010). A positive result may reflect a carrier state other than active 
infection state. In a previous study Creer et al., (2006) found that 2% and 6% of 
the healthy controls were positive for hRV and influenza A virus, respectively. The 
presence of hRV in healthy children is also associated with asymptomatic carriage 
or prolonged shedding of the virus (Nokso-Koivisto et al., 2002; Winther, et al., 
2006; Van Der Zalm, et al., 2009; Herberhold, et al., 2009). In another study hRV 
could be detected by PCR up to two weeks after infection or more than two weeks 
after appearance of symptoms (Brittain-Long et al., 2010). Immunocompromised 




patients may not show any clinical symptoms but shed a detectable amount of 
respiratory tract viruses, for example, RSV (Ison, 2007; Peck et al., 2007). Some 
other viruses such as human bocavirus can be secreted for several months (Von 
Linstow et al., 2008; Martin et al., 2010; Don et al., 2011). Quantification of 
pathogenic viruses in clinical specimen may help to determine the true causative 
agents by determining and comparing the threshold cycle (CT) values of different 
agents (Utokaparch et al., 2011; Gerna et al., 2009; Brittain-Long et al., 2010). Use 
of a panel of viruses can be more helpful for detection of multiple infections or for 
reconfirmation of a negative result. In such studies Influenza A and hRSV are 
strongly associated with clinical symptoms compared to other viruses thereby 
detection of low level of these viruses may be of clinical relevance. However, more 
clinical studies are required to standardize a quantitative molecular method to 
define cut off level for different clinical situations. Quantitative molecular methods 
will be more useful if clinical specimens are collected from nasopharynx and/or 
oropharynx in the early stage of infection containing high titre of viruses (Brittain-
Long et al., 2008). 
   
1.5.1.3 Unbiased approach for detection of a panel of viruses  
Respiratory tract viral infection is associated with a number of pathogenic viruses. 
There are approximately 200 known viruses that have been reported to be 
associated with respiratory tract infections (Abed and Boivin, 2006). A number of 
new virus types have been reported since 2000 for example, avian influenza 
viruses (H5N1, H7N7 and H7N3), human metapneumovirus (hMPV), severe acute 
respiratory syndrome (SARS) CoV and human CoVs (hCoV) NL63 and HKU1 
(reviewed by Mahony, 2008). Respiratory tract infections can cause mild infection 
such as, self-limiting upper respiratory tract infection to more serious lower 
respiratory tract infections. Conventional methods such as culture and 
immunofluorescence are still used in diagnostic laboratories for detection of 
respiratory tract viruses but they are often laborious, time consuming and less 
sensitive (Tregoning and Schwarze, 2010). With the development of multiplex 
molecular tests, it is now possible to detect 15-20 different viral agents 




simultaneously. This increased capacity not only improves the rate of virus 
detection but has also expanded our knowledge of the aetiology of respiratory tract 
infections. For example, Human RV and human CoV were previously recognised 
as mild causes of upper respiratory tract infections but have now been found to be 
associated with severe infections of lower respiratory tract (reviewed by Mahony, 
2008; Renwick et al., 2007; Louie et al., 2009). However, most of the respiratory 
tract viruses can show similar clinical manifestations thereby it is very difficult to 
diagnose any infection based on their clinical manifestations (Gravenstein et al., 
2000; Li et al., 2007; Mahony, 2007c). It has been reported that multiple 
respiratory tract viral infections could be detected in 10% of the respiratory 
specimens (reviewed by Mahony, 2008). Moreover, multiple viral infections were 
found to be associated with severe clinical symptoms (Utokaparch et al., 2011; 
Harvala et al., 2008; Schildgen et al., 2008; Paranos-Baccala et al., 2008). The 
inclusion of a panel of respiratory tract pathogenic viruses will not only help to 
diagnose infections more accurately but also reduce the cost associated with the 
individual test. 
  
1.5.2 PCR and RT-PCR 
PCR is a very sensitive technique for detection of any viral DNA genome target 
(Saiki et al., 1988). Primer design is very important in amplification and detection 
of a specific or multiple targets. In virology research primers are generally 
designed for detection of the relatively conserved sequences for example, 
replication genes and matrix protein coding genes for detection of different 
members of the same species or family. For example primers designed for 
detection of the hexone gene of adenovirus can detect 18 genotypes in urine 
samples (Echevarria et al., 1998b). Multiple sets of primers specific for different 
viruses are used for the detection of multiple viruses in multiplex PCR assay. In 
order to amplify all of the targets in the same amplification reaction it is necessary 
to optimise the thermocycling conditions for example, annealing temperature and 
extension time for all of the primers. DNA amplified by PCR can be detected 




through separation of the DNA on agarose gel and detection of the appropriate 
band or by using sequence specific oligonucleotide probes (Osiowy, 1998). 
 
Both one-step and two-step RT-PCR methods are used for detection of RNA 
viruses in clinical samples. In two-step RT-PCR, cDNA is first prepared from the 
viral RNA which is then used as template for further detection of target sequences 
by PCR. In one-step RT-PCR viruses can be detected directly from extracted 
RNA. One-step RT-PCR is more sensitive than the two-step RT-PCR because it 
includes relatively larger amount of RNA for reverse transcription and PCR 
amplification. One-step RT-PCR also amplifies cDNA using PCR in the same 
reaction after reverse transcription of RNA which excludes the possibility of 
pipetting errors and carryover contaminations. One-step RT-PCR was used to 
successfully amplify the matrix, nucleoprotein (NP) and haemagglutinin (HA) 
genes of influenza A and B viruses (Poddar, 2002). Amplified PCR products can 
be separated on agarose gels for detection of appropriate sizes of the bands. 
Multiplex RT-PCR can be developed after optimizing different primers for the 
detection of a panel of pathogenic viruses (Sanghavi et al., 2011; Bellau-Pujol et 
al., 2005). Multiplex RT-PCR has also been used for simultaneous detection of 
influenza A and differentiation of avian H5, H7 and H9 subtypes (Xie et al., 2006). 
 
1.5.3 Quantitation of virus using molecular methods 
Molecular methods are more sensitive than conventional methods and also allow 
quantification of the viral load. Detection of viral load can be useful for diagnosis of 
infection, to determine the shedding of viruses in different stages of infection and 
for monitoring of therapy. Rapid and accurate quantification of viral load by real-
time quantitative PCR has been found to be useful in clinical settings for detection 
and quantitation of 13 common respiratory tract viruses using fluorescence 
resonance energy transfer (FRET) hybridisation probes (Lassauniere et al., 2010; 
Kaltenboeck and Wang, 2005). Special clinical management policies and infection 
control measures (To et al., 2010) should be taken if high viral load and prolonged 
viral shedding is found in young children. It was also possible to determine the 




concentrations of different types of adenoviruses using multiplex type-specific real-
time PCR (Boivin et al., 2003). Recently, a super high speed real-time quantitative 
PCR was introduced by Sakurai et al. (2011) for rapid and sensitive detection of 
influenza viruses in less than 20 minutes. 
 
1.5.4 Loop-mediated isothermal amplification (LAMP) and reverse 
transcription loop-mediated isothermal amplification (RT-LAMP)  
LAMP is a very sensitive and rapid isothermal amplification method used for the 
detection of DNA. The principle of LAMP is based on autocycling strand-
displacement synthesis of DNA (Notomi et al., 2000). Two inner and two outer 
primers are used with Bst DNA polymerase for isothermal amplification of a target 
sequence in such amplification. Bst DNA polymerase is the large fragment of DNA 
polymerase derived from Bacillus stearothermophilus which has 5’3’ polymerase 
activity but no 5’3’ exonuclease activity (Aliotta et al., 1996). As a result of the 
LAMP reaction a mixture of stem-loop DNAs of different stem lengths comprising 
of multiple loops are produced. A positive amplification can be easily monitored 
either by gel electrophoresis or measuring the concentration of magnesium 
pyrophosphate (Mori et al., 2004). LAMP has been applied successfully for 
detection of RNA sequences by adding an initial reverse transcription (RT) step 
and additional pair of primers called RT-LAMP (Parida et al., 2004; Yoda et al., 
2007). LAMP was found to be 100 times more sensitive than PCR for detection of 
tomato yellow leaf curl virus DNA (Qu et al., 2010). RT-LAMP was also found to be 
10 times more sensitive than RT-PCR for detection of Taura syndrome virus (TSV) 
RNA (Kiatpathomchai et al., 2007). 
 
1.5.5 Nucleic acid sequence-based amplification (NASBA) 
In this technique an RNA template is amplified through simultaneous activities of 
three enzymes namely reverse transcriptase, RNase H and DNA-dependent RNA 
polymerase (Guatelli et al., 1990) (Figure 1.1). Initially a DNA primer hybridizes to 
the T7 promoter and is extended by reverse transcriptase (RT). RNase H 
degrades the RNA from the cDNA/RNA hybrid and double-stranded DNA is 




synthesized by reverse transcriptase (RT) using a second primer. Multiple copies 
of RNA are formed from this DNA template by T7 polymerase. Amplified RNA can 
be detected by electrochemiluminiscence and RT-PCR and has been used for 
rapid detection of various viruses including West Nile virus and St. Louis 













Figure 1.1: Nucleic acid sequence based amplification (NASBA). (A) Initial 
phase: (1) template RNA; (2) reverse transcription with primer (P1) containing T7 
promoter; (3) RNase H degrades RNA from cDNA-RNA hybrid; (4) Primer 2 (P2) 
binds to the promoter sequence and complementary DNA strand is extended by 
reverse transcriptase (DNA dependent DNA polymerase activity); (5) double 
stranded T7 promoter acts as a self-sustained template for T7 DNA-dependent 
RNA polymerase to generate complementary RNA; (B) Cycling phase: each RNA 
can be copied in cyclic order and amplified exponentially. Figure adapted from 
Asiello and Baeumner, 2011. 
 
1.5.6 Nucleic acid hybridization method 
The nucleic acid hybridisation technique can be used for the detection of specific 
nucleic acid sequences for example; viral genomes. A short labelled probe of 20-
30 bases is hybridized to a unique complementary piece of viral genome. This 
Primer 1 with T7 promoter (P1)
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short probe can be either DNA or RNA (riboprobe). This technique relies on the 
signal amplification system rather than amplification of the target genome. Signals 
from the hybridized probes can be amplified through chemiluminiscence or a 
hybrid-capture assay for quantitation of viruses. The nucleic acid hybridisation 
method has been used to monitor human immunodeficiency virus type 1 (HIV-1) 
RNA in plasma samples from patients enrolled in clinical trials for antiretroviral and 
immune-based therapies (Dewar et al., 1994).   
 
1.5.7 Microarray analysis of virus sequences 
Microarray technology is based on nucleic acids hybridisation method used for the 
detection and characterisation of different sequences. A range of single-stranded 
DNA oligonucleotide probes are spotted on a small glass slide, membrane or 
coated quartz microchip surface for hybridization and detection of complementary 
nucleic acid sequence. Genomic DNA or RNA is extracted from a desired sample 
and the target sequences are amplified and labelled with fluorescent markers. 
These labelled sequences are allowed to hybridize with complementary 
sequences in the array. Subsequently, fluorescence is monitored to determine the 
presence of particular sequence. Microarrays have already been used for the 
detection and typing of pathogenic viruses from the respiratory tract (Mehlmann et 
al., 2007; Thompson et al., 2003; Mahony et al., 2007a and 2007b). A commercial 
microarray device CLART PneumoVir (Genomica, Coslada, Madrid, Spain) was 
developed for the detection of multiple respiratory tract viral pathogens and is also 
considered to be cheaper than multiple multiplexed conventional PCR-based 
assays (Frobert et al., 2011). There is an enormous prospect for adopting 
microarray platforms for cheaper detection of multiple infectious agents such as 
bacteria, virus and fungi in patient samples. Microarray analysis can also be 
designed for detection and characterisation of different genotypes such as drug 








1.5.8 Multiplex PCR and emerging technologies for the detection 
of respiratory tract pathogens 
The application of molecular techniques is becoming widespread due to their 
performance, rapid turnaround time and ability to detect a range of different 
pathogens compared to other conventional techniques. It is also more convenient 
to set up multiplex assays after multiplex PCR amplification of the metagenome 
using modern techniques for example, ResPlex technology and Infinity system 
which are described in the following sections. Several emerging techniques are 
described in this section but none of them have yet been approved by the US 
Food and Drug Administration (FDA) with the exception of the ProFlu-1 assay.  
 
1.5.8.1 Micro-bead suspension array (EraGen Biosciences) 
multiplex PCR 
In this technique multiple targets are amplified using multiplex PCR. Consequently, 
amplified products are hybridized to target-specific capture probes covalently 
bound to colour-coded beads. Hybridization of coloured beads is detected using a 
dual-laser detection device for determining the presence or absence of particular 
pathogens in the sample. This technology has been successfully applied for the 
detection of common pathogenic respiratory tract viruses (Mahony et al., 2007a) 
and typing of human papillomaviruses (HPV) (Schmitt et al., 2006).  This 
technology offers detection of 100 different types of sequences in the same 
reaction. 
 
1.5.8.2 ResPlex Technology (Qiagen) 
This technology involves multiplex PCR amplification followed by bead-based 
detection such as Luminex xMAP. This technology is suitable for detection of 15 
pathogens from a single test. ResPlex I and ResPlex II are designed for 
detection of bacterial and viral respiratory pathogens, respectively. The ResPlex 
system was used for detection of 21 common pathogens including bacteria and 
viruses from patients having acute respiratory infections (Brunstein et al., 2008). 




ResPlex test was found to have a sensitivity of 84%-100% compared to direct 
fluorescent antibody (DFA) test for detection of influenza A and B, parainfluenza 1-
3 and RSV. However, ResPlex was found to be less than 10% sensitive 
compared to DFA when tested for adenovirus. 
 
1.5.8.3 Infiniti System 
In the Infiniti system (AutoGenomics) target sequences are amplified initially 
using multiplex PCR for subsequent detection using automated microarray 
hybridization in Infiniti analyser. Unincorporated nucleotides are removed 
through enzymatic digestion and amplicons are labelled using fluorescent 
nucleotides. In a recent study, this microarray approach was compared with 
quantitative real-time PCR for detection of 23 common respiratory tract viruses in 
children ≤3 years of age (Raymond et al., 2009). Microarray analysis was found to 
be ≥90% sensitive for all viruses other than adenoviruses and coronavirus NL63. 
Although throughput was higher for microarray analysis for detection of >15 
targets, a singleplex real-time PCR was found to be more sensitive for detection of 
an individual virus (Raymond et al., 2009).    
 
1.5.8.4 Jaguar system 
The Jaguar system (BD Diagnostic) is an automated nucleic acid extraction and 
real-time PCR detection technology for identification of multiple respiratory 
pathogens. Nucleic acid extraction occurs in individual cartridges. The 
amplification cartridge can accommodate 12 reactions of 4 µl each with 
multiplexing capabilities of 2-6 targets. It was found that the sensitivities for the 
detection of influenza A, influenza B and RSV were 100%, 90% and 100%, 
respectively compared to tissue culture detection (Beck et al., 2010). 
 
1.5.8.5 FilmArray technology 
The FilmArray system (Idaho Technologies) is an integrated automated system 
for nucleic acid extraction, nested PCR, detection and data analysis for the 




diagnosis of numerous viral and bacterial respiratory pathogens in a single-use 
pouch. A PCR reaction is performed in two steps; the first step is a multiplex PCR 
containing primers for all of the target sequences and the second step targets a 
specific pathogen. This technique has the potential for the detection of >15 target 
sequences in the same reaction within an hour (Rand et al., 2011; reviewed by 
Caliendo, 2011). 
 
1.5.8.6 Scalable target analysis routine (STAR) technology 
STAR technology (PrimeraDx) is a blend of PCR with a capillary electrophoresis 
system. Different targets are identified based on the sizes of the amplified 
products. It is possible to detect large number of pathogens (>20) in a single 
reaction. This system is still under study for the detection and quantification of 
viruses in clinical settings (Garcia et al., 2005). 
 
1.5.8.7 PLEX-ID technology 
In the PLEX-ID system (Abbott Molecular) target sequences are initially amplified 
by PCR using primers targeting highly conserved regions of pathogenic 
microorganisms that flank variable regions. PCR products are analysed using 
electronspray ionization mass spectrometry (ESI-MS) to determine the base 
composition of the amplified products. Sequence information is matched with a 
known sequence database to confirm the presence of any organism. PlEX-ID 
system 95% sensitivity was observed for the detection of influenza A and B and 
88% for RSV when compared with other tests such as antigen detection, culture 
and PCR. However, the PLEX-ID system was 100% sensitive for detection of 
adenovirus, parainfluenzavirus and coronavirus (Chen et al., 2008). 
 
1.5.8.8 ProFlu-1 
Pro-Flu-1 (Pro-Flu+; Prodesse Inc.) is a FDA approved multiplex real-time RT-
PCR system used for the detection of influenza A, influenza B and RSV. In two 
other studies the sensitivity and specificity of using ProFlu-1 assay for the 




detection of influenza A was 100% and 93% and for influenza B were 98% and 
99%, respectively, compared to immunofluorescence (IF) and culture assay 
(LeGoff et al., 2008; Liao et al., 2009).  
 
A summary of different molecular techniques with their salient features have been 
presented in table 1.1 (Adapted from Olofsson et al., 2011). 
 
Table 1.1: Overview of different molecular methods  
Molecular method Description Comment 
Conventional PCR Detection: colorimetric or 
agarose gel electrophoresis  
Quantitation: not possible 
Contamination: high risk 
Multiplexing: limited 
Real-time PCR Evaluation: colorimetric using 
light emitting probe 
Quantitation: possible 
Contamination: low risk 
Multiplexing: limited 
Specific detection: possible 
Multiplex PCR-based liquid 
array (Luminex®; Luminex 
Corporation);  
X-TAG® RVP (Abbott);  
ResPlex® (Qiagen);  
MultiCode®-PLx (EraGen 
Biosciences) 
PCR amplicons are hybridised 
to coloured beads 
Quantitation: not possible 
Multiplexing: excellent 
Contamination: low risk 
Cost: expensive 
NASBA, LAMP Amplification: isothermal 
Detection: colorimetric or 
agarose gel electrophoresis 
Thermocycler: not needed 
Sensitivity: high 
Quantitation: not possible 
Cost: affordable 
Rapid diagnostic PCR 
instruments:  
Xpert® (Cepheid)  
FilmArray® (Idaho)  
Jaguar® (BD diagnostics)  
Infiniti® (AutoGenomics) 
System: integrated extraction 
and PCR system 
Sample run: preloaded 
cassettes 
Hands on time: minimum 
Specimen batching: not 
required 
Cost: relatively expensive 
 
 




1.6 Non-PCR based isothermal amplification of DNA/RNA 
Isothermal amplification of nucleic acids in molecular biology has enabled 
scientists to amplify nucleic acids without using a thermocycler. Isothermal 
amplification of nucleic acid is relatively easy, cheap and can be done in remote 
areas where it is not possible to gain access to a thermocycler. Amplification of 
nucleic acids is essential in research, medicine and agriculture for the detection 
and characterization of genomic sequences (Moore, 2005). Although PCR-based 
amplification of target sequences is widespread, several non-PCR based 
amplification techniques have been developed in the last two decades. 
Development of these new isothermal amplification techniques has been possible 
through mimicking in vitro nucleic acid amplification by providing necessary 
proteins, dNTPs, primers and templates for synthesis of DNA/RNA. 
 
1.6.1 Transcription mediated amplification (TMA)/ nucleic acid 
sequence-based amplification (NASBA) 
Transcription mediated amplification (TMA) is very similar to nucleic acid 
sequence-based amplification (NASBA) (Compton et al., 1991) (Section 1.5.5). 
Three enzymes are used in this technique including reverse transcriptase, DNA 
dependent RNA polymerase and RNase H for reverse transcription and synthesis 
of multiple copies of RNA from the starting template RNA. NASBA can amplify 1 
billion copy of the RNA complementary to the target RNA in 1.5 hour at 41º C. 
Amplified products can be visualized after gel electrophoresis or detected using 
fluorescence probes in real-time PCR amplification or colorimetric assays (Abd et 
al., 2005; Gill et al., 2006; Polstra et al., 2002). NASBA has already been approved 
by the Food and Drug Administration, USA for detection of HCV and HIV-1 
(Guichon et al., 2004; Barker et al., 2000). NASBA amplified product was also 








1.6.2 Signal mediated amplification of RNA technology (SMART) 
The signal mediated amplification of RNA (SMART) technology (Figure 1.2) was 
developed by Cytocell Ltd., Banbury, UK for diagnosis of clinical samples 
(Wharam et al., 2001). SMART technology also known as CytAMP (British BioCell 
International, Cardiff, UK) has been compared with conventional methods for 
specific detection of methicillin resistant Staphylococcus aureus (MRSA) (Levi et 
al., 2003). The sensitivity and specificity of CytAMP for the diagnosis and 
susceptibility testing of methicillin resistant Staphylococcus aureus (MRSA) was 
found to be comparable to those of PCR (Brown et al., 2005). It was also found 
that SMART produces many copies of an RNA signal at 41º C in the presence of 
RNA or DNA. A three-way junction (3-WJ) is formed after hybridization between 
the target and two probes, one contains RNA signal sequence and the other 
contains T7 promoter sequence (Hall et al., 2002). Bst DNA polymerase extends 
the short probe to generate double stranded T7 RNA polymerase promoter for 
subsequent synthesis of multiple copies of RNA using T7 RNA polymerase. 
Synthesized RNA can bind to the second probe, extended by Bst DNA polymerase 
generating double stranded promoter leading to transcription of RNA. Amplified 
RNA can be detected by enzyme linked oligosorbent assay (ELOSA) or real-time 





































Figure 1.2: The signal mediated amplification of RNA technology (SMART). 
(a) Hybridization of probes to the specific target to form three way junction, 
synthesis of double stranded T7 RNA promoter by Bst DNA polymerase and 
synthesis of multiple copies of RNA from T7 RNA polymerase promoter (double 
stranded) using T7 RNA polymerase. (b) Detection of RNA signals by ELOSA 
(Enzyme Linked OligoSorbant Assay) using two specific probes: a biotinylated 
capture probe and enzyme (Alkaline phosphatase, AP) linked detection probe. 
Amplification of RNA determined after detection of change in the colour of the 
solution after adding the substrate to the reaction. Figure adapted from Wharam et 
al., 2007. 
Three-way junction
T7 RNA pol promoter 
(doble stranded)
Bst DNA pol 
& T7 RNA pol
Transcription 
template
























1.6.3 Strand displacement amplification (SDA) 
Strand displacement amplification (SDA) uses a restriction endonuclease to nick 
the unmodified strand of its target DNA and an exonuclease deficient DNA 
polymerase to extend the 3’ end at the nick and displace the downstream DNA 
strand. After an initial heat denaturation, four primers (B1, B2, S1 and S2) bind to 
the target strands flanking the sequence to be amplified. The four primers are 
extended simultaneously by exonuclease deficient DNA polymerase. Extension of 
B1 displaces the S1 primer and B2 displaces S2. SDA primers contain restriction 
sites and new DNA strand flanked by the nickable sites is synthesized through 
their extension and strand displacement activity. The newly synthesized DNA is 
nicked again, the 3’-end is extended, displacing a single stranded copy and 
regenerating double stranded DNA in the presence of excess primers. Each single 
stranded DNA can be amplified 1010-fold using this technology. SDA amplicons 
can be used for real time assay (Nycz et al., 1998). SDA technology has been 
used for detection of pathogenic microorganisms such as Chlamydia trachomatis 
and Neisseria gonorrhoeae using the Becton Dickinson Probe Tec ET System (BD 
Biosciences, Sparks, Md.) (Van Der Pol et al., 2001; Chan et al., 2000). SDA can 
also be used for amplification of RNA templates in RT-SDA format that will require 
addition of reverse transcriptase to the reaction mix (Nycz et al., 1998; Hellyer et 
al., 1999). 
 
1.7 Amp-PCR: Combining phi29 amplification with RT-PCR 
The sensitivity and specificity of real-time PCR for detection of any pathogen 
depends on several factors for example, binding of the primers to desired 
sequences, genome variability or mutation in the primer-binding region of the virus 
genome, copy number of genome and efficiency of the reaction. Sometimes, it is 
not possible to amplify any target sequence present in very low concentration from 
complex samples containing different types of templates by PCR (Karrer et al., 
1995; Schloss et al., 2003). This limitation of PCR can lead to false negative 
results which may delay accurate diagnosis and treatment of the patient. It was 




found in a study that the detection of herpes simplex virus was often missed in 
PCR detection when present in very low levels in cerebrospinal fluid (CSF) 
samples (Schloss et al., 2003). A new approach (Amp-PCR) has been developed 
recently to improve detection of samples containing as little as a single copy of a 
viral genome. The Amp-PCR technique combines random unbiased isothermal 
phi29-amplification with a virus-specific real-time PCR which enhances the PCR 
signal 100x106-fold. Phi29 amplification enriches the template concentration 
preceding the PCR in a single tube reaction which makes it possible to detect 
amounts of template normally below the detection limit of PCR (Erlandsson et al., 
2010).   
 
1.8 Viral metagenomics  
Metagenomics is a culture and sequence independent method to study genomic 
sequences in environmental and clinical samples. Metagenomic approaches can 
help study the genomic diversity in a specific environmental niche bypassing 
conventional culture techniques which have a number of limitations including 
isolation of the members present in nature. Metagenomic approaches to viral 
characterisation have been applied to seawater, near shore sediments, faeces, 
serum, plasma and respiratory secretions and have broadened the range of known 
viral diversity in these niches (Allander et al., 2001; Breitbart et al., 2005 and 2002; 
Mushahwar et al., 1999). The ability to detect previously uncharacterised viruses 
can be improved by the selection of samples with high viral loads such as during 
the acute phase of infection, purification of viral particles, removal of cellular 
nucleic acids, efficient sequence-independent amplification of viral RNA and DNA, 
recognisable sequence similarities to known viral sequences and the deep 
sampling of the nucleic acid populations through large scale sequencing. Some 
animal viruses have recently been identified using sequence-independent methods 
(Victoria et al., 2008). Viral metagenomic approaches provide novel opportunities 
to generate an unbiased characterisation of the viral populations in various 
systems and environments. The use of molecular tools is revolutionising our 
understanding of the composition and diversity of microbial communities. The 




study of bacterial communities using 16S ribosomal RNA gene sequencing in 
environmental and clinical samples has led to the recognition that around 99% of 
bacterial species cannot be cultured and bacterial communities are much more 
diverse in terms of community structure than previously thought (Singh et al., 
2009). More recently, similar observations have been made studying viral 
communities (Fadrosh et al., 2011; Cann et al., 2005; Breitbart et al., 2005 and 
2002).  
 
1.8.1 Molecular methods and approaches used in viral 
metagenomics for virus discovery 
1.8.1.1 Representational difference analysis  
Representational difference analysis combines subtractive hybridization with gene 
amplification to determine the differences between two samples. The subtractive 
hybridization technique is used for selective amplification of nucleic acids of 
pathogenic microorganisms. Nucleic acids from the infected tissue (tester) are 
hybridised with the uninfected (driver) nucleic acids for several rounds for 
separation of un-hybridised DNA. Un-hybridised single stranded tester nucleic 
acids are purified using hydroxyapatite chromatography (Vande Woude et al., 
1990; Marx et al., 1991) and subcloned to make a library. Subcloned libraries can 
be screened either by immunoscreening (using appropriate serum antibodies) or 
by matching the sequence homology to that of specific viruses. This technique 
requires large amounts of starting materials and is time consuming. However, 
several viruses have been discovered using a subtractive hybridization technique 
for example, Kaposis sarcoma-associated herpesvirus (HHV8) (Chang et al., 
1994), Torque teno virus (TTV) (Nishizawa et al., 1997) and GB virus A and B 
(Simons et al., 1995).   
 
1.8.1.2 Sequence-independent nucleic acid amplification (SISPA) 
Reyes et al., (1991) first reported the SISPA technique for the detection of 
unknown viral nucleic acids (Figure 1.3). Viruses containing RNA genomes are 




reverse transcribed to cDNA using random primers and reverse transcriptase. 
Double stranded cDNA is synthesized through digestion of the RNA (using RNase 
H) from RNA/DNA hybrid and synthesis of the second strand using DNA 
polymerase activity. The resulting double stranded cDNA is digested with 
appropriate restriction enzymes for example, EcoR1 and Not1 and ligated to 
adaptor linkers complementary to the restriction sites. The DNA is digested with a 
suitable enzyme for example, Mbo I for the ligation of adaptor linkers 
complementary to the restriction enzyme cleavage sites. This adapter linker 
portion contains primer sequence which is subsequently used for PCR 
amplification of the DNA fragments flanked by the adaptor linkers. PCR amplified 
products are cloned in suitable vectors to make a library of the whole genome 
sequences. The cloned library sequences can be screened through sequencing 
the inserted sequences or immunoscreening of the expression clones. 
Immunoscreening of the expression clones subsequent to library preparation using 
the SISPA technique was found to be useful for the characterisation of Norwalk 
viruses from faeces (Matsui et al., 1991). The authors used the SISPA technique 
to amplify cDNA prepared from 10 µg of nucleic acid extracted from 1.5 grams of 
faecal sample for detection of Norwalk virus. In a recent study, the SISPA 
technique has also been used for identification and genetic characterisation of 
































Figure 1.3: Schematic diagram of sequence independent single primer 
amplification (SISPA). (1) Sample is processed to remove other cells and cell 
free organelles and to digest cell free DNA; (2) ss or dsDNA; (3) in case of ssDNA 
second strnd is synthesized; (4) ssRNA; (5) RNA is reverse transcribed and the 
second strand is synthesized; (6) dsDNA,, (7) restriction digestion and adapter 
ligation; (8) ligation of adapter-linker to blunt-ended dsDNA; (9) PCR amplification 








a) microfiltration to remove cells and other organelles
b) DNase digestion
c) precipitation of virus particles by centrifugation and 
RNA extraction
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1.8.1.3 Linker amplified shotgun library (LASL) 
Linker amplified shotgun library (LASL) is another method for sequence 
independent amplification of whole genomes. Genomic DNA is sheared at random 
sites using HydroShear (Genomic Solutions, Inc.). The ragged ends are repaired 
using T4 DNA polymerase and phosphorylated using T4 polynucleotide kinase. 
Linker sequences are ligated to these fragments of DNA to allow primer binding. 
Primers complementary to the linker sequences are used for PCR amplification of 
the DNA fragments flanked by the linker sequences. Viral RNA can be reverse 
transcribed into cDNA followed by double strand synthesis which is used for linker 
amplified shotgun library preparation. PCR amplified products can be sub-cloned 
in suitable vectors to make a genomic library (Breitbart et al., 2002; Cann et al., 
2005). The LASL technique has recently been applied to the metagenomic 
analysis of RNA virus communities in sea water (Culley et al., 2006).  
 
1.8.2 Whole genome amplification (WGA) 
Whole genome amplification is very important for the amplification of nucleic acid 
sequences from limiting amount of samples for genomic research for example, 
microarray analysis and sequencing. It is challenging to amplify entire cellular DNA 
considering the mechanisms involved within a cell system. The cellular process for 
DNA replication is very complex and requires more than 20 different purified 
proteins to reconstitute replication of dsDNA in vitro (Kornberg and Baker, 1991). 
Unfortunately these reconstituted reactions are currently too complex to facilitate 
their replication in the laboratory and it has not been possible to set up complete 
chromosomal DNA replication as a routine laboratory technique. A number of 
whole genome amplification (WGA) methods have been introduced since the early 
1990s to amplify genomic DNA. Broadly there are two categories of WGA 
available. One approach uses variations of the polymerase chain reaction (PCR) 
to randomly amplify the genomic sequences using random or degenerate primers 
(Dean et al., 2002; Nanda et al., 2008). The first PCR based WGA amplification 
method was called primer-extension pre-amplification (PEP) (Zhang  et al., 1992) 
and uses random primers for amplification of DNA sequence. Alternatively, 




degenerate primers can be used in another method called degenerate 
oligonucleotide-primed PCR (DOP-PCR) (Telenius et al., 1992; Cheung and 
Nelson, 1996). In another PCR-based whole genome amplification method 
genomic DNA can be shredded to small fragments, ligated to suitable adaptors 
and amplified using the PCR primers from the adapter sequences (Cann et al., 
2005; Section 1.8.1.3). These PCR based amplification can generate microgram 
quantities of genomic-representative DNA.  
 
The other group of methods for WGA is based on isothermal amplification of DNA 
by adding special types of DNA polymerases for example, phi29 or Bst DNA 
polymerase in the presence of random primers. The process of phi29 and Bst DNA 
polymerase amplification is described in Section 1.8.2.1. 
 
1.8.2.1 Multiple displacement amplification of genomic DNA 
Multiple displacement amplification (MDA) is one type of whole genome 
amplification method that amplifies whole genomes isothermally in a similar way to 
the cellular processes. The enzymes used for MDA are phi29 and Bst 
(exonuclease minus) DNA polymerases which can invade the replication fork 
efficiently without the help of a helicase. The former binds tightly to single stranded 
DNA and replicate a new complementary strand by displacing the other strand of 
DNA. Phi29 and Bst (exonuclease minus) DNA polymerase have been isolated 
from bacteriophage phi29 and Bacillus stearothermophilus, respectively. DNA is 
denatured either by chemical denaturation (using KOH) or by heat (95 ºC). 
Random hexamers, dNTPs and DNA polymerase (phi29 or Bst) are added to the 
denatured single stranded DNA for primer extension and synthesis of the 
complementary strand. The enzyme extends the random primers and displaces 
the 5’-ends of the other synthesizing strands. Thus phi29 or Bst (exonuclease 
minus) DNA polymerase can establish a new replication fork when it encounters 
regions of double stranded DNA. Random primers bind to the newly formed single 
stranded DNA and initiate synthesis of multiple copies of template DNA.  
 




Phi29 DNA polymerase is derived from Bacillus subtilis phage phi29 having a 
processivity of about 70000 nucleotides, which means it synthesize 70000 
nucleotides every time it binds to the DNA and an initiation primer. Phi29 DNA 
polymerase is more efficient (error rate of 1 in 106) than Taq DNA polymerase 
(error rate 1 in 103) and helps to reduce the incidence of artificial mutation 
(Esteban, 1993). Bst DNA polymerase (exonuclease minus) is a recombinant form 
of a 67 kDa DNA polymerase protein which is derived from Bacillus 
stearothermophilus DNA polymerase (large fragment). Phi29 DNA polymerase has 
been used for the amplification of whole genomes in previous studies more than 
the Bst DNA polymerase. Both phi29 and Bst DNA polymerase amplifies the whole 
genome in a similar mechanism. However the optimum temperature for phi29 DNA 
polymerase activity is 30 C and for Bst DNA polymerase it is 60-65 C. 
 
MDA has been used to increase the supply of purified genomic DNA from very 
little amount of template DNA for various downstream applications for example, 
cloning, sequencing, hybridisation and microarray analysis. Obviously, the quality 
of the stored DNA to be used is critical in obtaining high quality amplified DNA. 
DNA can also be amplified directly from clinical and other biological samples for 
example, nasal swabs, blood, buffy coats, dried blood (Hosono et al., 2003; 
Lasken et al., 2004) cultured cells and tissues (Lasken et al., 2004). Whole 
genome amplification using the MDA technique can be useful for making a 
metagenomic library for detection and characterisation of previously undescribed 
viruses. Phi29 DNA polymerase has been used successfully for amplification and 
detection of polyomaviruses (Johne et al., 2006a and 2005), anellovirus (Niel et 
al., 2005) and circoviruses (Johne et al., 2006b). 
  
1.8.2.2 Multiple displacement amplification from a single bacterial 
cell 
Multiple displacement amplification (MDA) (Dean et al., 2001; Detter et al., 2002) 
is so efficient that it can amplify genomic DNA from a single bacterial cell 
(Raghunathan et al., 2005). A single MDA reaction starting from a single bacterium 




can be amplified approximately 5 billion-fold producing 24 µg of amplified product. 
Moreover, such amplified DNA is suitable for downstream applications such as 
species identification, genotyping, and DNA sequencing. A single bacterium can 
be isolated by simple dilution, using flow cytometer or using fluorescent in situ 
hybridization (FISH) combined with cell isolation by microcapillary 
micromanipulation (Ishøy et al., 2006). Cells isolated using such a technique will 
enable researchers an unprecedented ability to investigate the genome of a new 
species present in a niche with other microorganisms. MDA can be applied to such 
genomes (Schloss and Handelsman, 2003; Venter et al., 2004) to study diversity 
of microbial flora in clinical or environmental samples. Genomes of unculturable 
microorganisms can be directly amplified using MDA. This approach will 
complement the metagenomic shotgun approach (Venter et al., 2004) of 











































Figure 1.4 Cellular (1-2) and cell free (3-5) DNA replication processes.  (A) A 
simplified diagram of DNA replication within the cell; (1) replication bubble is 
formed; (2) DNA is replicated through extension of the primers using DNA 
polymerase III. (B) Isothermal whole genome amplification; (3) random primers 
bind to the denatured template DNA; (4) primers extends (using phi29 or Bst DNA 
polymerase) and displaces the 5’-end of the other primer replicating DNA template 
upstream; (5) formation of hyper-branched DNA due to the random priming and 
































1.8.2.3 Rolling circle amplification (RCA) 
Rolling circle amplification is most useful for amplification of circular DNA viral 
genomes or plasmids (Breitbart, 2005; Dean et al., 2001). Once the phi29 DNA 
polymerase starts synthesizing the complementary strand in a circular DNA, it 
displaces its 5’-end of the sequence and continues to synthesize a new strand 
multiple times around the circle. It is now possible to use either sequence specific 
primers or random primers for RCA of circular templates. RCA using random 
primers is often termed as multiply-primed RCA. The primers (random or 
sequence specific) bind to the displaced strands and convert them to double 
stranded DNA (Dean et al., 2001). This technique can be used for generating 
libraries from plasmids (Dean et al., 2001; Detter et al., 2002) and circular 
genomes of viruses for example, human papilloma virus in a cervical keratinocyte 
cell line (Rector et al., 2004). This powerful technique has also been applied to 
obtain the full genome sequence of polyomaviruses (Johne et al., 2006 and 2005), 
anellovirus (Niel, 2005), circoviruses (Johne et al., 2006b), geminiviruses (Haible, 
2006), plant begomovirus (Inoue-Nagata et al., 2004) and wasp polydnavirus 
(Espagne et al., 2004). 
 
1.8.3 Purification of viral nucleic acids 
Metagenomic studies of virus sequences are difficult due to the co-amplification of 
undesired sequences during sequence independent amplification of whole 
genomes using the sequence independent single primer amplification (SISPA) 
technique. Separation of viral particle from the other background of prokaryotic 
and eukaryotic nucleic acids will improve the selective amplification of viral nucleic 
acids. Several approaches have been used so far for example; filtration, density 
gradient centrifugation and enzymatic removal of non-particle protected nucleic 
acids for removing background sequences and selective amplification of virus 
sequences.  
 
Filters having pore sizes of 160-450 nm have been used for separation of bacteria, 
eukaryotes and large aggregates of cells from viruses in previous studies (Allander 




et al., 2005; Breitbart et al., 2002). Filtration works on the basis of a size exclusion 
mechanism allowing virus particles to pass through the membrane and sieve out 
larger particles. Virus particles can also be concentrated from larger volume of 
samples for example, sea water using tangential flow filtration technique (Breitbart 
et al., 2002; Culley et al., 2006 and 2003). Cesium chloride density gradient ultra-
centrifugation has also been used for separation of virus particles from 
environmental and clinical samples (Breitbart and Rohwer, 2005). 
 
Virus particles remain protected inside the capsid from DNase digestion. Non-
particle protected cell free nucleic acids can be easily digested using enzyme such 
as; DNase I. Digestion of the cell free nucleic acids will improve selective 
amplification of viral nucleic acids. Allander et al., (2001) used a DNase treatment 
step in order to remove host DNA from serum samples prior to SISPA amplification 
and following this could detect new types of bovine parvoviruses. 
 
1.8.4 Next generation sequencing (NGS) 
Sanger sequencing is the original sequencing method used for determination of 
DNA sequences. Sanger sequencing method requires specifically labelled 
nucleotides and a specific primer to start read at a specific location. Different 
labels of each nucleotide are recorded at different levels for sequencing DNA. It is 
now possible to determine DNA of 1000-1200 bp through Sanger sequencing. 
Relatively longer DNA sequences can be determined through shotgun sequencing 
method. In this method genomic DNA is sheared into smaller fragments and 
cloned into suitable vectors. Cloned DNA fragments can be sequenced individually 
to determine the cloned sequences. Individual sequences can be aligned and 
reassembled based on the partial sequence overlap to obtain the complete DNA 
sequences. 
  
Next Generation Sequencing has been developed from shotgun sequencing using 
the philosophy of massive parallel sequencing (Venter et al., 2003; Margulies et 
al., 2005; Shendure et al., 2005). In NGS DNA template is randomly broken to 




smaller fragments and ligated to designated adapter sequences. These DNA 
fragments are synthesized and sequenced using a primer complementary to the 
adapter sequences. NGS is also termed as massively parallel sequencing. There 
are five types of NGS technologies commercially available for whole genome 
sequencing for example, Roche GS-FLX 454 Genome Sequencer, the Illumina 
Genome Analyzer, the ABI SOLiD analyzer, Polonator G.007 and the Helicos 
HeliScope platforms. The performance of these platforms for sequencing varies for 
the read lengths, error rates and error profiles compared to the Sanger 
sequencing. The read lengths for NGS are relatively shorter compared to the 
Sanger sequencing which can vary between 50 and 500 continuous basepair 
reads depending on the type of NGS platform used. The high throughput 
capacities of the NGS technology has increased the speed and reduced the 
overall cost for sequencing (Mardis, 2006, 2009; Schuster, 2008; Shendure and Ji, 
2008; Ng et al., 2009; Tucker et al., 2009; Metzker, 2010). 
 
1.9 High resolution melting (HRM) analysis 
HRM analysis depends on the melting behaviour of the post-PCR amplified DNA. 
Most of the nucleic acid amplification and identification techniques depend on the 
hybridization of sequence specific primers and probes for example, in real-time 
PCR, fluorescent in situ hybridization (FISH) and microarray analysis (Wittwer and 
Kusukawa, 2005). High resolution melting (HRM) of DNA is a newer approach for 
detection and characterisation of PCR products by melting them in the presence of 
a DNA saturating dye. The DNA saturating dye (such as EvaGreen) actively binds 
to the double stranded DNA and emits fluorescence. The amount of fluorescence 
increases with the increase in DNA concentration. However, the double stranded 
DNA will melt to single stranded DNA at a higher temperature releasing the 
intercalating dye from the DNA. This will cause a gradual decrease in the 
fluorescence due to the release of the dye bound to the double stranded DNA. If 
the change in the fluorescence is plotted against the change in temperature it will 
produce a characteristic curve for a specific sequence (Figure 1.5). The 
temperature at which 50% of the DNA melts is considered as the melting 




temperature (Tm) of the DNA. The value of Tm will depend on different factors for 
example, buffer composition and G+C content of the sequence. The Tm can be 
estimated using the formula; Tm = 2º C x (number of [A+T] + 4º C x (number of 
[G+C]). This melting pattern and the melting temperature of DNA can be utilised to 
determine the similarities and differences of different DNA sequences after HRM 
analysis. HRM analysis requires sophisticated technology for highly controlled 
temperature transition, data acquisition and software analysis to determine the 
variations in the amplified DNA. After analysis of the HRM data normalised 
fluorescence curves are generated for accurate detection of variations in the DNA 
sequences (Gundry et al., 2003). During normalisation, fluorescence signals 
generated from all samples are set within a range of 100% to 0% to help 
determining the similarities and differences of different sequences. The 
normalisation process will bring the similar sequences closer and move different 
sequences apart. The melting pattern of the PCR product depends on the inherent 
property of the DNA such as the length of DNA and GC content of the sequence. 
This DNA melting pattern can also vary with the other factors for example, buffer 
composition, DNA quality and concentration of the template DNA (Martín-Núñez et 
al., 2011; Taylor et al., 2001). Similar concentration of the DNA template should be 
used for PCR amplification to obtain similar concentrations of the amplified 
products so that they can be analysed using the same software with little variations 
in different samples. Very low concentrations of the template (CT value >30) may 
produce nonspecific products which may interfere with the HRM analysis. Different 
nucleic acid extraction methods may vary in the concentrations of inhibitors in the 
extracted nucleic acid templates which may produce false positive results 




































Figure 1.5: High resolution melting curve of DNA in the presence of DNA 
saturating dye. (A) melting curve before normalisation, (B) melting curve after 
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HRM technology has been applied in different types of assays including SNP 
genotyping, scanning for mutations in diseases and cancer related genes, DNA 
fingerprinting, species identification and genotyping (Martín-Núñez et al., 2011; 
Erali et al., 2008). HRM analysis was applied by Wittwer et al., (2003) for typing six 
common beta-globin genotypes (AA, AS, AC, SS, CC, and SC). HRM analysis was 
also used for the characterisation of short (38-50 bp) and large (600 bp) fragments 
of DNA. However, shorter fragments are more useful for accurate detection of 
mutations or variation in the sequences (Liew et al., 2004). The HRM technique 
has been applied for screening large fragments of DNA before sending them for 
sequencing.  
 
Provaznikova et al., (2008) applied HRM technology for screening myosin heavy 
chain 9 (MYH9) gene which avoided more than 85% of unnecessary sequencing 
of the MHY9 gene. The application of HRM analysis for SNP-typing is relatively 
cheaper and faster than PCR amplification and sequence analysis. Sensitivity of 
SNP typing can be increased by amplifying a smaller fragment of 80-100 bp. 
Addition of an unlabelled melt probe was found to be useful for determining 
homozygote variants in SNP typing in cancer patients (Nguyen-Dumont et al., 
2009; Zhou et al., 2008). Lately, HRM analysis has been used for epigenetic study 
for the diagnosis of disease states for example, inherited disorders and cancer 
(Egger et al., 2004). High resolution melting analysis of the amplified DNA can 
easily reflect on the methylation status of the original DNA template (Dahl and 
Guldberg, 2007). Unlike other types of HRM analysis the epigenetic study requires 
a bisulphite treatment for determination of methylation pattern. Bisulphite treatment 
converts unmethylated cytosines to uracil in the sequence. Consequently a 
thymine will be incorporated instead of uracil in the DNA sequence during PCR 
amplification. Bisulphite treatment will not be effective on methylated cytosines 
which will increase the GC content in the PCR product compared to the 
unmethylated sequences. Consequently, post-PCR high resolution melting 
analysis will show the differences between methylated and unmethylated 
sequences. HRM analysis has been used for screening methylation in the BRCA1 




gene promoter associated with breast cancer (Snell et al., 2008). HRM technology 
has also been used for determining the similarities and differences between 
different clonal sequences (Pepers et al., 2009). 
 
1.10 Aims and objectives of the present study  
Based on previous studies it has been observed that most respiratory tract 
infections are associated with viruses. A wide range of pathogens are associated 
with respiratory tract infections. It is difficult for even an experienced clinician to 
determine the causative agent of the infection based on clinical data alone 
therefore it is more useful to detect a panel of pathogenic microorganisms for 
accurate diagnosis of respiratory tract infections. Rapid developments in molecular 
techniques have improved the multiplex detection of pathogenic viruses of the 
respiratory tract. It is now possible to detect a panel of pathogenic viruses 
qualitatively and quantitatively in a single reaction (Sanghavi et al., 2011; Fan et 
al., 1998). Besides PCR-based techniques a large number of isothermal nucleic 
acid amplification techniques have also been introduced by different workers for 
multiplex detection of respiratory viruses (Wat et al., 2008; Lau et al., 2010). Loop-
mediated isothermal amplification (LAMP) and reverse transcription loop-mediated 
isothermal amplification (RT-LAMP) have been considered as commercial tests for 
diagnosis of viruses (Parida, 2008). Appropriate diagnosis of respiratory viruses 
using molecular methods is limited by technical complexity, cost and lack of 
validation and standardization of assays. Interpretation of reports can also be 
difficult due to the frequent co-infection caused by multiple viruses in the 
respiratory tract (Zhang et al., 2011). However, the development of alternate new 
molecular methods for multiplex detection of respiratory viruses can help accurate 
detection pathogenic viruses for the control of spread and intervention of infections 
caused by pathogenic viruses of the respiratory tract.  
 
In this thesis a systematic study was conducted to evaluate the isothermal 
amplification of nucleic acids to enrich the template concentration to enhance the 
molecular detection of pathogenic viruses. A novel protocol was developed by 




combining reverse transcription and Bst DNA polymerase amplification to enrich 
the copy number of cDNA to increase sensitivity of molecular detection by PCR. A 
laboratory based study was conducted to evaluate the use of RT-Bst technique on 
known RNA virus genomes for example, bacteriophage MS2 and hRSV. This 
novel protocol was applied on seventy patient samples to evaluate the applicability 
of RT-Bst PCR compared to other molecular tests such as one-step RT-PCR and 
immunofluorescence. RT-Bst PCR was further modified for the development of a 
novel, low-cost and simple protocol for whole genome amplification of RNA viruses 
as an alternate to sequence independent single primer amplification (SISPA). 
Screening the whole genome amplification library using the sequencing or 
immunoscreening technique is laborious and expensive. In this study high 
resolution melting (HRM) analysis was used to demonstrate its application as an 
alternative and cheaper method for screening library sequences. HRM analysis 
was also used to demonstrate its application for rapid detection and identification 










2.1 Viral and bacterial stocks and patient samples used in this 
study 
2.1.1 Viral stocks used in this study 
Bacteriophage lambda (a gift from Professor Anne Moir, University of Sheffield) 
and MS2 (DSMZ, Braunschweig, Germany) were used as controls for DNA and 
RNA viruses, respectively (Mahony et al., 2007). Stocks of influenza B, 
parainfluenza 2, human respiratory syncytial viruses (tissue culture extracts) were 
used as positive control samples for assays which will be described in the results 
section. These virus stocks were kindly provided by Jeremy Bishop, St. Mary’s 
Hospital, Imperial College London, UK.  
   
2.1.2 Bacterial stocks used in this study 
Bacterial strains used in this study were Staphylococcus aureus and chemically 
competent Escherichia coli, XL1-Blue. S. aureus DNA was added to bacteriophage 
lambda DNA to mimic the undesired DNA present in clinical samples and set up 
assays. Commercially available chemically competent E coli XL1-Blue (Agilent 
Technology, Edinburgh, UK) cells were used for transformation of cloned plasmids 
(Table 2.1). 
 
Table 2.1: Bacterial strains used in this study 
Strain Genotype/phenotype Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacIqZΔ M15 Tn10 (Tetr)] 
Agilent Technology, 
Edinburgh, UK 
SA-1 Staphylococcus aureus Laboratory stocks 




2.1.3 Patient samples used in this study 
Patient sample were collected from Dr Mark Atkins, Department of Virology, 
Chelsea and Westminster Hospital for this study after obtaining ethical approval 
from the University of Westminster, London, UK (App. No. 09/10/07, Date: 
28/04/2010) and the NHS. For the latter, ethical approval was granted following an 
application via the Integrated Research Application System Proportionate Review 
scheme (reference 10/H0808/50). Nasopharyngeal swabs were collected by 
physicians during their routine diagnosis of patients reporting to hospital. Only 
excess residual samples were provided after being anonymised by Dr Mark Atkins 
as part of this study. A total of 70 samples were analysed in this study which is 
further described in chapter 5.  
 
2.2 DNA, RNA and plasmid stocks used in this study 
Commercially available purified DNA of bacteriophage lambda () (Invitrogen, 
Paisley, UK or Fermentas, York, UK) and RNA of bacteriophage MS2 (Roche 
Applied Biosciences, Burgess Hill, UK) were used to set up different assays as 
described in the following chapters (Chapter 3-7). Bacteriophage  DNA was used 
as a representative of double stranded DNA (48.0 kb). Reverse transcribed cDNA 
from MS2 RNA (3.6 kb) was used as a representative of single stranded DNA. 
Two plasmids pUC18 (2.6 kb) and , pKEYE (8.6 kb), provided by Dr Rebecca 
Smith, University of Leicester were used as representative of circular double 
stranded DNA. 
Alternatively, carrier RNA provided with the QIAamp Viral RNA mini kit was added 
to a known RNA (MS2 RNA) to mimic the presence of undesired RNA in clinical 
samples. Specific details on how the assays were set up are elaborated in the 
results section. 
 




2.3 Reagents and solutions 
All solutions were prepared using deionized water produced from a Milli-Q water 
purification system (Millipore, Watford, UK). Solutions were sterilized by 
autoclaving at 121 ºC for 15 minutes. Ethanol (99.9%), isopropanol (99.5%), acetic 
acid (99%) and hydrochloric acid (32%) were purchased from Fisher Scientific, 
Loughborough, UK. The common reagents for example, ethidium bromide, sodium 
acetate (3.0 M, pH 5.0), ethylene diamine tetraacetic acid (0.5 M, pH8.0), 50X tris 
acetate and dNTPs were prepared following the protocol described in Sambrook et 
al., (1989).  
 
2.4 Media and antibiotics 
Luria-Bertani agar media containing kanamycin (30 µg ml-1) was also prepared 
following standard methods (Sambrook et al., 1989). 
 
2.5 Plaque assay and quantification of virus 
Concentration of bacteriophage lambda () particles in the stock was determined 
according to the protocol provided in the laboratory manual of Sambrook et al., 
(1989). Briefly, Escherichia coli XL1-Blue cells (Table 2.1) were propagated 
overnight at 37º C at 200 revolutions per minute (rpm) in Luria-Bertani (LB) broth. 
Maltose, 0.2% (w/v) and 10 mM MgSO4 were added to the media to induce 
receptors for bacteriophage lambda particles. E. coli cells containing broth media 
were diluted to a concentration to have an optical density (OD) of 0.5 at 600 nm 
wavelength. An equal volume (50 µl) of E coli suspension and bacteriophage 
lambda particles were mixed, added to 10 ml of top agar media (0.8% w/v agarose) 
at 55º C and poured on to the Luria-Bertani agar plate. Plates were incubated 
overnight at 37º C to allow plaque formation. After overnight incubation at 37º C 




the surface of the LB agar plate will show confluent growth of E. coli cells if they 
are not infected by any  phage. If there is one  phage particle it will infect and 
lyse E. coli cell and produce a clear zone of no growth on the plate, known as a 
plaque. The number of plaques will represent the number of bacteriophage  
particles in the tested sample. 
 
2.6 Nucleic acid analysis 
2.6.1 Agarose gel electrophoresis 
Dehydrated, molecular grade agarose was obtained from Web scientific, Crewe, 
UK to prepare either 1.5 % (w/v) or 1% (w/v) agarose gels in 1X TAE buffer. All 
PCR products were run on a 1.5% (w/v) agarose gel for separation of individual 
band. Plasmids were electrophoresed on 1% (w/v) agarose gel to determine the 
size of the plasmids. Gels were stained in 1X TAE buffer containing 0.5 µg ml-1 
ethidium bromide for 15 minutes before visualizing using a gel imaging system 
UVIPRO (UVITEC, Cambridge, UK). Gel images were presented in the result 
section either choosing normal or inverted depending on which gave the clearest 
image.  
DNA samples were mixed with 1:5 volume of loading dye before loading into the 
well in the agarose gel. All PCR product sizes were determined by comparing their 
relative sizes with those of 100 bp DNA ladder. A 1 kb DNA ladder was used to 
determine the size of the plasmids in this study. Both 100 bp and 1 kb DNA 








2.6.2 Quantification of nucleic acids 
2.6.2.1 Quantitation of DNA using NanoDrop  
Concentrations of different structures of DNA, purified PCR products and plasmids 
were quantified by measuring the optical density at 260 nm using a Nano Drop 
1000 spectrophotometer (Thermo Scientific, Horsham, UK). The purity of DNA 
samples was determined from the ratio of the absorbance in the 
spectrophotometer at A260nm/A280nm. Pure preparations of DNA have ratios between 
1.8 and 2.0. In cases of any significant contamination such as from protein or 
phenol, the ratio will be lower.  
 
2.6.2.2 Quantitation of amplified DNA using Picogreen dye 
Quant-iT PicoGreen dsDNA reagents and kit (Invitrogen, Paisley, UK) were used 
to determine the concentration of DNA both before and after phi29 DNA 
polymerase amplification (Section 3.4). Picogreen dye binds only to double 
stranded DNA and as a result emits fluorescence (520 nm) when they are excited 
with light (480 nm). The amount of fluorescence emitted is proportional to the 
concentration of DNA in the sample. This kit contains a stock of bacteriophage  
DNA (100 µg ml-1) which acts as a reference, 20X TE buffer and concentrated 
picogreen dye for preparation of standard curves. 
Bacteriophage  DNA was diluted at concentration of 400 ng ml-1, 200 ng ml-1, 100 
ng ml-1, 50 ng ml-1 and 25 ng ml-1 in 1X TE buffer (10 mM Tris-HCl, 1 mM EDTA, 
pH 7.5) provided with the kit. Picogreen dye was freshly prepared by diluting 
(1:200) in 1X TE buffer. An equal volume (50 µl) of  DNA was added to picogreen 
dye in a MicroWell plate (Fisher Scientific, Loughborough, UK). The fluorescence 
generated from the sample in the MicroWell plate (Fisher Scientific, Loughborough, 
UK) was measured in a fluorescence microplate reader. The samples were excited 




at 480 nm to determine the fluorescence emission at 520 nm using 
spectrophotometer. The fluorescence reading of the dilution series of  DNA was 
plotted against their respective concentrations to obtain a standard curve. The 
fluorescence reading of test samples was plotted on the standard curve to 
determine their concentration. 
 
2.6.3 Extraction of virus genomes 
Bacteriophage lambda DNA was extracted using the QIAamp DNA Mini kit 
(QIAGEN, Crawley, UK). Briefly, 100 µl of sample was mixed with 100 µl of lysis 
buffer (AL), incubated for 10 minutes at room temperature and 100 µl of ethanol 
(96-100%) was added and mixed gently for 15 seconds. This mixture was loaded 
into a spin column and centrifuged at 6000 x g  for 1 minute to bind DNA to the 
column. This column was washed by passing 500 µl of wash buffer AW1 and AW2 
at 6000 x g  for 1 minute and 20000 x g  for 3 minute respectively. DNA was eluted 
with 100 µl of AE buffer. 
Viral RNA was extracted with either the QIAamp DNA Mini kit or QIAamp Viral 
RNA Mini Kit (QIAGEN, Crawley, UK). Carrier RNA (100 nanograms) was added 
to 400 µl of buffer AVL either from the provided RNA in the QIAamp Viral RNA Mini 
Kit or commercially available MS2 RNA (Roche Applied Biosciences, Burgess Hill, 
UK). Carrier RNA was added to the buffer in order to protect RNA from 
degradation and improve the binding and recovery of small amount of RNA from 
the column. 100 µl of nasopharyngeal sample was mixed with buffer AVL 
containing carrier RNA, incubated for 10 minutes at room temperature and mixed 
with ethanol (96-100%). This mixture was loaded into a QIAamp Mini column and 
centrifuged at 6000 x g for 1 minute to bind RNA to the column. This column was 
washed by passing 500 µl of buffer AW1 centrifuging at 6000 x g for 1 minute. This 
column was washed again with buffer AW2 centrifuging at 20000 x g  for 3 minutes. 
RNA was eluted with 60 µl of AVE buffer. 




Extracted nucleic acids were used immediately either for PCR, one step RT-PCR 
or RT-Bst amplification (Section 2.6.6). Any remaining nucleic acids were aliquoted 
into PCR tubes and stored at -80 ºC for future use. 
 
2.6.4 Reverse transcription and preparation of cDNA 
Complementary DNA was prepared from commercially available MS2 RNA (Roche 
Applied Biosciences, Burgess Hill, UK), using the 1st strand synthesis kit (NEB, 
Hitchin, UK) or QuanTitect reverse transcription kit (QIAGEN, Crawley, UK).  
For 1st strand synthesis kit (NEB, Hitchin, UK), 5 µl of RNA was mixed with 1 µl of 
random primer (oligo dN9, 15 µM) and 2 µl of dNTP mix (2.5 mM each), heated for 
5 minutes at 70 C and cooled on ice for denaturation of RNA and hybridisation of 
the primers. 1 µl of 10X RT buffer, 0.5 µl of RNase inhibitor (10 units µl-1) and 0.5 
µl of M-MuLV reverse transcriptase (25 units µl-1) were added to 8 µl of denatured 
RNA from previous step and incubated at 42 C for 1 hour. Enzymes were 
inactivated at 95 C for 5 minutes.  
In case of QuantiTect reverse transcription kit 7 µl of RNA was added to 0.5 µl of 
Quantiscript reverse transcriptase, 2 µl of 5X Quantiscript RT buffer  and 0.5 µl of 
RT primer mix and incubated for 15 minutes at 42 C. The reaction was inactivated 
at 95 C for 3 minutes. 
Freshly prepared cDNA was used for PCR amplification and any excess was 
aliquoted into PCR tubes and stored at -80 C for future use. 
 
2.6.5 OneStep RT-PCR 
Reverse transcription for preparation of cDNA from RNA and PCR amplification of 
target sequences are two separate reactions. If these two steps are performed 




separately, it is called two-step RT-PCR. On the other hand if reverse transcription 
and PCR amplification are combined in the same tube it is called one-step RT-
PCR. The OneStep RT-PCR kit (QIAGEN, Crawley, UK) was used for detection 
of RNA viruses in this study.  
 
2.6.5.1 OneStep RT-PCR (multiplex) 
Three multiplex one step RT-PCR reactions were set up for detection of 12 
common pathogenic viruses of the respiratory tract (Table 2.4). Multiplex 1 was set 
up for hRSV, influenza A, influenza B and hMPV; multiplex 2 was set up for 
parainfluenza 1-4; multiplex 3 was set up for hRV, HCoV 229E, HCoV OC43 and 
influenza C respectively. In case of multiplex reactions equimolar concentration of 
four sets of primers were added for detection of 4 viruses in multiplex 1, 2 and 3. 
An additional set of RT-PCR reactions was set up for detection of an internal 
control, MS2 RNA. Primer sets were selected from published papers (Table 2.4) 
and checked by bioinformatics analysis before use. The reaction mix was set up 













Table 2.2: One-step RT-PCR mix for multiplex 1, 2 and 3  
Reaction component Multiplex 1 and 3* Multiplex 2* 
Nuclease free water 0.5 µl 2.3 µl 
5X RT buffer 3.0 µl 3.0 µl 
dNTP (10 mM each) 0.6 µl 0.6 µl 
Primer, forward 10 µM (0.75x4=) 3.0 µl 3.0 µl 
Primer, reverse 10 µM (0.75x4=) 3.0 µl 3.0 µl 
One step RT enzyme mix 0.6 µl 0.6 µl 
Q solution 1.8 µl 0.0 µl 
RNA 2.5 µl 2.5 µl 
Total= 15.0 µl 15.0 µl 
*Primer sets were selected from table 2.4 for multiplex 1, 2 and 3 
 
PCR cycling: RT-PCR was initiated with 30 minutes at 50 ºC with reverse 
transcription reaction step followed by heat activation of hot start Taq polymerase 
at 94 ºC for 15 minutes. Then the thermal cycler was programed for 40 cycles, 94 
ºC for 30 seconds, 55 ºC for 30 seconds and 72 ºC for 1 minute. A final extension 
step was performed at 72 ºC for 10 minutes. The annealing temperature for 
multiplex 1, 2 and internal control was 55 ºC for 30 seconds whereas annealing 
temperature for multiplex 3 was 58 ºC for 30 seconds (Bellau-Pujol et al., 2005).  
 
2.6.5.2 One-step RT-PCR (singleplex):  
One step RT-PCR reactions (singleplex) were set up according to table 2.3 for 
amplification and detection of internal control MS2 RNA or any single virus. If any 
reaction was positive for virus sequences after multiplex one-step RT-PCR 
amplification, the assay was repeated using one set of primers corresponding to 
each virus in a singleplex one-step RT-PCR reaction. 




Table 2.3: One step RT-PCR mix (singleplex)   
Reaction component Reaction volume 
Nuclease free water 6.8 µl 
5X RT buffer 3.0 µl 
dNTP (10 mM each) 0.6 µl 
Primer, forward 10 µM 0.75 µl 
Primer, reverse 10 µM 0.75 µl 
One step RT enzyme mix 0.6 µl 
Q solution 1.8 µl 
RNA 2.5 µl 


















Table 2.4: Primers used for multiplex 1, 2 and 3 
Virus Primer 
name 





hRSV vrs P1 5’-GGAACAAGTTGTTGAGGTT 
TATGAATATGC-3’ 
Nucleocapsid 279 Cane and 
Pringle 
(1991) vrs P2 5’-TTCTGCTGTCAAGTCTAGT 
ACACTGTAGT-3’ 
Influenza A mia 1 5’-CAGAGACTTGAAGATGTCT 
TTGCTGG-3’ 
Matrix protein 212 Donofrio et 
al. (1992) 
mia 2 5’-GCTCTGTCCATGTTATTTG-3’ 
Influenza B Mib 1 5’-AAAATTACATGTTGGTTCG GTG-3’ Matrix protein 362 Donofrio et 
al. (1992) Mib 2 5’-AGCGTTCCTAGTTTTACT TG-3’ 
hMPV hmpv1 5’-CCCTTTGTTTCAGGCCAA-3’ Matrix protein 416 Donofrio et 
al. (1992) hmpv2 5’-GCAGCTTCAACAGTAGCTG-3’ 
Multiplex 2 
Parainfluenza 1 PIS1+ 5’-CCGGTAATTTCTCATACCT ATG-3’ Haemagglutinin-
Neuraminidase  
317 Echevarria 
et al. (1998) PIS1- 5’-CCTTGGAGCGGAGTTGTT AAG-3’ 
Parainfluenza 2 PIP2+ 5’-AACAATCTGCTGCAGCAT TT-3’ Haemagglutinin-
Neuraminidase 
507 Echevarria 
et al. (1998) PIP2- 5’-ATGTCAGACAATGGGCAA AT-3’ 
Parainfluenza 3 Para 3.1 5’-CTCGAGGTTGTCAGGATA TAG-3’ Haemagglutinin-
Neuraminidase 
189 Karron et al. 
(1994) Para 3.2 5’-CTTTGGGAGTTGAACACAG TT-3’ 
Parainfluenza 4 PIP4+ 5’-CTGAACGGTTGCATTCAG GT-3’ Phosphoprotein 451 Aguilar et al. 
(2000) PIP4- 5’-TTGCATCAAGAATGAGTC CT-3’ 
Multiplex 3 
h RV SRHI1 5’-GCATCIGGYARYTTCCACC 
ACCANCC-3’ 
VP4/VP2/5’NC 549 Savolainen 
et al. (2002) 
SRHI2 5’-GGGACCAACTACTTTGGG 
TGTCCGTGT-3’ 
HCoV 229E MD1 5’-TGGCCCCATTAAAAATGT GT-3’ Gene M 573 Vabret et al. 
(2001) MD3 5’-CCTGAACACCTGAAGCCA AT-3’ 
HCoV OC43 MF1 5’-GGCTTATGTGGCCCCTTA CT-3’ Gene M 335 Vabret et al. 
(2001) MF3 5’-GGCAAATCTGCCCAAGAA TA-3’ 




485 Zhang and 
Evans 
(1991) CHAD 5’-CCTGACAGCAACTCCCTC AT-3’ 
Internal controls 
GAPDH GAPDH1 5’-TCATCCATGACA 
ACTTTGGTATCGTG-3’ 
GAPDH 564 Gueudin et 
al. (2003) 
GAPDH2 5’-CTCTTCCTCTTGTGCTCT TG-3’ 
MS2 MS2-F 5’-CTGGGCAATAGTCAAA-3’ MS2 genome 314 Dreier et al. 
(2005) MS2-R 5’-CGTGGATCTGACATAC-3’ 
  




2.6.6 Nucleic acid amplification 
2.6.6.1 RT-Bst amplification 
RT-Bst is a novel protocol developed in this study by combining reverse 
transcription and Bst DNA polymerase amplification in the same reaction. Unlike 
other reverse transcription reactions, RT-Bst will not only synthesize cDNA from 
RNA template but also amplify it. It is envisaged that RT-Bst amplification of cDNA 
will amplify the template (cDNA) concentrations above the normal detection level 
of PCR methods used in the diagnostic laboratories. This will possibly improve the 
sensitivity of PCR detection of samples containing very low concentration of RNA 
template (under the normal detection limit). RT-Bst amplification was carried out 
according to Table 2.5. RNase inhibitor and premium reverse transcriptase was 
obtained from Fermentas, York, UK. Bst DNA polymerase was obtained from 
Cambridge Biosciences, Cambridge, UK. 
 
Table 2.5: RT-Bst reaction mix for preparation of cDNA 
Reaction component Reaction volume 
Nuclease free water 3.85 µl 
10X RT buffer 1.0 µl 
N15 random primer (10 µM) 1.0 µl 
dNTP (10 mM each) 0.5 µl 
RNase inhibitor (40.0 U µl-1) 0.25 µl 
Premium reverse transcriptase (200 U µl-1) 0.5 µl 
Bst DNA polymerase (8.0 U µl-1) 0.4 µl 
Template RNA 2.5 µl 
Total= 10.0 µl 
 
The RT-Bst reaction was incubated at 25 ºC for 10 minutes for hybridization of the 
random primer, 50 ºC for 30 minutes for reverse transcription and 60 ºC for 1 hour 




for Bst DNA polymerase amplification. Following this, the reaction was heat 
inactivated at 85 ºC for 5 minutes. After RT-Bst amplification 1 to 2 µl of cDNA was 
added to 20 µl of hot start Taq PCR reaction as described in section 2.6.7 for 
detection of viruses for multiplex 1, 2, 3  and internal control (MS2 RNA).  
 
2.6.6.2 REPLIg amplification of DNA 
Nucleic acids were amplified using the REPLIg kit (QIAGEN, Crawley, UK) 
following the protocol provided by the manufacturer. Briefly 2.5 µl of DNA sample 
was added to 2.5 µl of D1 (denaturation) buffer, mixed gently, centrifuged briefly 
and incubated at room temperature for 3 minutes. 5 µl of N1 (neutralization) buffer 
was added to the sample, mixed gently and centrifuged briefly. 40 µl of DNA 
polymerase master mix was added to the 10 µl of denatured DNA and incubated 
at 30 ºC for 16 hours using a thermocycler. REPLIg DNA polymerase was 
inactivated at 65º C for 3 minutes. REPLIg amplicons were diluted 1:20 and 2 µl 
was added as template in 20 µl of PCR reaction.  
 
2.6.7 HotStarTaq PCR 
HotStarTaq PCR reaction was used for multiplex detection of 12 respiratory tract 
viruses from RT-Bst amplified products in 3 multiplex reactions to compare this 
result with multiplex one-step RT-PCR reaction for any improvement in detection. 
Multiplex 1 was set up for hRSV, influenza A, influenza B and hMPV; multiplex 2 
was set up for parainfluenza 1-4; multiplex 3 was set up for hRV, HCoV 229E, 
HCoV OC43 and influenza C. In case of multiplex reactions equimolar 
concentrations of four sets of primers were added for detection of 4 viruses in each 
multiplex 1, 2 and 3. An additional set of HotStarTaq PCR reactions was set up 
for detection of an internal control, MS2 RNA. Primer sets were selected from 




published papers (Table 2.4) and the reaction mix (Bellau-Pujol et al., 2005) was 
set up as described in Table 2.6. HotStarTaq polymerase was obtained from 
QIAGEN, Crawley, UK.  
 
2.6.7.1 Multiplex HotStarTaq PCR reactions 
Multiplex HotStarTaq PCR was set up for detection of 12 common respiratory 
tract viruses in three separate multiplex reactions using RT-Bst amplified product 
as template (Section 2.6.7). Primer sets were selected from published papers 
(Table 2.4) and the reaction mix was set up as described in tables 2.6 and 2.7. 
 
Table 2.6: HotStarTaq PCR mix for multiplex 1, 2 and 3  
Reaction component Multiplex 1 and 3* Multiplex 2* 
Nuclease free water 3.9 µl 6.3 µl 
10X PCR buffer 2.0 µl 2.0 µl 
MgCl2 (15 mM) 1.2 µl 1.2 µl 
dNTP (10 mM each) 0.4 µl 0.4 µl 
Primer, forward 10 µM (1.0x4=) 4.0 µl 4.0 µl 
Primer, reverse 10 µM (1.0x4=) 4.0 µl 4.0 µl 
HotStarTaq DNA polymerase (5.0 U µl-1) 0.1 µl 0.1 µl 
Q solution 2.4 µl 0.0 µl 
Template 2.0 µl 2.0 µl 
Total= 20.0 µl 20.0 µl 
*Primer sets were selected from table 2.5.1.3 for multiplex 1, 2 and 3 
PCR cycling: PCR was initiated by heat activation of HotStarTaq polymerase at 
94 ºC for 15 minutes. Then the thermal cycler was programed for 40 cycles, 94 ºC 
for 30 seconds, 55 ºC for 30 seconds or 58 ºC for 30 seconds and 72 ºC for 1 
minute. A final extension was performed at 72 ºC for 10 minutes. The annealing 




temperature for multiplex 1, 2 and internal control was 55 ºC for 30 seconds 
whereas annealing temperature for multiplex 3 was 58 ºC for 30 seconds (Bellau-
Pujol et al., 2005).  
 
2.6.7.2 HotStarTaq PCR (singleplex) 
Singleplex HotStarTaq - PCR reaction was set up for detection of the internal 
control, MS2 RNA using RT-Bst amplified product as template (Table 2.7). In 
cases when more than one virus appeared positive in multiplex HotStarTaq PCR, 
detection of each virus was repeated using singleplex HotStarTaq PCR using 
single primer sets for each virus. This singleplex HotStarTaq PCR reaction was 
also used for all other PCR reactions for setting up assays in chapter 3-6, unless 
stated otherwise.  
 
Table 2.7: HotStarTaq PCR mix (singleplex)   
Reaction component Reaction volume 
Nuclease free water 9.9 µl 
10X PCR buffer 2.0 µl 
MgCl2 (15 mM) 1.2 µl 
dNTP (10 mM each) 0.4 µl 
Primer, forward 10 µM  1.0 µl 
Primer, reverse 10 µM 1.0 µl 
HotStarTaq DNA polymerase 0.1 µl 
Q solution 2.4 µl 
Template 2.0 µl 
Total= 20.0 µl 
 




PCR cycling: PCR was started with heat activation of HotStarTaq polymerase at 
94 ºC for 15 minutes. Then the cycler was set for 40 cycles, 94 ºC for 30 seconds, 
55 ºC for 30 seconds and 72 ºC for 1 minute. Final extension was 72 ºC for 10 
minutes.  
 
2.6.8 Cloning PCR products using the TOPO TA cloning kit 
PCR products were prepared for TA cloning by including a final extension step at 
72 ºC for 7-10 minutes after the PCR cycle to generate a 3’ adenine overhangs. 
On the other hand linearized vectors supplied with the kit contain 3’ 
deoxythymidine (T) residues. This will allow PCR inserts to ligate efficiently with 
the vector with Topoisomerase I. PCR products were purified (Section 2.6.11) 
before TA cloning. TOPO TA cloning was performed using the TOPO TA cloning 
kit (Invitrogen, Paisley, UK). Briefly, 4 µl of purified PCR product was mixed with 1 
µl of salt solution and 1 µl of TOPO vector and incubated at room temperature for 
5 minutes for cloning the PCR insert. Chemically competent Escherichia coli XL1-
Blue (Agilent Technology, Edinburgh, UK) cells were used for transformation of 
this cloned product. A total of 2 µl of TOPO cloning reaction was added to 40 µl of 
chemically competent Escherichia coli XL1-Blue cells and incubated on ice for 30 
minutes. The tube containing cells was heated briefly for 45 seconds in a heating 
block at 42º C and immediately transferred to ice. A total of 200 µl of LB broth was 
added to the cell mixture and incubated at 37º C for 1 hour at 200 revolutions per 
minute (rpm). A total of 50 µl of broth was spread on LB agar plates containing 
kanamycin (30 µg ml-1). Plates were incubated at 37º C overnight to allow the 
transformed cells to grow. Colonies were picked randomly and screened for the 
presence of the insert by colony PCR (Section 2.6.9).   
 
 




2.6.9 Colony PCR 
Colony PCR technique was used to screen colonies from kanamycin LB agar 
plates for confirmation of cloning and transformation. A portion of a bacterial 
colony was resuspended in 200 µl of sterile distilled water and heated at 95 ºC for 
15 minutes. Heated cells were then centrifuged for 5 minutes at 20000 g to pellet 
the debris. Finally, 2 µl of supernatant was used as template for PCR reaction 
(Section 2.6.7.2). Colonies showing the predicted size of the PCR products were 
further analysed by plasmid extraction (Section 2.6.10) and sequencing (Section 
2.7). 
 
2.6.10 Plasmid extraction 
Colonies which gave the anticipated sized product by PCR (Section 2.6.9) were 
propagated in LB broth containing kanamycin (30 µg µl-1) overnight at 37 ºC at 250 
revolutions per minute. LB broth containing the cells was used for plasmid 
extraction using the PureLink™ Quick Plasmid Miniprep Kit (Invitrogen, Paisley, 
UK). Briefly, 1-5 ml of overnight culture was centrifuged at 20000 g to pellet cells 
and remove all medium from cell pellet. Cell pellet was suspended completely in 
resuspension buffer (B3) with RNase A. 250 µl of lysis buffer (L7) was added to 
cells and mixed gently and incubated for 5 minutes at room temperature. A total of 
350 µl of precipitation buffer was added and mixed thoroughly to produce a 
homogenous solution. The mixture was centrifuged at 12000 g for 10 minutes at 
room temperature to clarify the lysate from debris. Supernatant was loaded into a 
spin column and centrifuged at 12000 g for 1 minute to bind the plasmid to the 
column. The spin column was washed with 700 µl wash buffer (W9) by loading 
and centrifuging the column at 12000 g for 1 minute. The column was centrifuged 
for additional 1 minute at 12000 g to remove any residual wash buffer. Plasmid 
was eluted with 50 µl elution buffer (Tris-HCl, pH 8.5) by centrifuging at 12000 g 
for 1 minute. Purified plasmids were sequenced as described in section 2.7. 




2.6.11 PCR product purification 
PCR products were purified using QIA-quick PCR purification kit (QIAGEN, 
Crawley, UK) following the manufacturer’s instructions. Briefly, 100 µl of buffer PB 
were added to 20 µl of PCR product and mixed gently. A total of 10 µl of 3 M 
sodium acetate was added to the mixture in order to drop the pH of the solution 
<7.5. An acidic pH of the solution will improve binding of the DNA to the column. 
The change in pH can be determined from the change in the colour of the solution 
to yellow. The solution was passed through the QIAquick column by centrifuging 
for 30-60s so that the DNA can bind to the column. Columns were washed with 
750 µl of PE buffer to remove any contaminants or inhibitors from the solution. 
DNA was eluted from the column with 50 µl of EB buffer. Purified PCR products 
were either used for cloning (Section 2.6.8) or sent for DNA sequencing (Section 
2.7). 
 
2.6.12 Gel extraction of PCR product 
Individual PCR bands were excised from the gel using a scalpel and purified using 
the QIAquick gel extraction kit (QIAGEN, Crawley, UK) following the protocol 
provided by the manufacturer. Briefly, DNA band was excised from the agarose 
gel using a clean scalpel and weighed in an electronic balance. 3 volume of QX1 
buffer and 2 volume of H2O were added to the gel containing DNA. 10 µl of QIAEX 
II particle was added to the solution. The agarose was dissolved in the buffer QX1 
by heating at 50 C for 10 minutes and vortexing the tube. 10 µl of 3M sodium 
acetate was added to the solution to reduce the pH to below 7.5. An acidic pH 
helps binding the DNA to the QIAEX II particles. The sample was centrifuged for 
30 seconds to pellet the QIAEX II particle from the solution. The pellet was washed 
with 500 µl of QX1 and 500 µl of PE buffers and dried for 10-15 minutes at room 
temperature followed by elution in 20 µl of 10 mM Tris-HCl, pH 8.5. 




2.7 DNA sequencing 
Prepaid barcodes were used to send DNA samples to GATC Biotech Ltd. (London, 
UK) for Sanger sequencing at. 20 µl of purified PCR product (20 ng µl-1) or purified 
plasmid containing the insert (100 ng µl-1) was sent in 1.5 ml eppendorf tube to the 
collection point of GATC Biotech, London. Either forward or reverse primer (20 µl) 
corresponding to the PCR product was sent with the purified PCR product for 
sequencing. M13 forward (5’-TGTAAAACGACGGCCAGT-3’) or M13 reverse (5’-
CAGGAAACAGCTATGACC-3’) primers were selected from the GATC website for 
sequencing purified plasmids. 
 
2.8 Sequence analysis 
Any DNA sequence received from GATC Biotech Ltd was further analysed using 
the Basic Local Alignment Search Tool for nucleotide (BLASTn) 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) available in the NCBI sequence database to 
determine sequence homology. The BLASTn tool searches the nucleotide 
database using an internet-based nucleotide query. Once the query is sent, the 
program searches the NCBI database and servers, and the results are posted in 
the same browser window in the chosen format. The window will show some 
results for example, maximum score, total score, query coverage, maximum 
identity and the expect (E) value. It is possible to determine by how much the 
query sequence is similar to other sequences in the existing database after such 
analysis. E value is a statistical value generated after the search for similarity of 
sequences. The E value is also considered as the statistical significance of a 
match. A default threshold for matching the sequence against the database can be 
set during the sequence search which is 10. The default value for expect threshold 
is 10 because it is highly unlikely to find such 10 matches by chance. In BLASTn 
analysis the lower the E value the more significant the sequence similarity is.   
 




Similar sequences were further analysed using multiple sequence alignment 
program CLUSTALW (http://www.ebi.ac.uk/Tools/msa/clustalw2/) to determine the 
identity amongst the similar sequences. In this analysis DNA sequences are 
entered in one of the supported format for example, FASTA format having 
annotated properly. Nucleotide sequences are submitted online for multiple 
sequence alignment of the similar sequences. Sequence analysis results of 10 
clones selected from the whole genome library prepared from MS2 RNA and 
tissue culture sample positive for hRSV and influenza B using CLUSTALW are 






Evaluation of phi29-amplification 
of different structural 
conformations of DNA 




3.1 Introduction and aims  
The recent development in molecular biology has revolutionized the clinical 
diagnosis of infectious diseases. Nucleic acid-based detection of pathogenic 
microorganisms has been shown to be more sensitive and specific compared to 
traditional methods (Templeton et al., 2004). Many new virus types have also been 
discovered or characterized in the last two decades with the advent of molecular 
techniques. For example, Allander et al. (2007) identified human polyomavirus 
using a sequence independent single primer amplification (SISPA) technique and 
Lambden et al., (1992) detected a non-cultivatable human rotavirus using the 
SISPA technique. Extraction of nucleic acids from clinical samples is a bottleneck 
for the detection of specific sequences by PCR. The nucleic acid extraction 
process is usually rigorous, lengthy and involves multiple steps such as, cell lysis 
using alkali and/or heating, centrifugation to separate cell debris and column 
purification. The nucleic acid extraction process is also associated with significant 
loss of template and integrity of the nucleic acids of pathogenic microorganisms 
present in the original sample. This reduced concentration and poor integrity of 
nucleic acids often leads to lower sensitivity of detection of any pathogenic 
microorganisms by PCR (Wilson, 1997).  
PCR is a very sensitive molecular method which can be used for the specific 
detection of pathogenic microorganisms (Vosberg, 1989). However, very low copy 
numbers of nucleic acids at femtogram levels are often not detected by PCR from 
complex samples such as samples containing various types of cDNA due to the 
“Monte Carlo effect” (Karrer et al., 1995; Schloss et al., 2003). This is defined as 
an inherent limitation of the PCR technique for detection of a target sequence from 
small amount of any complex template such as samples containing different types 
and sizes of cDNA. This limitation of PCR arises due to small and random 
differences in amplification efficiency between individual templates in the 
amplifying reaction, leading to false negative results. Amplification of nucleic acid 
from very low concentrations of template using whole genome amplification 




techniques (Section 1.8.2) may alleviate these problems by increasing the 
template concentration for subsequent detection by PCR. 
There are broadly two types of whole genome amplification methods available for 
amplification of nucleic acids, PCR and non-PCR based techniques (Section 1.5.8 
and 1.6). PCR-based amplification is often biased; preferentially amplifying some 
portions of the genomes over others, compared to non-PCR based whole genome 
amplification (Hosono et al., 2003; Dean et al., 2002). Certain factors may 
contribute towards amplification bias, such as priming efficiency, template 
accessibility and GC content (Dean et al., 2002). Moreover, most of the PCR-
based whole genome amplified products contains amplification artefacts due to the 
non-specific priming such as from degenerate primers and amplification of non-
specific DNA (Cheung and Nelson, 1996).  In a previous study, Dean et al. (2002) 
amplified a human genome using degenerate oligonucleotide-primed (DOP) PCR 
and multiple displacement amplification (MDA) method (Section 1.8.2) to compare 
the amplification bias, loss of certain loci during amplification, using these PCR-
based and non-PCR based whole genome amplification techniques. Amplification 
of different loci of the human genome was determined by a quantitative real-time 
PCR technique and compared with that of unamplified human genome. 
Amplification bias or drop out of certain loci after this amplification was less than 3-
fold for non-PCR based amplification whereas 104-106-fold for a PCR-based whole 
genome amplification method (Dean et al., 2002). In isothermal amplification phi29 
DNA polymerase amplifies the whole genome uniformly. This enzyme has unique 
strand displacement activity and efficiency producing only 1 error per 106-107 
bases (Esteban et al., 1993). 
Phi29-amplification of nucleic acids has also been found to be useful for 
subsequent microarray analysis for the detection of both DNA and RNA viruses in 
clinical samples received for routine diagnostic analysis (Erlandsson et al., 2011). 
Jaing et al. (2008) reported a high density NimbleGen microarray system for the 
detection of specific genes related to microbial antibiotic resistance and virulence 




mechanisms. The authors could detect these genetic characteristics of bacteria 
from femtogram concentrations of DNA after whole genome amplification using the 
REPLIg kit (QIAGEN, Crawley, UK) and microarray analysis. Wu et al. (2006) 
amplified the whole community microbial genome from picogram quantities using 
phi29 DNA polymerase for subsequent detection of microbial diversity by 
microarray analysis from groundwater contaminated with uranium and other 
metals. The authors found that the diversity of microorganisms containing genes 
involved in degradation of contaminants was greatly reduced in highly 
contaminated environments. It is now theoretically possible to detect pathogenic 
viruses, as well as previously undescribed viruses types within existing virus 
families using microarray platforms (Berthet et al., 2008; Palacios et al., 2007; 
Wang et al., 2002). Some of these microarray platforms have been used for the 
detection of viruses in respiratory samples (Berthet et al., 2008; Palacios et al., 
2007; Wang et al., 2002; Kistler et al., 2007). In a recent study, Gardner et al. 
(2010) designed a pan-microbial detection array for detection of viruses (including 
bacteriophages), bacteria and plasmids using a novel statistical method. The 
authors designed an array containing larger numbers of family specific nucleic acid 
probes per sequence, 50 or more for viruses, 15 or more for bacteria compared to 
2-10 probes per target in previous array based on the recent sequence database. 
They were able to detect and characterise multiple viruses, bacterophage and 
bacteria in faecal, serum and respiratory samples to the family and species level 
using this new technology.  
One of the objectives of this thesis was to improve the detection of pathogenic 
viruses of the respiratory tract through nucleic acid amplification using phi29 DNA 
polymerase. The rationale for nucleic acid amplification (Section 1.8.2) was that 
such amplification produces large quantities of DNA from a very minute amount of 
sample (Hosono et al., 2003). Multiple displacement amplification (Section 1.8.2) is 
a cell-free whole genome amplification system which uses random primers and 
phi29 DNA polymerase and amplifies DNA from femtogram to microgram levels 
using strand displacement activity (Jaing et al. 2008) (Section 1.8.2). This cell-free 




system of phi-29 amplification will eliminate the necessity of propagation of cells 
and viruses in larger volumes for the amplification of nucleic acids. Phi29-
amplification using a two-step priming reaction was successfully used to amplify 
and detect 25 picogram of circular DNA from Borrelia burgdorferi B31 amongst 
vast excess of human DNA (Xu et al., 2008). Phi29 DNA polymerase has also 
been used for multiple displacement amplification (MDA) (Section 1.8.2) of 
template DNA from clinical and other biological samples such as nasal swabs, 
blood, buffy coats, dried blood (Hosono et al., 2003; Lasken et al., 2004) cultured 
cells and tissues (Lasken et al., 2004). It is possible to amplify DNA up to 1000-
10000-fold from small amounts of whole blood, dried blood, buccal cells and buffy 
coats specimen using phi29 DNA polymerase (Hosono et al., 2003). This 
significant amplification ability of phi29 DNA polymerase can be employed to 
increase the concentration of template and improve detection of limiting amounts 
of any nucleic acid of pathogenic microorganism in patient samples when they are 
below the normal PCR detection limit.  
This chapter describes a preliminary study conducted to determine the efficiency 
of phi29-amplification to amplify different structural conformations of DNA present 
in limiting concentrations to improve detection of target sequences by PCR. Phi29-
amplification was initially used to amplify genomic DNA extracted from 
bacteriophage lambda () particles. Subsequently, four different structural 
conformations of DNA — bacteriophage  DNA (dsDNA 48.0 kb), cDNA prepared 
from MS2 RNA (sscDNA, 3.6 kb), pUC18 (circular dsDNA, 2.6 kb) and pKEYE 
(circular dsDNA, 8.6 kb, containing a copy of Escherichia coli recA gene) were 
used in limiting concentrations to determine the efficiency of phi29-amplificaiton on 








3.2 Improved detection of bacteriophage  particles DNA using 
phi29 DNA polymerase 
A stock of bacteriophage lambda () particles was prepared, quantified and serially 
diluted between 1010 pfu ml-1 and 101 pfu ml-1 (Section 2.5). Bacteriophage  DNA 
was extracted from all of these different concentrations and divided into two 
portions. One aliquot was amplified using the REPLIg kit (QIAGEN, Crawly, UK) 
and the other aliquot was not amplified. Both of the amplified and non-amplified  
DNA was then used as template for PCR (Section 2.6.7) using  genome specific 
primers (Appendix A1). Extracted bacteriophage  DNA could not be detected 
below a concentration of 105 pfu ml-1 without phi29-amplification (Figure 3.1, L7). 
However, after phi29-amplification it was possible to detect bacteriophage  DNA 
at a lower concentration of 103 pfu ml-1 (Figure 3.1, L14). We observed that there 
was 100-fold improvement in detection of bacteriophage  DNA after phi29-











 L1       L2       L3      L4      L5      L6       L7     L8     L9     L10     L11   L12     L13   L14 
500 bp 
Figure 3.1: PCR detection of extracted lambda DNA before and after 
phi29 DNA polymerase amplification. Lane: L2-L10: before phi29 DNA 
polymerase amplification; L12-L14: after phi29 DNA polymerase 
amplification; L1: 100 bp DNA ladder (NEB, Hitchin, UK); L2: 1010; L3: 109; 
L4: 108; L5: 107; L6: 106; L7: 105; L8: 104; L9: 103; L10: 102 pfu ml-1. L11: 
negative control; L12: 105; L13: 104; L14: 103 pfu ml-1.  
 




3.3 Protocol for phi29 amplification of different structural 
conformations of DNA 
A protocol was designed to determine the improvement in detection of four 
different structures of purified DNA. These four structures of DNA were chosen as 
representatives of different structural conformations of viral nucleic acids so that 
this protocol could be evaluated for further applications on clinical samples. Four 
different types of DNA templates were chosen for this assay, bacteriophage  DNA 
(dsDNA 48.0 kb), cDNA prepared from MS2 RNA (sscDNA, 3.6 kb), pUC18 
(circular dsDNA, 2.6 kb) and pKEYE (circular dsDNA, 8.6 kb, containing a copy of 
the Escherichia coli recA gene). Each of the four different structural forms of DNA 
was diluted in 10 mM Tris-HCl (pH 8.0) in different concentrations from a known 
stock in a 1:10 fold serial dilution to determine the endpoint of detection by PCR. 
These different concentrations of DNA were amplified using the REPLIg kit 
(QIAGEN, Crawley, UK) (Section 2.6.8). Amplified DNA was diluted (1:20) in Tris-
HCl (pH 8.0) following the protocol provided by the manufacturers (QIAGEN, 
Crawley, UK) to use as a template for subsequent detection by PCR (Section 
2.6.7.2). The DNA concentration was also measured both before and after phi29 
DNA polymerase amplification using the Quanti-iT PicoGreen dsDNA reagent kit 
(Invitrogen, Paisley, UK) (Section 2.6.2.2). 
 
3.4 Improved detection of different structural conformations of 
DNA after phi29 DNA polymerase amplification 
Different structures of DNA at various concentrations were detected by PCR 
technique both before and after phi29 amplification to determine any improvement 
in detection after such amplification. Detection of , pKEYE and pUC18 DNA could 
be improved from 10 to 100-fold but MS2 cDNA could not be amplified significantly 
after phi29 DNA polymerase amplification (Table 3.1).  




Template DNA concentrations were determined both before and after phi29 DNA 
polymerase amplification using a picogreen dye method (Section 2.6.2). 
Concentrations of all four structural conformations of DNA were amplified 106-108-
fold after phi29-amplification as determined by the picogreen assay. The amount 
of amplification was determined by comparing the calculated concentrations of 
DNA in different dilutions prepared from known stocks with those after phi29-
amplification and picogreen assay. It was found that double stranded DNA was 
amplified more efficiently than the single stranded DNA with phi29 DNA 
polymerase as determined by picogreen assay (Table 3.1). This assay was 
repeated three times and similar results were found. The PCR detection was done 
to determine presence of target sequences and picogreen assay was done for 
determination of total amount of DNA before and after phi29 amplification. The 
average value total amount of DNA from three replicate experiments in picogreen 
















Table 3.1: Detection of different structures of DNA in different 
concentrations using PCR technique and picogreen dye both before and 
after phi29 DNA polymerase amplification  
DNA (type and 
size) 
Concentrations 
of DNA  
PCR detection of target 
sequences (copy µl-1)  
 Detection of 
total amount of 
DNA, Picogreen 
assay 




Before + - - - -  Below detection 
level* 
After + + + - -  399.26 µg ml-1 
pUC18 (circular 
dsDNA, 2.6 kb) 
 
Before + + + - -  Below detection 
level* 
After + + + + +  197.25 µg ml-1 
pKEYE (circular 
dsDNA, 8.6 kb) 
 
Before + - - - -  Below detection 
level* 




Before + + - - -  Below detection 
level* 
After + + - - -  186.92 µg ml-1 









We evaluated the application of phi29 DNA polymerase for isothermal 
amplification of four different structural conformations of DNA from limiting 
concentrations. These four different structural conformations were selected as 
representatives of different structural conformations of nucleic acids of viruses so 
that similar approach can be applied for amplification of genomes of pathogenic 
viruses from clinical samples. Although it was not possible to cover all variety of 
virus nucleic acids such as double stranded RNA this study sheds light on how 
much these selected forms of DNA could be amplified using phi29 DNA 
polymerase.  
It was found that the efficiency of phi29 DNA polymerase mediated amplification 
varied for the different structural conformations of DNA which could be due to 
several reasons. Larger DNA fragments (>2.0 kb) are amplified more efficiently 
than shorter fragments of linear DNA using phi29 DNA polymerase (Bergen et al., 
2005; Brukner et al., 2006). On the other hand, small circular structure of DNA 
(150 bp) could be amplified 107-fold using phi29 DNA polymerase in multiply-
primed rolling circle amplification (Nelson et al., 2002; Brukner et al., 2006) 
(Section 1.6). The REPLIg kit (QIAGEN, Crawley, UK) was used for amplification 
of all different types of templates in this study. This kit uses a chemical 
denaturation step for denaturing template DNA which is critical for binding of 
primers and efficient amplification of template DNA. It was found that  DNA, 
pUC18 and pKEYE plasmid DNA could be amplified efficiently using this system 
but sscDNA prepared from MS2 could not (Table 3.1). It was also found that the 
protocol of the REPLIg kit (QIAGEN, Crawley, UK) worked better for linear dsDNA 
and different sizes of circular dsDNA than the sscDNA in this study. This could be 
due to the limitation of the REPLIg kit for efficient amplification of ssDNA. Similar 
amplification of the human genome (Dean et al., 2002), plasmid and phage DNA 
(Dean et al., 2001) using phi29 DNA polymerase has been reported by other 
workers. Improved detection of circular and linear viral dsDNA in clinical samples 




by real-time PCR after incorporating a pre-amplification step using phi29 DNA 
polymerase has recently been reported by other workers (Erlandsson et al., 2010).  
Single stranded cDNA prepared from MS2 RNA is very labile and degrades quickly 
which may be one of the reasons for it not being amplified using the whole 
genome amplification method in the REPLIg kit (Section 2.6.6.2). Shorter lengths 
of cDNA prepared from the MS2 genomic RNA (3.8 kb) could be another reason 
for not being amplified after whole genome amplification using phi29 DNA 
polymerase in the REPLIg kit (Section 2.6.6.2). However, a modified method of 
ligation-mediated phi29 DNA polymerase amplification was found to be useful for 
the amplification of RNA of all sizes by other workers (Berthet et al., 2008). Berthet 
et al. (2008) used whole transcriptome amplification (WTA) kit (QIAGEN, Crawley, 
UK) instead of REPLIg kit (QIAGEN, Crawley, UK) for ligation-mediated 
amplification of different sizes of virus RNAs. The WTA kit (QIAGEN, Crawley, UK) 
is relatively expensive compared to any other kits (reagent cost £ 25.0 per sample) 
and will not be feasible for pre-amplification of nucleic acids before routine 
laboratory diagnosis by PCR.  
The Quanti-iT PicoGreen dsDNA reagent kit (Invitrogen, Paisley, UK) was used 
to determine the concentration of all four types of templates directly and after 
phi29 DNA polymerase amplification. Initial concentrations of templates were 
below the detection level by picogreen assay (Table 3.1 and Section 2.6.2.2) for all 
four types of templates but their concentrations increased after phi29 DNA 
polymerase amplification. In this study it was possible to amplify the 
concentrations of , pUC18 and pKEYE DNA up to 399.26 µg ml-1, 197.25 µg ml-1 
and 196.05 µg ml-1 respectively from limiting concentrations (Table 3.1). After 
comparing the calculated concentration of the diluted templates with those after 
phi29-amplification it was found that all four structures were amplified 106-108-fold 
by picogreen assay. Amplification of single stranded cDNA (prepared from 
bacteriophage MS2 RNA) showed a concentration of 186.92 µg ml-1 of DNA after 
phi29 amplification in the picogreen assay. However, the target sequence could 




not be detected by PCR from this amplified product. This indicates that 
amplification of single stranded cDNA was actually nonspecific or template 
independent. It was reported by other workers that the nonspecific or template 
independent DNA synthesis was completely suppressed when modified primers 
with two 5’-nitroindole (universal base) were used (Lage et al., 2003). In a recent 
study it was also found that addition of trehalose during phi29-amplification 
significantly improved the amplification bias and template independent products 
from as little as 0.5-0.25 nanogram of human genomic DNA or a few cells (Pan et 
al., 2008). Trehalose is a disaccharide that contains glucose molecules bound in 
an -1,1 linkage. Trehalose was found to increases the phi29-amplification activity 
at an elevated temperature of 40 C and helps to maintain activity of the enzyme 
at 30 C for at least 26 hours (Pan et al., 2008). This finding is in concordance with 
the findings of other workers performing amplification of template DNA from 
limiting concentrations which could be useful for improving detection of any 
pathogen present in clinical samples (Brukner et al., 2006; Lasken and Egholm, 
2003). Picogreen dye was also used in another study for quantitation of DNA after 
phi29 DNA polymerase amplification to be used for checkerboard DNA-DNA 
hybridization (Teles, et al., 2007). It was found that bacterial DNA could be 
amplified 1000-fold using phi29-amplification as determined by picogreen assay 
(Teles et al., 2007). In this study, the REPLIg kit (QIAGEN, Crawley, UK) was used 
for phi29-amplification of template DNA, so there was no scope to change the 
random primers or add trehalose to the reaction to reduce nonspecific 
amplification. 
Based on the available literature and the findings in this section it is clear that, 
phi29-amplification may be useful for the amplification of various nucleic acids of 
pathogenic microorganisms from clinical samples to improve subsequent detection 
by PCR. Phi29 DNA polymerase amplification could be further improved by 
adopting modified protocols such as using modified primer having two 5’-
nitroindole (universal base) and adding trehalose to the amplification reaction. An 
alternative cheaper protocol for ligation-mediated phi29-amplification could be 




used for the amplification of nucleic acids in order to improve detection of single 
stranded cDNA. Several modified protocols for ligation-mediated phi29 
amplification and a new protocol for RT-Bst amplification have been developed 





Development of a novel method 
— RT-Bst for amplification of viral 
RNA 




4.1 Introduction and aims 
The advancements in molecular diagnostic tests have significantly improved our 
ability to detect pathogenic microorganisms and has expanded our knowledge of 
the diversity of microorganisms associated with infections (reviewed by Olofsson 
et al., 2011; Delwart, 2007). Crucially, in some instances, pathogens may not be 
detected due to the lack of sensitivity of the existing methods and/or the presence 
of previously unrecognised pathogens (Allander et al., 2007; Fox, 2007). 
Unsatisfactory detection of pathogenic viruses of the respiratory tract may also be 
associated with the lower abundance of virus particles and the poor quality of 
samples collected from patients. Very low quantities (femtogram levels) of target 
nucleic acids present in any sample may not be amplified by PCR thereby 
producing false negative results (Karrer et al., 1995; Schloss et al., 2003). This 
limitation of PCR detection could be due to small and random differences in 
amplification efficiency between individual templates in amplifying nucleic acids. 
However, cell free nucleic acid amplification techniques using phi29 or the large 
fragment of Bst DNA polymerase (Section 1.6) can be useful for the amplification 
of large amounts of nucleic acids from a limited amount of nucleic acid or few cells 
to improve subsequent detection of target sequences by PCR (Dean et al., 2001; 
Lizardi et al., 1998). Both phi29 and the large fragment of Bst DNA polymerase 
use random primers and nucleotides to amplify the nucleic acid copy number 
through multiple displacement amplification (Section 1.6). Random primers bind to 
the denatured templates and the polymerase extends the primers and replicate the 
copy of the template DNA. Random primers are simultaneously extended by 
replicating the template DNA and displacing the 5’ end of the other strand from the 
template producing multiple copies of the starting template. As a result of 
increasing numbers of priming events the amplified product forms a network of 
hyper-branched DNA. Phi29 and the large fragment of Bst DNA polymerase 
amplify the template DNA by similar mechanisms at 30 C and 60-65 C, 
respectively.  




PCR-based and non-PCR-based isothermal amplification of target sequences 
have been found to be useful to improve the sensitivity of PCR detection of nucleic 
acids from very low concentrations from clinical and laboratory samples 
(Erlandsson et al., 2011 and 2010; Dean et al., 2002). Multiple displacement 
amplification of whole genome using phi29 DNA polymerase was found to be 
useful for amplification and sequencing of an environmental strain of Vibrio 
cholerae 01 from 10 nanograms of extracted genomic DNA (Pérez Chaparro et al., 
2011).  Circular and linear viral dsDNA could be amplified significantly from clinical 
samples using phi29 DNA polymerase which improved detection of positive 
samples normally below the detection limit of specific real time PCR assay 
(Erlandsson et al. 2011). 
The large fragment of Bst DNA polymerases has been less frequently used for 
whole genome amplification than phi29 DNA polymerase possibly due to its lower 
efficiency of amplification of nucleic acids. Lage et al. (2003) developed a simple 
method to generate thousands of copies of a human genome from 500 cells in 
only a few hours using large fragments of Bst DNA polymerase. Other workers 
also found that multiple displacement amplification (MDA) (Section 1.6) using Bst 
DNA polymerase of intact DNA, such as DNA isolated from fresh or snap-frozen 
tissue, showed representational distortion of less than three-fold (Lage et al., 2003; 
Dean et al., 2002; Rook et al., 2004). Bst DNA polymerase amplified products 
were found to be more useful for its fidelity over phi29 DNA polymerase in 
comparative genomic hybridization array analysis using the human genome (Dean 
et al., 2002; Aviel-Ronen et al., 2006).  
In a recent study, Erlandsson et al., (2011) demonstrated a new diagnostic tool for 
virus detection by combining microarray detection with phi29-amplification. They 
showed that this method detects both DNA and RNA viruses and differentiates 
between different virus subtypes. Human papilloma virus (HPV) specific PCR 
amplification from low virus titre in clinical samples was found useful for the 
diagnosis of HPV by subsequent microarray hybridization (Mejlhede et al., 2009; 




Oh et al., 2004). The sensitivity of real-time PCR detection of circular and linear 
viral dsDNA genomes in clinical samples was increased by Amp-PCR (Erlandsson 
et al., 2010). Amp-PCR technology uses a pre-amplification of whole genome 
using phi29 DNA polymerase to improve detection of target sequence by specific 
real-time PCR (Section 1.7).  
Nucleic acid sequence based amplification (NASBA) is an in vitro isothermal 
amplification system for RNA (Section 1.5.5). NASBA has been widely used for 
detection of pathogens in clinical, environmental and food samples (Fu et al., 2011; 
Gracias et al., 2007). NASBA has been successfully used by other workers to 
amplify the copy number of RNA to improve detection of rabies virus (Sugiyama et 
al., 2003) and rapid confirmation of influenza A H5N1 virus in clinical samples 
(Moore et al., 2010). Real time NASBA using a molecular beacon probe was found 
to be more sensitive than a cell culture-based method for detection of wide range 
of influenza A virus subtypes (Moore et al., 2004) whereas NASBA alone was 
found to have sensitivity equivalent to the egg culture method (Shan et al., 2003). 
These culture-based detection methods are still used as the gold standard for 
virology diagnostics. Signal mediated amplification of RNA technology (SMART) is 
another method for isothermal amplification of RNA (Wharam et al., 2001) (Section 
1.6.2; Figure 1.2).  
Inefficient template extraction and co-purification of inhibitors during nucleic acid 
extraction procedures are major hurdles for successful amplification and detection 
of pathogenic microorganisms by PCR. PCR inhibitors either can bind and interact 
with a DNA template (Eckhart et al., 2000; Bickley et al., 1996) or interact with 
DNA polymerase during primer extension. An application of sequence specific 5’-
biotinylated probes for hybridization and concentration of specific sequences using 
magnetic beads to improve detection of target sequences has been reported by 
other workers (Li et al., 2011). Magnetic beads have also been used for isolation 
and concentration of minute quantities of nucleic acids from clinical samples and 




improve detection of HPV16 viruses (Peeters, et al., 2011) and hepatitis C viruses 
(Miyachi et al., 2003). 
In the light of previous studies and findings, different protocols were validated in 
this chapter to enrich low copy number cDNA (prepared from MS2 RNA) to 
evaluate the performances of the protocols. 5’-biotinylated probes were used to 
concentrate bacteriophage lambda () and MS2 genome sequences. Ligation-
mediated phi29 DNA polymerase amplification was used to enrich the copy 
number of single stranded cDNA (sscDNA) and double stranded cDNA (dscDNA) 
prepared from MS2 RNA. CircLigase II ssDNA ligase was also used for 
circularization of single stranded MS2 cDNA to improve amplification of 
circularized DNA structures using phi29 DNA polymerase. A novel protocol was 
developed in this study through combining reverse transcription and Bst DNA 
polymerase amplification in a single reaction for synthesis and amplification of 
cDNA directly from RNA templates in order to improve sensitivity of PCR. 
 
4.2 Concentration of lambda () DNA using a 5’-biotinylated probe 
in the presence of Staphylococcus aureus DNA  
Aliquots of lambda () DNA (104, 102 and 101 copy µl-1) were added to a known 
concentration of Staphylococcus aureus DNA (104 copy µl-1). Lambda DNA 
specific 5’-biotinylated and non-biotinylated probes were hybridized with  DNA 
present in each sample. Both biotinylated and non-biotinylated probes hybridized 
to  DNA were concentrated using streptavidin coated beads (MyOne C1 from 
Invitrogen, Paisley, UK). Briefly, MyOne C1 beads were suspended in 2X binding 
and washing (B&W) buffer to a final concentration of 5 µg µl-1. An equal volume of  
both biotinylated DNA (100 µl) was added in the 2X B&W buffer containing beads 
and incubated for 15 minutes at room temperature using gentle rotation. The 
biotinylated DNA coated beads were separated using a magnet for 2-3 minutes, 




washed with B&W buffer and resuspended in 50 µl of elution buffer (Tris-HCl, pH 
8.5) for further analysis. Non-biotinylated DNA (used as a control) was also 
concentrated using the same protocol. The efficiency of biotinylated and non-
biotinylated probes to enrich  DNA sequences was compared by PCR (Section 
2.6.7) using  DNA specific primers (Appendix, Table A1). Lambda DNA could not 
be detected below 104 copy µl-1 using a non-biotinylated sequence specific probe 
(Figure 4.1, L2). However, lambda DNA could be detected at a lower concentration 
(102 copy µI-1) after using a 5’-biotinylated sequence specific probe (Figure 4.1, 
L6). It was found that PCR detection of  DNA was improved 100-fold after 
concentrating the DNA using 5’-biotinylated probes (Figure 4.1). 
 
 
      
 
 
4.3 Concentration of MS2 cDNA using biotinylated probe when 
mixed with different concentrations of lambda () DNA 
Equal amounts of MS2 single stranded cDNA (105 copy µl-1) was added to 
different concentrations of lambda () DNA (0.1 ng µl-1, 0.01 ng µl-1, 1 pg µl-1, 0.1 
pg µl-1, 0.01 pg µl-1). MS2 cDNA specific 5’-biotinylated probes were allowed to 
hybridize with MS2 cDNA. Streptavidin beads, MyOne C1, (Invitrogen, Paisley, 
UK) were used to concentrate MS2 cDNA from these samples and remove excess 
background  DNA. Both the target sequences of MS2 and  DNA were detected 
by PCR before and after concentrating MS2 cDNA using biotinylated probes and 
streptavidin beads. It was found that 5’-biotinylated probes (specific for MS2 
sequence) were useful to capture MS2 sequences successfully in the presence of 
 L1    L2     L3   L4    L5    L6    L7  L8 
500 bp 
Figure 4.1: Enrichment of  DNA using 5’-biotinylated probe. L2-L4: after 
hybridization with non-biotinylated probes; L1: 100 bp DNA ladder (NEB, Hitchin, 
UK); L5-L7: after hybridization with biotinylated probes; L2 and L5: Staphylococcus 
aureus (Sa) 104 copy µl-1 + Lambda () 104 copy µl-1; L3 and L6: Sa 104 copy µl-1 + 
 102 copy µl-1; L4 and L7: Sa 104 copy µl-1 +  1 copy µl-1; L8: negative control.  




 DNA at all concentrations of 0.1 ng µl-1 to 0.01 pg µl-1. Biotinylated probes 
(specific for MS2 sequence) were also found to be useful to concentrate MS2 
cDNA and remove the  DNA from the background at a concentration of 0.01 




























Figure 4.2: PCR detection of MS2 single stranded cDNA and lambda () 
DNA both before and after MS2 cDNA specific biotinylated probe capture 
assay. M: 100 bp DNA ladder (NEB, Hitchin, UK); A: before probe hybridization 
and capture; B: after probe hybridization and capture; A1-5 & B1-5: PCR 
detection of  DNA; A7-11 & B7-11: PCR detection of MS2 sscDNA; 1 and 7:  
(0.1 ng µl-1) + MS2 (105 copy µl-1); 2 and 8:  (0.01 ng µl-1) + MS2 (105 copy µl-1); 
3 and 9:  (1 pg µl-1)  + MS2 (105 copy µl-1); 4 and 10:  (0.1 pg µl-1) + MS2 (105 
copy µl-1); 5 and 11,  (0.01 pg µl-1) + MS2 (105 copy µl-1); 6 and 12: negative 
control; Amplicon sizes;  DNA: 500 bp; MS2: 314 bp.  
 
 




4.3 Protocols for ligation-mediated phi29-amplification to enrich 
the target sequences 
In the previous chapter (Chapter 3), it was found that double stranded DNA 
(dsDNA), either linear or circular forms could be amplified efficiently using phi29 
DNA polymerase. This was not the case for single stranded cDNA (sscDNA). One 
of the reasons could be that the sizes of cDNA converted from MS2 RNA were 
relatively small; the genome of MS2 RNA is only 3.8 kb. Moreover, sscDNA is 
more labile and degrades more easily than dsDNA. It was also found that the 
larger molecules of linear DNA (>2 kb) are amplified more easily than the smaller 
ones using phi29 DNA polymerase (Dean et al., 2001; Brukner et al., 2006). This 
led to the suggestion that different protocols will be necessary for the successful 
amplification of sscDNA such as ligation of sscDNA creating concatemers to 
increase their size before phi29 DNA polymerase amplification (Berthet et al., 
2008). Phi29 DNA polymerase binds to any template DNA and replicates the DNA 
up to 70 kb without dissociating from the DNA strand. Therefore a larger molecular 
weight DNA molecule will be amplified more efficiently than lower molecular weight 
one. 
  
4.3.1 T4 RNA ligase-mediated phi29-amplification of MS2 sscDNA  
T4 RNA ligase assay was performed in the presence and absence of carrier RNA 
to determine the effect of carrier RNA in ligation-mediated phi29-amplification. The 
carrier RNA was used from the QIAamp RNA extraction Mini Kit (QIAGEN, 
Crawley, UK) in order to protect the target RNA from degradation and improve the 
yield during spin column extraction. One assay was set up adding MS2 RNA (107 
copy µl-1) to carrier RNA (50 ng µl-1) and another adding MS2 RNA (107 copy µl-1) 
only without carrier RNA. Both reactions were further diluted to 103 copy µl-1 and 
reverse transcribed to sscDNA using 5’-phosphorylated random hexamers 
(Appendix, Table A1) according to the protocol described in section 2.6.4. The 




diluted cDNA (107 to 103 copy µl-1) was ligated using T4 RNA ligase according to 
table 4.1. 
 
Table 4.1: Ligation mix for sscDNA using T4 RNA ligase  
Reaction component Reaction volume 
Linear sscDNA 2-20 ng or 12.0 µl 
10X reaction buffer 2.0 µl 
T4 RNA ligase (Fermentas, York, UK) 10 U or 1.0 µl 
ATP 10 mM 1.0 µl 
BSA 1 mg ml-1 2.0 µl 
Nuclease free water 2.0 µl 
Total volume 20.0 µl 
Incubation 37 ºC for 30 min 
Inactivation 70 ºC for 10 min 
    
As a result of this ligation of the 5’-phosphorylated cDNA with T4 RNA ligase, 
single stranded cDNA (sscDNA) is predicted to form concatemers of sscDNA in 























Ligated products were purified through DNA purification columns and immediately 
amplified using the REPLIg kit (QIAGEN, Crawley, UK) for subsequent detection 
by PCR. MS2 sequence could be detected at a concentration of 104 copy µl-1 
(Figure 4.4, A4) after phi29-amplification without a ligation step whereas the same 
sequence could be detected at a lower concentration of 103 copy µl-1 (Figure 4.4, 
B5) after including a ligation step (in the presence of carrier RNA). This assay 
demonstrated that PCR detection of MS2 sequence was improved 10-fold after 
ligation-mediated phi29-amplification in the presence of carrier RNA (Figure 4.4). 
On the other hand, MS2 sequence could be detected at a concentration of 103 
copy µl-1 (Figure 4.4, A11) without ligation and phi29-amplification in the absence 
of carrier RNA. The sensitivity of PCR detection of MS2 sequence was observed 
to be lower and could only detect MS2 sequence at a higher concentration (104 
copy µl-1) after ligation-mediated phi29-amplification in the absence of carrier RNA 
(Figure 4.4, B10). This confirmed that ligation-mediated phi29-amplification was 
MS2 RNA with or without carrier RNA 
Reverse transcription using 5’phosphorylated random hexamer 
Ligation of sscDNA using T4 RNA ligase  
Purification through column 
Phi29 DNA polymerase amplification 
Preparation of larger linear and circular forms of sscDNA 
Preparation of sscDNA 
PCR detection of MS2 cDNA 
Figure 4.3: Flowchart showing the protocol for T4 RNA ligase-
mediated phi29-amplification  




useful to improve detection (10-fold) of target sequence in the presence of carrier 
RNA whereas the same assay was less sensitive (10-times) in the absence of 
carrier RNA. There were some non-specific bands observed after PCR 
amplification (Figure 4.4) of the ligated and phi29-amplified products which could 






















Figure 4.4: T4 RNA ligase-mediated phi29-amplification in the 
presence or absence of total RNA. A 1-12: before phi29-amplification; B1-12: 
after phi29-amplification using REPLIg kit (QIAGEN, Crawley, UK). M: 100 bp DNA 
ladder (NEB, Hitchin, UK); A 1-5 and B 1-5: MS2 RNA with carrier RNA (50 ng µl-
1); A 7-11 and B 7-11: MS2 RNA only as control. A1, A7, B1, B7: 107 copy µl-1; A2, 
A8, B2, B8: 106 copy µl-1; A3, A9, B3, B9: 105 copy µl-1; A4, A10, B4, B10: 104 copy 
µl-1; A5, A11, B5, B11: 103 copy µl-1 MS2 RNA; A6, A12, B6, B12: negative control; 








4.3.2 T4 DNA ligase-mediated phi29-amplification of double 
stranded cDNA generated from MS2 RNA  
4.3.2.1 Preparation of blunt end double stranded cDNA 
Single stranded cDNA was prepared from MS2 RNA (108 copy µl-1) according to 
the protocol described in section 2.6.4. Second strand synthesis was performed 
using DNA polymerase I according to the method described in Table 4.2. 
Table 4.2: Reaction mix for second strand synthesis from sscDNA 
Reaction component Reaction volume 
From first strand synthesis reaction  20.0 µl 
10X reaction buffer for DNA Polymerase I 8.0 µl 
RNase H, E coli (Fermentas, York, UK) 0.2 µl 
DNA Polymerase I, E. coli (Fermentas, York, UK) 3 µl (30 U) 
Water, nuclease-free Up to 100 µl 
Total volume 100 µl 
 
The reaction mix (Table 4.2) was vortexed gently, centrifuged briefly and incubated 
at 15º C for 2 hours.  2.5 µl (12.5 U) of T4 DNA polymerase was added to the 
reaction and incubated at 15º C for 5 minutes for generating blunt end double 
stranded cDNA. This reaction was terminated by adding 5 µl of 0.5 M EDTA, pH 
8.0. Prepared double stranded cDNA was purified through a DNA purification 
column (QIAGEN, Crawley, UK) and used in T4 DNA ligase reactions. 
 
4.3.2.2 Ligation of double stranded cDNA produced from MS2 
RNA 
Blunted double stranded cDNA was ligated using T4 DNA ligase according to the 
protocol in Table 4.3 in the presence of polyethylene glycol 4000 at a final 




concentration of 5% (w/v). Such a ligation reaction using T4 DNA ligase will 
generate two different types of products, both linear and circular forms which may 
be concatemers of double stranded cDNA derived from MS2 RNA. 
 
Table 4.3: Ligation of double stranded cDNA using T4 DNA ligase  
Reaction component Reaction volume 
Linear sscDNA 2.0-20.0 ng or 12.0 µl 
10X reaction buffer 2.0 µl 
T4 DNA ligase (Fermentas, York, UK) 2.0 U or 0.2 µl 
50% (w/v) PEG 4000 2.0 µl 
Nuclease free water 3.8 µl 
Total volume 20.0 µl 
Incubation 22 ºC for 1 h 
Inactivation 65º C for 10 min or 70º C for 5 min 
 
 
4.3.2.3 T4 DNA ligase-mediated phi29-amplification  
Double stranded blunt end MS2 cDNA was prepared from a stock of MS2 RNA 
(108 copy µl-1) and divided into two fractions. Complementary DNA (cDNA) in one 
portion was ligated with T4 DNA ligase and the other was untreated. Both of these 
ligated and non-ligated double stranded cDNAs were diluted to 106-103 copy µl-1 
and detected by PCR (Section 2.6.7.2). Both of these sets of dilutions prepared 
from ligated and non-ligated double stranded cDNA were further amplified using 
the REPLIg kit (QIAGEN, Crawley, UK) and subsequently detected by PCR 
(Figure 4.5). It was found that phi29 DNA polymerase improved the detection of 
the ligated products more than that of the non-ligated products. But it was not clear 
from Figure 4.5 (B1-4) how much amplification was achieved after such ligation 




and amplification. So this assay was repeated for one of the dilutions (108 copy µl-
1), to determine the magnitude of amplification through ligation-mediated phi29-




















Figure 4.5: Effect of T4 DNA ligase-mediated phi29-amplification to increase 
copy number of double stranded MS2 cDNA at different concentrations. A1-10: 
before phi29-amplification; B1-10: after phi29-amplification using REPLIg kit 
(QIAGEN, Crawley, UK); M: 100 bp DNA ladder (NEB, Hitchin, UK); A1-4 and B1-4: 
double stranded cDNA ligated with T4 DNA ligase; A 6-9 and B 6-9: double stranded 
cDNA was not ligated with T4 DNA ligase; A1 and A6: 106 copy µl-1;   A2 and A7: 105 
copy µl-1; A3 and A8: 104 copy µl-1; A4 and A9: 103 copy µl-1 of MS2 RNA; A5 and 
A10: negative control; B1 and B6: 106 copy µl-1; B2 and B7: 105 copy µl-1; B3 and 
B8: 104 copy µl-1; B4 and B9: 103 copy µl-1; B5 and B10: negative control; MS2 
amplicon size: 314 bp. 
 




Another assay was set up to ligate double stranded cDNA (108 copy µl-1) which 
was subsequently diluted to 105 copy µl-1. In a control tube double stranded cDNA 
(108 copy µl-1) was not ligated by T4 DNA ligase but diluted to 105 copy µl-1. These 
ligated and non-ligated products were amplified by REPLIg kit (QIAGEN, Crawley, 
UK) for subsequent detection by PCR (Figure 4.6). Ligated double stranded cDNA 
(prepared form MS2 RNA) was amplified >105 times compared to the non-ligated 
double stranded cDNA (Figure 4.6, B). This result showed that ligation of double 
stranded cDNA with T4 DNA ligase before phi29-amplification was useful for 
increasing the template copy number to improve detection of the target sequence 
(MS2 cDNA). Multiple bands appeared after PCR amplification of ligated products 
(Figure 4.6, A1-7) which could be due to concatemers formation after ligation using 
T4 DNA ligase. A faint band (314 bp) was also observed in Figure 4.6 (B6), which 
was possibly due to carryover contamination of template during PCR amplification. 
All of the assays in this section were performed in triplicate to determine the 




























4.3.3 CircLigase-mediated phi29-amplification of single 
stranded MS2 cDNA 
Circular structures of DNA can be amplified efficiently using phi29 DNA 
polymerase which is not possible for low molecular weight linear DNA (Liu et al., 
1996; Dean et al., 2001; Gadkar et al., 2011). Phi29 DNA polymerase synthesizes 
up to 70 kb of DNA once it binds to any template DNA. So, when this enzyme 
binds to small linear DNA, it replicates a copy of the DNA and dissociates from the 
template. In contrast, small circular DNA can be amplified multiple times once 
phi29 DNA polymerase binds to it. Such amplification of circular DNA will 
significantly improve detection of target sequence. CircLigase II ssDNA 
 
Figure 4.6: T4 DNA ligase-mediated phi29-amplification to enrich copy 
number of double stranded cDNA (prepared from MS2). A 1-8: after ligation 
and phi29-amplification; B 1-8: without ligation and phi29-amplification; (1) 1:20; 
(2) 1:200; (3) 1:2000; (4) 1:20000; (5) 1:200000; (6) 1:2000000; (7) 1:20000000; 
(8) negative control; M: 100 bp DNA ladder (NEB, Hitchin, UK). 
 




(Epicentre Biotechnology, Cambridge, UK) ligase was used in this study for 
circularization of single stranded MS2 cDNA and to determine any improvement in 
amplification using REPLIg kit (QIAGEN, Crawley, UK). CircLigase II ssDNA 
ligase is a thermostable ATP dependent enzyme that preferably catalyses 
intramolecular ligation of ssDNA. This enzyme was isolated from a thermophilic 
bacteriophage TS2126 (Blondal et al., 2005). This enzyme efficiently ligates the 5’-
phosphate and 3’-hydroxyl group of ssDNA (>15 bases) at 60-65 C.  
Single stranded cDNA was prepared from MS2 RNA stock (108 copy µl-1) (Section 
2.6.4) using 5’-phosphorylated random hexamers (Appendix, Table A1) to 
generate 5’-phosphorylated cDNA. This 5’-phosphorylated cDNA was divided into 
two fractions. One fraction was treated with CircLigase II ssDNA ligase and the 
other fraction was untreated to compare the effect of CircLigase II ssDNA ligase-
mediated phi29-amplification. Circular structures of cDNA were prepared from 
linear structures of 5’-phosphorylated cDNA using CircLigase II ssDNA ligase 
according to the protocol in Table 4.4.  
Both ligated (circularized) and non-ligated (linear sscDNA) were purified through 
DNA purification columns and amplified with the REPLIg kit (QIAGEN, Crawley, 
UK). Both of these amplicons were diluted in 1:10 dilution series to 1:(2x10-7) 
dilutions to be used as templates for detection of MS2 sequence. PCR detection of 
MS2 sequence after phi29-amplification was compared with that without phi29 
DNA polymerase amplification. CircLigase II ssDNA ligase-mediated phi29-
amplification was found to enhance PCR detection of MS2 sequence >107-fold 
compared to the non-ligated sscDNA (Figure 4.7). However, nonspecific bands 
(Figure 4.7, A1-3) were observed after PCR amplification which is possibly due to 
the synthesis of concatemers of templates after ligation mediated phi29-
amplification. All of the assays in this section was carried out in triplicate and found 
similar results.  
 




Table 4.4: Reaction mix for CircLigase II ss DNA ligase 
Reaction component Reaction volume 
sscDNA 10 pM or 12.0 µl 
CircLigase II 10X reaction buffer 2.0 µl 
Magnesium chloride, MgCl2 (50 mM) 1.0 µl 
5M Betain (optional) 4.0 µl  
CircLigase II ss DNA ligase  (100 U µl-1) 
(Epicentre Biotechnology, Cambridge, UK) 
1.0 µl 
Total volume 20.0 µl 
Incubation 60° C for 1 hour 







































Figure 4.7: Effect of CircLigase II ssDNA ligase-mediated phi29-
amplification to improve detection MS2 sequence by PCR. M: 100 bp DNA 
ladder (NEB, Hitchin, UK); A 1-8: after ligation and phi29 DNA polymerase 
amplification; B 1-8: without ligation but after phi29 DNA polymerase 
amplification; (1) 1:20; (2) 1:200; (3) 1:2000; (4) 1:20000; (5) 1:200000; (6) 








 4.4 Development of a novel protocol — RT-Bst for reverse 
transcription of RNA and amplification of cDNA 
RT-Bst is a novel protocol for reverse transcription and Bst polymerase 
amplification in a one tube reaction (Figure 4.8). This will significantly amplify the 
cDNA copy number in the RT-Bst reaction compared to that of reverse 













Figure 4.8: Flow chart of RT-Bst amplification. (1) viral RNA; (2) random 
primers bound to viral RNA; (3) synthesis of cDNA; (4) RNA is degraded due to 
RNase H activity or heat; (5) random primers bound to sscDNA; (6) extension of 
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An assay was set up to compare the performance of RT-Bst for amplification of 
known concentrations of MS2 RNA. Reverse transcription is an inefficient process 
that converts 30-40% of input RNA to cDNA in the reaction (Stangegaard et al., 
2006). PCR detection of RNA sequence appears to be less sensitive due to the 
lower efficiency of the reverse transcription especially when the initial RNA is 
present in low concentration. A novel protocol was designed combining reverse 
transcription and Bst DNA polymerase amplification (RT-Bst) together to boost the 
synthesis of cDNA from RNA templates. The RT-Bst reaction was prepared 
according to table 4.5. RNase inhibitor was obtained from Fermentas, York, UK; 
Moloney Murine Leukemia Virus (MMuLV) and Avian Myeloblastosis Virus (AMV) 
reverse transcriptases were obtained from NEB, Hitchin, UK; Bst DNA polymerase 
was obtained from Cambridge Biosciences, Cambridge, UK. 
 
Table 4.5: RT-Bst reaction for preparation and amplification of cDNA 
Reaction component Reaction volume 
Nuclease free water 4.23 µl 
10X RT buffer 1.0 µl 
N15 random primer (10 µM) 1.0 µl 
dNTP (10 mM each) 0.5 µl 
RNase inhibitor (40.0 U µl-1) 0.25 µl 
MMuLV (200 U µl-1) or  
AMV (10.0 U µl-1) reverse transcriptase  
0.125 µl 
Bst DNA polymerase (8.0 U µl-1) 0.4 µl 
Template RNA 2.5 µl 
Total 10.0 µl 
 
Incubation conditions for RT-Bst amplification: RT-Bst amplification was 
performed in a thermocycler in three steps for reverse transcription of RNA 




templates and subsequent amplification of cDNA. The RT-Bst reaction was 
incubated at 25º C for 10 minutes to allow hybridization of random primers, 42º C 
for 30 minutes for reverse transcription and 60º C for 1 hour for Bst DNA 
polymerase amplification. The reaction was inactivated by heating at 85º C for 5 
minutes.  
After RT-Bst amplification concentrations of cDNA templates are amplified to a 
higher level which enhances sensitivity of detection by PCR. 1 µl of RT-Bst 
amplified cDNA was added in 20 µl HotStarTaq PCR reaction as described in 
section 2.6.7 for detection of MS2 virus sequences. 
Two different concentrations of MS2 RNA 8 ng µl-1 and 40 ng µl-1 were reverse 
transcribed using the QuantiTect Reverse Transcription kit (QIAGEN, Crawley, 
UK). The same concentrations of RNA were converted to cDNA using RT-Bst 
reaction using MMuLV and AMV reverse transcriptase as mentioned in Table 4.5. 
The performances of the three types of reverse transcription reactions were 
compared qualitatively from the intensity of PCR bands (Figure 4.9). This assay 
was repeated in triplicate and similar results were observed. The efficiency of RT-
Bst amplification is further investigated in Section 4.4.1 and 4.4.2 for amplification 
and detection of different sites of hRSV genome. 
RT-Bst amplification using MMuLV reverse transcriptase was found to be better 
than QuantiTect reverse transcription kit (QIAGEN, Crawley, UK) and AMV 
reverse transcriptase (NEB, Hitchin, UK) in this study. However, a quantitative 




















4.4.1 Relative efficiency the QuantiTect reverse transcription kit 
and the RT-Bst reaction for reverse transcription of the hRSV 
genome  
It appears from the results in section 4.4 that viral RNA could be reverse 
transcribed and cDNA enriched efficiently using a RT-Bst amplification technique. 
However, it was not clear from this work whether it amplified whole genomic RNA 
or a particular portion of genomic RNA compared to the QuantiTect reverse 
transcription kit (QIAGEN, Crawley, UK).  Eight pairs of primers were designed to 
span the entire genome of hRSV (Gene bank accession number AF013254) using 
the primer BLAST site from NCBI (http://www.ncbi.nlm.nih.gov/tools/primer-blast/). 
These eight pairs of primers were designed to determine representative 
amplification of the entire genome of hRSV after RT-Bst amplification by PCR 
(Table 4.6, Figure 4.10). Genomic RNA of hRSV was extracted from tissue culture 
 
314 bp 
Figure 4.9: RT-Bst amplification using different types of reverse 
transcriptases. M: 100 bp DNA ladder (Fermentas, York, UK); 1 and 2: reverse 
transcription using QuantiTect reverse transcription kit (QIAGEN, Crawley, UK); 
3 and 4: RT-Bst amplification using MMuLV reverse transcriptase (NEB, Hitchin, 
UK); 5 and 6: RT-Bst using AMV reverse transcriptase (NEB, Hitchin, UK); 7: 
negative control; 1, 3  and 5: MS2 RNA (8 ng µl-1); 2, 4 and 6: MS2 RNA (40 ng 
µl-1); MS2 amplicon size: 314 bp. 
 




medium using the QIAamp RNA mini kit (QIAGEN, Crawley, UK) (Section 
2.6.3). Complementary DNA (cDNA) was prepared from 2.5 µl of extracted RNA 
using both the QuantiTect reverse transcription kit (Section 2.6.4) and the RT-Bst 
protocol using Maxima reverse transcriptase (Fermentas, York, UK) (Section 
2.6.6). 1 µl of cDNA after reverse transcription and RT-Bst amplification was used 
in 20 µl of PCR reaction for amplification and detection of 8 target sites of hRSV 
genome. Eight pairs of primers with their corresponding positions in the hRSV 
genome and amplicon sizes are shown in table 4.6 and figure 4.10. 
 
Table 4.6: Primers used to represent the entire genome of hRSV 









5’-ACGGACATGAGACCCCTGTCGA-3’ Primer-1-F1 671-692 532 bp 
5’-TGCTGGATGACAGCAGCTGATCC-3’ Primer-1-R2 1181-1203 
5’-AGGACCCACTTCAGCTCGCGAT-3’ Primer-2-F 2818-2839 363 bp 
5’-GTTGGTGGTTCCGCTGACGGA-3’ Primer-2-R 3161-3181 
5’-TGGTGTCGCAAAACCACGCCA-3’ Primer-3-F 4576-4596 149 bp 
5’-AGTCCTGGCAGTGCGTTGATTCT-3’ Primer-3-R 4703-4725 
5’-CCACCCCCGAAAACACACCCAA-3’ Primer-4-F 5495-5516 498 bp 
5’-CTCTTCTGGCCCGGTTGTTGGC-3’ Primer-4-R 5972-5993 
5’-AGCTGGGGCAAATATGTCGCGA-3’ Primer-5-F 7605-7626 214 bp 
5’-TGTCCAGTTCAGCAGCTCCACT-3’ Primer-5-R 7798-7819 
5’-AGCTTAGGGCTGAGATGTGGATTCA-3’ Primer-6-F 9400-9424 565 bp 
5’-GCATTCCTTAAAGTGGGCCATCTGT-3’ Primer-6-R 9941-9965 
5’-GGGTGGTATTGAGGGCTGGTGTC-3’ Primer-7-F 10830-10852 920 bp 
5’-GACCCTAACGCCTGTGGATCCCT-3’ Primer-7-R 11683-11705 
5’-GCCATGGGTAGGTTCATCTACGCA-3’ Primer-8-F 12288-12311 422 bp 










It was shown that 5 out of 8 targets could be amplified after RT-Bst amplification 
whereas only 3 targets could be amplified after reverse transcription using the 
Figure 4.10: Schematic diagram of hRSV genomic RNA (lin ar 15225 bp). A1 to A8 
shows amplicons corresponding to the 8 pair of primers in table 4.6. 
 




QuantiTect reverse transcription kit (Figure 4.11). This assay in this section was 
















4.4.2 Effect of MMuLV and Maxima reverse transcriptases for 
RT-Bst amplification of the entire hRSV genome 
Based on the assays in sections 4.4 and 4.4.1 it was found that RT-Bst 
amplification was more efficient for the preparation of cDNA from viral RNA for 
subsequent detection by PCR. Two enzymes, MMuLV (NEB, Hitchin, UK) and 
thermostable form of MMuLV, Maxima reverse transcriptase (Fermentas, York, 
UK) were used in RT-Bst amplification to compare their efficiencies for 
amplification of hRSV genome (Figure 4.12). Reverse transcriptions using MMuLV 
and Maxima reverse transcriptase were carried out according to the protocol 
described in Section 4.4 and 2.6.6, respectively, using 2.5 µl of template RNA. 
A 
B 
Figure 4.11: Relative efficiency of reverse transcription of the hRSV 
genome using the QuantiTect kit and the RT-Bst amplification. A: Reverse 
transcription of hRSV RNA using QuantiTect reverse transcription kit (QIAGEN, 
Crawley, UK); B: RT-Bst amplification using Maxima reverse transcriptase 
(Fermentas, York, UK); M: 100 bp DNA ladder (Fermentas, York, UK); 1-8: PCR 










Uniform and representative amplification of the whole genome was determined by 
PCR technique using 8 pairs of designed primers spanned throughout the entire 
hRVS genome (Table 4.6). According to the company information (Fermentas, 
York, UK) Maxima reverse transcriptase is a thermostable form of MMuLV 
reverse transcriptase which contains RNA dependent and DNA dependent DNA 
polymerase activity along with RNase H activity. The Maxima reverse 
transcriptase (engineered enzyme) was found to improve the thermostability, 
robustness, and rate of synthesis of wild type MMuLV reverse transcriptase. Due 
to the thermostable nature the Maxima reverse transcriptase can remain fully 
active during the entire reverse transcription reaction. The Maxima reverse 
transcriptase can act on a range of input total RNA and can transcribe the 
secondary structures more efficiently at an elevated temperature (optimum 
temperature 50-65º C) than the wild type MMuLV reverse transcriptase (optimum 





























It was found that Maxima performed better than the MMuLV reverse 
transcriptase and showed more intense bands on agarose gels following PCR 
amplification in Lane 2, 4, 6, 7 and 8 in Figure 4.12. This assay was repeated in 
triplicate with similar results to verify the reproducibility of this result. Although we 
determined the efficiency of RT-Bst amplification of the hRSV genome using a 
qualitative PCR assay a quantitative PCR assay could be more useful to 







Figure 4.12: Effect MMuLV and Maxima reverse transcriptase for RT-Bst 
amplification of the entire hRSV genome. A: RT-Bst amplification using 
MMuLV reverse transcriptase (NEB, Hitchin, UK); B: RT-Bst amplification using 
maxima reverse transcriptase (Fermentas, York, UK); M: 100 bp DNA ladder 
(Fermentas, York, UK); 1-8: PCR detection for sites 1-8 of hRSV genome (Table 








4.4.3 RT-Bst amplification of the entire hRSV genome using 
random and specific primers  
An assay was set up to determine how efficiently RT-Bst could amplify the entire 
genome of hRSV using random and specific primers. It is understood from the 
work described in section 4.4.1 that random primers can initiate sequence 
independent amplification of all different types of nucleic acids templates present 
in the reaction. Sequence specific primers (8 pairs) were used in this assay for 
specific amplification of the entire genome of hRSV. Genomic RNA extracted from 
hRSV (tissue culture media) was reverse transcribed separately using the RT-Bst 
protocol (Section 2.6.6) using both pentadecamer primer (N15) (Appendix, Table 
A1) and 8 pairs of hRSV specific primers (Table 4.6) and the RevertAid Premium 
reverse transcriptase (Section 4.4). According to the company information 
(Fermentas, York, UK) the RevertAid Premium reverse transcriptase is a 
thermostable form of MMuLV reverse transcriptase similar to the Maxima reverse 
transcriptase as discussed before (Section 4.4.2). However, the RNase H activity 
of the MMuLV reverse transcriptase is eliminated by incorporating a point mutation 
in the RNase H domain of the MMuLV reverse transcriptase. Mutation in the 
RNase activity will ensure high yields of full length of cDNA (up to 20 kb). For 8 
pairs of primers, equimolar concentrations (0.5 µM) of both forward and reverse 
primers were added instead of random primers to set up the RT-Bst reaction. MS2 
RNA was added as carrier RNA (Section 2.6.3) instead of total RNA to protect 
hRSV RNA from degradation. This excess amount of MS2 RNA in the reaction will 





















The RT-Bst amplification using both the random and genome specific primers 
were successful for amplification of the central portion of the hRSV genomic RNA 
but no detectable amplification was observed for the terminal sequences of the 
hRSV genome when sequence specific primers were used for RT-Bst amplification. 
Five out of eight segments could be amplified by PCR when RT-Bst reaction was 
carried out using random primers (N15). Three out of eight segments could be 
amplified by PCR when RT-Bst reaction was carried out using eight pairs of 
sequence specific primers. It was also possible to selectively amplify hRSV 
genome sequence using multiplex  primers when it was mixed with excess amount 
of MS2 RNA (Figure 4.13, B10). The central portion of the hRSV genome was 
amplified successfully using both random and multiplex primers. The lack of 




Figure 4.13: RT-Bst amplification of the entire hRSV genome using random 
and multiplex (sequence specific) primers. A: RT-Bst amplification using N15 
random primers and the RevertAid Premium reverse transcriptase (Fermentas, 
York, UK); B: RT-Bst amplification using 8 pairs of hRSV genome specific 
primers and RevertAid Premium reverse transcriptase (Fermentas, York, UK); 
M: 100 bp DNA ladder (Fermentas, York, UK); 1-8: PCR detection for 8 different 









lower concentration of the input RNA (nanogram) or formation of strong secondary 
structures in the hRSV RNA. Nonspecific PCR products were amplified after PCR 
amplification of the RT-Bst amplified products using 8 pairs of sequence specific 
primers (multiplex) which could be due to the presence of the excess primers in 
the RT-Bst reaction. 
  
4.5 Discussion 
This study focuses on the validation of different protocols for concentrating 
different target sequences using 5’-biotinylated probes and enhancement of copy 
number of sscDNA through different types of ligation-mediated phi29-amplification. 
Different protocols for specific and nonspecific amplification of the bacteriophage 
MS2 and hRSV genomes through reverse transcription and Bst polymerase 
amplification were also validated to increase the copy number of cDNA. The novel 
method, RT-Bst, was found to be more efficient than the QuantiTect reverse 
transcription kit. 
Sequence specific 5’-biotinylated probes and streptavidin beads were useful for 
concentrating lambda () DNA and MS2 cDNA in this study. Detection of  DNA 
was improved 100-fold (Figure 4.1) when it was concentrated using sequence 
specific 5’-biotinylated probes and streptavidin beads. MS2 sequence specific 5’-
biotinylated probes were also found to be useful to concentrate the MS2 cDNA and 
remove the  DNA from the background at picogram levels. Sequence specific 
probes were also found useful for concentrating Hepatitis C virus RNA by other 
workers. Purified RNA was used for amplification and detection of Hepatitis C virus 
from serum samples using fully automated PCR system, COBAS AMPLICOR, 
Roche Diagnostic System (Li et al., 2011; Miyachi et al., 2003). Isolation and 
concentration of episomal HPV16 DNA using sequence specific probes and 
magnetic beads to improve detection HPV16 by real-time PCR have been reported 
by Peeters et al. (2011). The application of magnetic beads for extraction of viral 




RNA from serum sample to eliminate variety of amplification inhibitors such as 
heparin, haemoglobin and haeme urea has also been reported by other workers 
(Greenfield et al., 1993; Rolfs et al., 1992). In this study biotinylated probe capture 
assay was limited to the laboratory scale study and was not applied to any patient 
sample.  
Ligation-mediated phi29 DNA polymerase amplification was found to be useful for 
nonspecific amplification of cDNA (prepared from MS2 RNA) at picogram 
concentrations (105 copy µl-1) in this study. Phi29-amplification increased with the 
increase in the concentration of single stranded cDNA when excess amount of 
carrier RNA (nanogram level) was added to the reaction for T4 RNA ligase 
mediated phi29 DNA polymerase amplification (Section 4.3.1). In this study double 
stranded cDNA could be amplified from picogram concentrations (105 copy µl-1) 
using T4 DNA ligase-mediated phi29 DNA polymerase amplification (Section 
4.3.2). The amount of template used in this study was 10 times less than that 
required in the Templify DNA sequencing template amplification kit (Reagin et al., 
2003). However, in another study it was found that blunt end ligation of pUC19 
(<0.1 pg reaction-1) did not improve whole genome amplification (WGA) by PCR 
assay (Brukner et al., 2006). Ligation-mediated phi29-amplification was found 
useful to improve detection of small genomes and fragments of nucleic acids in 
this study and in previous studies by other workers (Berthet et al., 2008; Xu et al., 
2008).    
CircLigase-mediated phi29 DNA polymerase amplification of circularized single 
stranded cDNA (sscDNA) was also found to be useful at nanogram level of 
sscDNA (108 copy µl-1) in this study.  Gadkar and Filion (2011) developed a novel 
method for genome walking using CircLigase-mediate phi29 DNA polymerase 
amplification of single stranded DNA. Successful rolling circle amplification 
(Section 1.8.2.3) of circular DNA using phi29 DNA polymerase (Beyer et al., 2005) 
and DNA polymerase enzyme (Liu et al., 1996) has also been reported by other 
workers. Circularization and rolling circle amplification of ssDNA has also been 




used for amplification of 5’ and 3’ cDNA ends by other workers (Polidoros et al., 
2006). This protocol for circularization and phi29 DNA polymerase amplification 
can be useful for different objectives for example, rapid amplification of cDNA ends 
(RACE), improve detection of target sequence and synthesis of template DNA for 
sequencing (Nelson et al., 2002). 
In all assays of ligation-mediated phi29-amplification multiple bands were 
observed when PCR detection was used. Amplification of these multiple bands in 
PCR was possibly due to the effect of ligation which caused the template to form 
concatemers of the same sequence. However, concentration of single stranded 
DNA using 5’-biotinylated probes and ligation mediated phi29 DNA polymerase 
amplification of single stranded cDNA was not found to be more sensitive 
compared to the commercially available reverse transcription kit in this study. The 
efficiency of these methods relies on the performance of reverse transcription and 
preparation of cDNA using commercial kit and enzyme. Moreover, the protocols for 
biotinylated probe capture and ligations-mediated phi29-amplification were 
relatively lengthy, time consuming and laborious compared to RT-Bst amplification. 
Application of an automated system could be an alternative approach but can be 
relatively expensive and may not be affordable by diagnostic laboratories (Miyachi 
et al., 2003). It was necessary therefore to design an alternative protocol to 
improve detection of virus sequences.  
The novel method developed in this study, RT-Bst, was found to be more effective 
for reverse transcription and amplification of cDNA directly from RNA template 
compared to reverse transcription alone (Section 4.4). Unlike reverse transcription, 
RT-Bst amplification not only synthesizes cDNA from MS2 RNA but also increases 
its copy number. Amplification of cDNA copy number after RT-Bst reaction was 
determined by comparing the band intensities of PCR products using RT-Bst 
amplicon with those of cDNA from the QauntiTect reverse transcription kit 
(QIAGEN, Crawley, UK) (Figure 4.11). RT-Bst is a novel method for isothermal 
amplification of nucleic acids compared to other existing methods for example, 




nucleic acid sequence based amplification (NASBA) (Moore et al., 2010; Shan et 
al., 2003) and signal mediated amplification of RNA technology (SMART) 
(Wharam et al., 2001). Unlike NASBA and SMART technique RT-Bst synthesizes 
multiple copies of cDNA from RNA template instead of making many copies of 
RNA. Moreover, cDNA is more stable than RNA as a template, therefore will be 
more suitable for handling compared to RNA templates in diagnostic laboratories. 
On the other hand, synthesis of multiple copies of cDNA after RT-Bst reaction will 
eliminate the necessity for additional reverse transcription step as is required in 
NASBA and SMART techniques. So, PCR detection of the pathogenic viruses 
after RT-Bst reaction will be cheaper than those of NASBA and SMART reactions. 
RT-Bst technique was found useful for amplification and detection of linear viral 
single stranded RNA genomes in this study. However, this technique can be 
applied to other forms of DNA and RNA genomes.  
It was reported that NASBA and SMART techniques can work optimally at 41 C 
and 42 C, respectively. We found that RT-Bst amplification can be performed at 
42 C and 50 C using MMuLV and RevertAid Premium/Maxima reverse 
transcriptase, respectively. This option of RT-Bst amplification at an elevated 
temperature of 50 C will help to eliminate secondary structures of RNA template 
to improve transcription as well as amplification of full length cDNA. RT-Bst worked 
efficiently and amplified different sections of hRSV genome compared to the 
QuantiTect reverse transcription kit in this study (Section 4.4.1). The 
performance of RT-Bst amplification for the whole genome amplification was 
improved when the thermostable forms of MMuLV reverse transcriptase, Maxima 
and RevertAid Premium reverse transcriptases (Fermentas, York, UK), were 
used. Therefore, the thermostable form of MMuLV reverse transcriptase, 
RevertAid premium reverse transcriptase (Fermentas, York, UK), was used for 
RT-Bst amplification of viral RNA extracted from nasal samples (Chapter 5) to 
validate its application for multiplex detection of pathogenic viruses of the 
respiratory tract. Based on the findings in this study it is proposed that RT-Bst 




method can be a potentially better substitute for commercial reverse transcription 
kit for example, QuantiTect reverse transcription kit (QIAGEN, Crawley, UK).   
Whole genome amplification is an important and useful method for nonspecific 
amplification and detection of novel virus sequences (reviewed by Ambrose and 
Clewley, 2006). RT-Bst PCR is a novel approach developed in this study for 
amplification of whole genome of RNA viruses. This approach provides the 
opportunity for WGA using both random and sequence specific primers (Section 
4.5.3). Multiple PCR bands appeared after using cDNA as template from RT-Bst 
reaction using 8 pairs of sequence specific primers (Figure 4.13). These multiple 
bands could be due to the presence of excess primers in the RT-Bst reaction 
which was carried over in the subsequent PCR reaction. This technique also 
enables scientists to amplify viral RNA directly without going through the series of 
steps such as, 1st strand synthesis, 2nd strand synthesis, synthesis of blunt ended 
double stranded cDNA, adapter ligation, PCR amplification, cloning and 
sequencing (Reyes and Kim, 1991). A further modification of the WGA using the 
RT-Bst PCR technique from RNA viruses using random hexamers with tail 
sequences has been described in Chapter 6. Whole genome amplification using 
the RT-Bst PCR is a cheaper and simpler method for whole genome amplification 
compared to the SISPA technique (Section 6.5). 
RT-Bst amplification was found to be the most effective protocol for synthesis and 
amplification of cDNA from RNA samples in a one-tube reaction from nanogram 
concentrations in this study. RT-Bst amplified products can be used as template 
for PCR detection similar to other commercially available reverse transcription kit. 
RT-Bst amplified product was also found to be suitable for quantitative PCR 
(qPCR) amplification when they were diluted 1:10 (data not shown). RT-Bst 
amplification can be used for producing sufficient nucleic acid material to enhance 
broad-spectrum pathogen detection using microarray platforms. Similar 
amplification of viral nucleic acids from clinical samples using phi29 DNA 
polymerase was found to improve detection and characterization of pathogenic 




viruses in microarray analysis by other workers (Erlandsson et al., 2011). Although 
RT-Bst amplification was found useful for MS2 and hRSV in this study, a larger 
scale study of this technique will be necessary to validate its application to improve 
detection of pathogenic viruses in patient samples. In this study we determine the 
sensitivity of the RT-Bst technique using a qualitative PCR based assay. However, 
a quantitative real-time PCR assay will be more realistic to determine the 
sensitivity of the RT-Bst amplification. This technique was used to validate its 
efficiency for multiplex detection of the pathogenic viruses in 70 nasopharyngeal 





RT-Bst amplification for detection 
and characterization of pathogenic 
viruses of the respiratory tract 




5.1 Introduction and aim 
The developments of molecular diagnostic methods have revolutionized the 
detection of pathogenic viruses of the respiratory tract not only for unparalleled 
sensitivity of detection  but also for assaying a large number of causative agents at 
a reasonable cost (Antonishyn and Levett, 2010; Beck and Henrickson, 2010),. 
This has the opportunity to better understand the clinical significance of infections 
involving multiple agents (reviewed by Olofsson et al., 2011). Conventional culture 
and serological techniques are routinely used for diagnosis of pathogenic viruses 
of the respiratory tract (Gardner and McQuillin, 1968). Although cell culture is still 
considered as the gold standard for virus detection it is usually too slow to be used 
for timely diagnosis of any infection (Leland et al., 2007).  The use of 
immunofluorescence assays can speed up detection but are less sensitive (45 to 
98%) compared to that of culture methods (Takimoto et al., 1991). Other major 
limitations of tissue culture methods are the requirement for complicated 
procedure for propagation of some viruses for example, coxsackieviruses. This 
method is cumbersome and diagnostic laboratories must maintain several cell 
lines simultaneously for propagating such viruses. Molecular biology techniques 
such as PCR and RT-PCR are more sensitive and rapid compared to cell culture 
and antigenic detection methods and hence could solve these problems.  
PCR and RT-PCR are frequently used for detection and typing of respiratory tract 
viruses (Donofrio et al., 1992; Eugene-Ruellan et al., 1998; Freymuth et al., 1997; 
Gilbert et al., 1996). Cold and flu-like illness (CFLIs) is mostly caused by either 
single or multiple viruses associated with respiratory tract infections for example, 
influenza A, B and C; parainfluenza 1-4, human coronavirus (229E and OC43), 
human respiratory syncytial virus (hRSV), human adenovirus (hAdV) and human 
enteroviruses (hEV) (Turner, 1998). Human rhinoviruses are the most common 
cause (50-80%) of CFLIs (Arruda et al., 1997; Johnston et al., 1993). The other 
common pathogenic viruses responsible for an estimated 8-15% of cold and flu 
like illness include; human influenza viruses A, B and C; human parainfluenza 




viruses 1-4; human coronaviruses 229E and OC43; respiratory syncytial viruses, 
human adenoviruses and human enteroviruses (Turner, 1998; Pappas et al., 2008; 
Eccles et al., 2007; Pizzichini et al., 1998). Cold infections can also be complicated 
by additional bacterial infection causing pharyngitis or sinusitis. Consequently 
multiplexed detection of a panel of common pathogenic viruses of the respiratory 
tract could aid in the detection, intervention and prevention of respiratory tract 
infections. 
Multiplex RT-PCR methods are steadily being embraced by diagnostic laboratories 
for the detection of a complete panel of respiratory tract viruses (Aguilar et al., 
2000; Coiras et al., 2003, 2004; Echevarria et al., 1998a; Fan et al., 1998; 
Grondahl et al., 1999; Osiowy, 1998; Templeton et al., 2004). There are a number 
of new multiplex PCR-based technologies that have been introduced by different 
companies such as, micro-bead suspension array (Mahony et al., 2007a), ResPlex 
technology (Brunstein et al., 2008), Infinity system (Raymond et al., 2009) and 
Jaguar system (Beck et al., 2010) for the detection of a panel of respiratory tract 
pathogens (Section 1.5.8). However, none of these emerging technologies have 
yet been approved by the FDA for clinical diagnosis and they have only been 
recommended for research use. These technologies also require sophisticated 
instruments and may not be appropriate for each and every diagnostic laboratory. 
In a recent study, Raymond et al. (2009) developed and compared two methods –
single TaqMan quantitative real-time PCR and automated microarray analysis 
using an Infiniti analyser for detection of 23 common respiratory tract viruses 
associated with infected and hospitalized children. The performance of microarray 
analysis for detection of viruses was assessed by TaqMan real-time PCR and was 
found to be similar detecting 94.1% of specimens as positive. The success of 
microarray detection depends on the hybridisation of nucleic acid probes to target 
nucleic acid. Therefore, often it is necessary to amplify the amount of nucleic acid 
in the study sample for appropriate detection in microarray analysis. Genomic 
nucleic acids present in a sample can be amplified by either PCR or non-PCR 




based isothermal nucleic acid amplification techniques (Raymond et al., 2009; Wu 
et al., 2006; Arriola et al., 2007; Erlandsson et al., 2011). It is worth mentioning that 
isothermal whole genome amplification (phi29 amplification) technique is less error 
prone producing only 1 error per 106-107 bases (Esteban et al., 1993) and is also 
less biased, producing less than 3-fold bias compared to PCR-based whole 
genome amplification (Dean et al., 2002; Blanco et al., 1989; Hosono et al., 2003; 
Lasken et al., 2003). On the contrary, a PCR based whole genome amplification 
technique produces 1 error per 103 bases and introduces a bias of 104-106-fold in 
the representation of the amplified DNA producing a distorted representation of the 
starting template. Although it is possible to detect a panel of viruses using 
microarray technology, it is highly sophisticated and relatively expensive for 
individual laboratories to use for routine diagnosis of viral infections during 
seasonal outbreaks (Finkelman et al., 2007; To et al., 2009). 
One step RT-PCR is the most commonly used technique for molecular detection of 
respiratory tract viruses (Bellau-Pujol et al., 2005; Poddar, 2002) but is expensive 
compared to two-step RT-PCR as a routine diagnostic test (Sections 2.6.5). 
Screening a panel of viruses causing respiratory tract infections using one step 
RT-PCR requires more template RNA and is also more expensive (Section 5.3). 
The application of multiplex two-step RT-PCR requires less template RNA and is 
less expensive. However, the low copy number of viral genomes at femtogram 
levels may not be amplified by PCR leading to false negative results. Recently, a 
new technique, Amp-PCR (Section 1.7), has been introduced by Erlandsson et al., 
(2010) to enrich low copy of virus genomes containing linear and circular dsDNA 
from clinical samples. Unlike other PCR techniques, this technique combines 
phi29-amplification and real-time PCR amplification in the same tube. Initially, two 
reactions are separated by a wax layer so that they cannot mix. Phi29-
amplification preceding the real-time PCR amplification increases PCR signals 
100x106-fold and enables detection of samples containing target nucleic acids 
normally below the detection limit of specific real-time PCR. 




In this study, a new protocol called ‘RT-Bst’ was developed (discussed in Section 
4.4) by combining reverse transcription and Bst DNA polymerase amplification to 
enrich for cDNAs in a one tube reaction. Amplification of cDNA from a minute 
amount of template RNA is expected to improve the sensitivity of subsequent 
detection of target sequences using singleplex and multiplex PCR (Section 4.4). It 
was observed in this study that RT-Bst amplification can be used for the synthesis 
and amplification of cDNA from the bacteriophage MS2 RNA virus genome 
(Section 4.4). It was demonstrated that this RT-Bst technique can be applied for 
the synthesis and amplification of cDNA from RNA viruses in patient samples. 
Seventy nasopharyngeal samples (collected from Chelsea and Westminster 
Hospital, London, Section 2.1.3) were screened in this study using a multiplex 
OneStep RT-PCR kit (QIAGEN, Crawley, UK) and a newly developed protocol 
RT-Bst (Section 4.4) which was followed by multiplex PCR for detection of 12 
common respiratory tract viruses in 3 multiplex assays (Section 2.6.6). Results 
obtained after multiplex RT-Bst PCR detection were compared with those of 
multiplex one-step RT-PCR detection to validate the performance of the newly 
developed RT-Bst method for detection of common respiratory tract viruses. These 
findings were also compared with those of the diagnostic tests performed at the 
Chelsea and Westminster Hospital as part of their standard operating procedures 
for further evaluation of the method.  
 
5.2 Application of a RT-Bst technique for amplification of cDNA 
from RNA viruses in nasopharyngeal samples 
RNA from the nasopharyngeal aspirates was extracted using the QIAamp viral 
RNA mini kit (Section 2.6.3). 2.5 µl of extracted RNA was amplified using the RT-
Bst protocol (Section 2.6.6.1) and used for the detection of 12 common respiratory 
tract viruses in 3 multiplex PCR formats (Section 2.6.7). The same extracted 
nasopharyngeal sample RNA (2.5 µl for each multiplex reaction) was used in three 




multiplex one-step RT-PCR reactions for the detection of 12 respiratory tract 
viruses (Section 2.6.5).  This allowed a comparison to be made between the virus 
detection performances of each technique.  
Additional primers recommended by the WHO for detection of influenza A and 
swine influenza A were used to screen all samples using either a singleplex one-
step RT-PCR or a singleplex PCR subsequent to RT-Bst amplification. MS2 RNA 
was used as carrier RNA instead of the carrier RNA provided with the QIAamp 
viral RNA kit. MS2 RNA was also used as an internal control to check the 
performance of RNA extraction, reverse transcription and PCR detection 
processes.  
PCR amplification bands which appeared positive for any virus were purified from 
the above samples using a PCR product purification column (Section 2.6.11) and 
the purified DNA was sequenced (Section 2.7) either using forward or reverse 
primers previously used for the PCR amplification. In the case where PCR was 
positive for both one step RT-PCR and RT-Bst amplification, either one of the PCR 
products was purified and sequenced. Samples positive for multiple viruses in 
multiplex PCR or multiplex RT-PCR were repeated in singleplex PCR or singleplex 
RT-PCR using corresponding virus specific primers for purification of the PCR 
product and sequencing. Alternatively, PCR products were cloned into a pCR 2.1 
cloning vector using the TOPO-TA cloning kit (Section 2.6.8). One or two colonies 
obtained from the transformation of E. coli with plasmids (selected on LB agar 
containing kanamycin (30.0 µg µl-1) were picked at random to confirm the 
presence of a cloned PCR product insert by colony PCR (Section 2.6.9). Clones 
positive for the desired PCR products were subsequently cultured in LB broth 
containing kanamycin (30.0 µg µl-1) for plasmid extraction (Section 2.6.10). 
Purified plasmids were sequenced using M13 forward or reverse primer (Section 
2.7). Sequences information was analysed using the BLASTn tool 
(http://blast.ncbi.nlm.nih.gov/Blast.cgi) and matching with other sequences in the 
NCBI database for confirmation of viral sequences (Section 2.8). 




The one-step RT-PCR and RT-Bst PCR techniques described in this section were 
used for the detection of twelve common respiratory tract viruses in three multiplex 
assays in seventy patient nasopharyngeal samples (Table 2.4). Prior to this, these 
seventy samples were also analysed by the Department of Virology, Chelsea and 
Westminster Hospital using immunofluorescence (IF) and/or PCR techniques. Our 
results were compared with that of the hospital data in Table 5.1 (samples 1-25), 
Table 5.2 (samples 26-50) and Table 5.3 (samples 51-70). The performances of 
the different techniques in terms of detecting viruses assayed are compared in 
these tables. 
It was found that compared to one-step RT-PCR, RT-Bst PCR detected 4.3% 
more influenza A virus, 20% more for hRSV, 1.4% more SWA and 1.4% more 
hMPV. The RT-Bst PCR detection was respectively 4.3%, 1.4% and 4.2% less 
effective in the detection of hRV, parainfluenza 1 and influenza B. Overall RT-Bst 
PCR in this study was found to be 2.8% less efficient than multiplex one-step RT-
PCR for detection of 12 common respiratory tract viruses.   
The findings of this study were compared with those of the initial hospital diagnosis 
to evaluate our detection methods. Multiplex RT-Bst PCR was able to detect virus 
in 7.8% and 8.6% more samples compared to IF detection for hRSV and IA 
respectively. SWA, hRV, hMPV and parainfluenza 4 were detected in 1.4% more 
samples using multiplex RT-Bst PCR compared to the IF technique. Influenza B 
was detected only by IF technique (1.4%) and was not detected using RT-Bst PCR. 
Parainfluenza 1 virus was only detected using one-step RT-PCR in this study. It 
was not possible to detect parainfluenza 1 virus by any of the RT-Bst PCR and IF 
techniques. Overall detection of any virus in 70 samples tested was enhanced 
17.2% using multiplex RT-Bst PCR compared to the IF method. However, it was 
not possible to compare RT-Bst PCR results with those of the hospital PCR results 
due to inadequate data available for PCR detection of the samples. 
Co-infections were found in 5.6% and 2.4% of the total samples using the one-step 
RT-PCR and RT-Bst PCR techniques, respectively. Human respiratory syncytial 




virus was found to be present in all of the co-infections detected in different 























Table 5.1: Results for the detection of 12 respiratory tract viruses in 








Chelsea and Westminster 






          
NS1 m1861375 IA H1N1 IA IA 
NS2 W1911400 Negative Negative hRSV hRSV 
NS3 W188400 Negative n/a1 Negative Negative 
NS4 M1881699 
Positive after 5 
days n/a Negative hRSV 
NS5 T2060569 Negative Negative Negative Negative 
NS6 1117207H Negative n/a Negative Negative 
NS7 S591685 Negative n/a Negative Negative 
NS8 T2082489 
Negative but 
transplant patient n/a Negative hRSV 
NS9 F1750270 Negative n/a hRSV hRSV 
NS10 H2002593 Negative n/a Negative Negative 
NS11 
CID503072
0 Negative n/a  Negative Negative 
NS12 H2024910 Negative Negative  Negative Negative 
NS13 S592481 Negative n/a  Negative Negative 
NS14 T12077805 Negative Negative  Negative Negative 
NS15 1200415H Negative hRSV   hRV hRV 
NS16 M1877965 Negative Negative  Negative Negative 
NS17 T2061970 Negative Negative  Negative Negative 
NS18 M1877977 Negative Negative  Negative Negative 
NS19 M1861081 Negative n/a  Negative Negative 
NS20 T2055922 Negative n/a  Negative Negative 
NS21 T2078974 Negative Negative  Negative Negative 
NS22 M1903348 Negative n/a  Negative Negative 
NS23 W1890524 hRSV  n/a IA IA, hRSV 
NS24 H2017121 Negative n/a  Negative Negative 
NS25 1057339H Negative Negative  Negative Negative 
1
, not available 
 




Table 5.2: Results for the detection of 12 respiratory tract viruses in 







Westminster Hospital  
 This study 




      
NS26 W1891748  Negative hRSV  hRV Negative 
NS27 T2082278  Negative hRV  hRV Negative 
NS28 T2078395  Negative hRSV  hRSV Negative 
NS29 W1884596  Negative Negative  Negative Negative 
NS30 W1890529  Negative n/a1  Negative Negative 
NS31 M1903413  Negative n/a  Negative IA* 
NS32 T2082862  Negative n/a  Negative Negative 
NS33 H2005688  Negative Negative  Negative IA* 
NS34 X503019  Negative n/a  Negative IA* 
NS35 T2082072  hRSV hRSV  hRSV hRSV 
NS36 M1908183  Negative Negative  Negative Negative 
NS37 W1889652  Negative Negative  Negative Negative 
NS38 H2005727  Negative n/a  Negative Negative 
NS39 M1856019  hRSV hRSV  hRSV hRSV 
NS40 M1880106  Negative n/a  Negative Negative 
NS41 T2078454  hRSV n/a  hRSV, RV, IA IA 
NS42 M1864581  hRSV hRSV  hRSV, hRV hRSV 
NS43 W1884898  Negative Negative  Negative Negative  
NS44 T2080387  Negative Negative  Negative Negative  
NS45 H2005617  Negative Negative  Negative Negative  
NS46 T2079023  Negative hRSV  hRSV hRSV 
NS47 M1902196  Negative IA  IA IA 
NS48 S605599  hRSV hRSV  hRSV hRSV 
NS49 H2023649  hRSV hRSV  hRSV hRSV 
NS50 T2059421  Negative hRSV  hRSV hRSV 
1
, not available; *Primers used according to WHO recommendation  
 
 




Table 5.3: Results for the detection of 12 respiratory tract viruses in 







Westminster Hospital  
This study 
IF PCR One step 
RTPCR 
RTBst PCR 
      
NS51 X509003 Negative Negative Negative Negative 
NS52 W1914290 hRSV n/a1 hMPV, hRSV hMPV, hRSV 
NS53 W1890542 Negative Negative Negative Negative 
NS54 T2057728 Negative Negative Negative Negative 
NS55 M1882085 Negative Negative Negative Negative 
NS56 S591988 Negative n/a1 Negative Negative 
NS57 M1880948 Negative Negative Negative Negative 
NS58 H2015945 Negative Negative Negative Negative 
NS59 H2007221 Negative n/a1 Negative Negative 









a 1 Negative 
NS62 F1746086 Negative Negative Negative Negative 
NS63 F1748369 Negative Negative Negative Negative 
NS64 W1890500 Negative Influenza B Influenza B Negative 
NS65 H2016724 Negative hRSV hRSV hRSV 
NS66 W1932015 Negative n/a1 
hRSV, 
Influenza B Negative 
NS67 T2078447 hRSV hRSV hRSV hRSV 
NS68 H2046830 
Influenza 
B Influenza B Influenza B Negative 




7 Negative Negative Negative Negative 
1, not available 
 
 





The application of a novel method — RT-Bst for reverse transcription and 
amplification of cDNA from RNA extracted from 70 nasopharyngeal samples was 
validated.  The performance of RT-Bst PCR detection was compared with a 
commercially available OneStep RT-PCR kit (QIAGEN, Crawley, UK) to 
determine the feasibility of RT-Bst PCR technique as an alternative approach. 
Random pentadecamer primers were used in this study to increase the yield of 
RT-Bst amplification as it was found to be useful to improve the performance of 
reverse transcription in previous studies (Stangegaard et al., 2006). All of the 
samples were detected in duplicate for both multiplex one-step RT-PCR and RT-
Bst PCR in order to compare their performances for detection of 12 common 
respiratory tract viruses. Although the initial template RNA amount (2.5 µl) was the 
same for both one step RT-PCR and RT-Bst amplification, only 1.0-2.0 µl of RT-
Bst amplicons were used as templates for multiplex PCR detection of 12 
respiratory tract viruses. As a result, multiplex RT-Bst PCR represented 1:10 to 1:5 
times less template included for PCR amplification compared to multiplex one-step 
RT-PCR. This is possibly one of the reasons for the observed lower efficiency of 
RT-Bst PCR detection in some cases. 
In the study, all of the seventy samples were tested using multiplex one-step RT-
PCR and RT-Bst PCR to determine the performance of RT-Bst PCR compared to 
the commercial OneStep RT-PCR kit (QIAGEN, Crawley, UK). Multiplex RT-Bst 
PCR was repeated an additional three times after the duplicate detection of 
viruses (only for the first 25 samples). It was possible to detect two more samples 
(4 and 8) positive for hRSV compared to the one-step RT-PCR (Table 5.1) after 
this repeat experiment. Detection of hRSV in sample 4 and 8 was further 
supported by patient information from the hospital. These two patients were organ 
transplant recipients and they developed hRSV infection subsequently after five 
days of collecting the nasopharyngeal samples. This result indicates that it was 
possible to detect viruses present in the samples normally below the PCR 




detection limit after amplifying the cDNA copy using RT-Bst technique and by 
repeating the PCR for additional three times. Therefore, for all of the remaining 
samples (26-70), RT-Bst PCR represented 1:5 to 1:10 times less template 
amplification in PCR compared to one-step RT-PCR. On the other hand virus 
genomes could be detected successfully using one-step RT-PCR even from a 
sheared RNA as long as the target sequence was intact which could possibly not 
be amplified using RT-Bst technique as it requires relatively larger piece of RNA 
for RT-Bst amplification. RNA is labile and degrades easily even during the nucleic 
acid extraction and sample processing. However, a positive result in molecular 
diagnostic test may not always be associated with infection state but can be a 
clinically irrelevant carrier state (Brittain-Long et al., 2010). 
It is envisaged that RT-Bst amplification becomes successful only when the 
template length is reasonably long (> 2.0 kb), which is a precondition for whole 
genome amplification of DNA using a similar enzyme, phi29 DNA polymerase 
(Berthet et al., 2008). It was shown in a previous study that the quality of the 
extracted RNA was important for efficient reverse transcription which will also be 
necessary for RT-Bst amplification (Bustin and Mueller, 2005). Primer design, the 
position of the target sequence in the whole genome and the amplicon size for 
PCR detection were also important factors to be considered for RT-Bst PCR 
detection as it was also found to be critical for RT-PCR in previous studies 
(Mueller et al., 2004; Raengsakulrach et al., 2002; Bustin and Mueller, 2005 ). The 
central portion of the hRSV genome was found to amplify more efficiently than the 
terminal parts of the RNA genome as observed in previous assays (Section 4.4.1, 
4.4.2, 4.4.3). This type of amplification was possibly due to the random binding of 
primers throughout the genome and amplifying cDNA using Bst DNA polymerase 
starting from the terminal ends towards the central part of the cDNA. 
In virology research, the sensitivity of the PCR technique is determined by 
comparing the results with that of immunofluorescence and tissue culture (Bellau-
Pujol et al., 2005; Hindiyeh et al., 2001). In this study, it was not possible to 




determine the sensitivity of the RT-Bst PCR method due to the lack of facilities in 
house to perform tissue culture and immunofluorescence tests. If we compare the 
performance of the newly designed RT-Bst PCR with the standard one-step RT-
PCR technique, they were comparable. We found the performance of RT-Bst PCR 
better than the immunofluorescence tests performed by the hospital team on 70 
samples. It may be noted that hospital samples were collected and tested 6-12 
months before we detected viruses in the laboratory using multiplex RT-Bst PCR 
and one-step RT-PCR. This late processing of samples may cause loss of 
templates in the nasopharyngeal samples. A comparison of the detection of 
viruses by the hospital team and this study is shown in Table 5.1, 5.2 and 5.3. The 
sensitivity of the different assays varied for detection of different types of viruses. 
In a previous study Hindiyeh et al., (2001) used Prodesse Hexaplex multiplex PCR 
for the detection of pathogenic viruses of the respiratory tract. They found that 
detection of hRSV (91%) was less sensitive compared to the other viruses such as 
influenza A, influenza B and PIV1-3 showing sensitivity of 98.6%, 100% and 100%, 
respectively. In this study, performances of one-step RT-PCR and RT-Bst PCR 
were the same for detection of hRSV whereas the performance of RT-Bst PCR 
was 4.3% better for detection of influenza A and 4.3% less for detection of hRV.  
In earlier studies, other workers used multiplex hemi-nested (Bellau-Pujol et al., 
2005) and nested (Coiras et al., 2003) PCR to confirm the sequences of the 
amplified products in their multiplex PCR assays. However, in this study we 
sequenced (Section 2.7) the amplified products after multiplex PCR assay to 
determine the presence of any pathogenic virus. Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) sequence was used as internal control in another study 
to monitor the performance of RNA extraction and PCR amplification (Bellau-Pujol 
et al., 2005). GAPDH was chosen as an internal control as it is transcribed by 
nasal mucous cell and would be present in all samples to monitor the assays. 
However, GAPDH was not found to be useful as an internal control in this study 
owing to the inconsistent amplification of GAPDH sequences from different 
samples using one-step RT-PCR and RT-Bst PCR techniques. This could be due 




to the poor abundance of nasal mucosal cells or degradation of the transcribed 
products. Moreover, the amplicon size of GAPDH was close to that of 
parainfluenza 2 (in multiplex 2) (Table 2.4) in this study and it was difficult to 
differentiate parainfluenza 2 and GAPDH PCR bands on the same gel after 
multiplex PCR amplification. Consequently, it was necessary to repeat the PCR 
using individual primer sets to determine the presence of GAPDH or parainfluenza 
2 virus. Other workers also used internal control supplied with the Promega kit to 
determine the presence of any amplification inhibitors during multiplex reverse 
transcription nested-PCR detection of respiratory tract viruses from clinical 
samples (Coiras et al., 2003). In this study bacteriophage MS2 RNA was used as 
carrier RNA instead of the total RNA provided with the QIAamp RNA mini kit 
(QIAGEN, Crawley, UK). MS2 RNA was also used as internal control to check the 
performance of the test. Unlike GAPDH sequence as internal control, MS2 
sequence consistently produced positive bands and reflected upon the 
performance of tests starting from extraction to amplification. MS2 sequence was 
detected from each and every sample by singleplex PCR in addition to three 
multiplex one-step RT-PCR and RT-Bst PCR detection. If it was not possible to 
amplify the MS2 sequence properly in any of the samples, possibly due to the 
presence of any contaminants or inhibitors, the whole process was repeated to 
obtain more acceptable results. MS2 RNA was also used as a control RNA by 
Mahony et al. (2007a) during detection of a panel of twenty human respiratory tract 
viruses using multiplex PCR and a fluid microbead-based assay. However, in a 
previous study it was found that only 6% of researchers test their nucleic acid 
samples for the presence of inhibitors (Bustin, 2005). 
Appropriate primer design to amplify a suitable size of product could be useful to 
improve RT-Bst PCR detection. It was not possible to design and optimise new 
primer pairs in this study for pathogenic viruses of the respiratory tract due to the 
lack of facility to propagate viruses. In the case of influenza A virus detection two 
different primers were used and one of them was a degenerate primer 
recommended by WHO for detection of influenza A virus (Appendix Table A1). The 




RT-Bst PCR amplification and detection was enhanced when both the primers 
were used for detection of influenza A virus in samples 31, 33 and 34 (Table 5.2). 
Ideally, it is necessary to use positive control stocks of viruses to evaluate the 
performance of any method (Bellau-Pujol et al., 2005). However, due to the 
restrictions on propagating pathogenic viruses in this study consequently tissue 
culture media positive for hRSV, parainfluenza 2 and influenza B, (provided by 
Saint Marys Hospital, London), were used to check the performance of multiplex 
one-step RT-PCR and RT-Bst PCR amplification. Primers used for the detection of 
hRV in this study were shown to amplify over 60 serotypes (Savolainen et al., 
2002) which under represents detection of the full range of 100 genotypes of hRV.  
 
Nuclease contamination of viral RNAs is very common when they are present in 
any live sample e.g. intraocular fluids (Wiedbrauk et al., 1995) and urine 
(Chernesky et al., 1997). This might lead to false-negative results especially during 
detection by PCR. The quality of template RNA is also important for reverse 
transcription (Berthet et al., 2008) as well as important for RT-Bst amplification. In 
order to carry out multiple tests from the same sample, viral samples and extracted 
RNA were aliquoted upon receipt to avoid multiple freeze-thaw cycle. In this study 
it was found that the performance of nucleic acid extraction and PCR detection 
varied with the variation in the sample for example, presence of host cells and 
virus types. It was also observed that RT-Bst amplification was more efficient when 
RNA was used immediately after extraction of hRSV RNA from tissue culture 
media and commercially available MS2 RNA (Section 4.4). Adding MS2 RNA as 
carrier RNA instead of the carrier RNA provided by Qiagen performed better for 
RT-Bst amplification and PCR detection of viruses which could be due to the purity 
and linearity of MS2 RNA over the total RNA provided with the kit (data not shown). 
One drawback with the RT-Bst amplification was that the reaction was found to be 
more sensitive when it was set up using newly purchased enzymes and the 
reaction efficiency gradually dropped with the time and use of the enzymes (data 
not shown). 




A super high speed quantitative real time PCR has been introduced recently by 
Sakurai et al. (2011) for rapid typing of influenza virus in less than 20 minutes. 
However, it normally requires approximately 2 hours for a qPCR run using other 
thermal cyclers. This high speed qRT-PCR takes the advantage of newly designed 
heating system in the block. Although the authors used RNA transcripts from 
reconstructed plasmids and tissue culture fluid for validating the methods, their 
approach was very sensitive and could detect 1 copy of RNA transcript reaction-1 
and 10-1 pfu reaction-1 in tissue culture fluid. This rapid method would be very 
useful for monitoring the outbreak and control the spread of respiratory tract 
infections especially in the hospital environment. A pre-enrichment of cDNA using 
the RT-Bst technique could be useful for such rapid detection of any pathogenic 
viruses using qRT-PCR from broad range of clinical and environmental samples. 
Screening patient samples for a panel of viruses could be helpful for appropriate 
and timely management of spread of infections and unwanted prescription of 
antibiotics (Lee et al., 2011; Dosh, 2000). Although RT-Bst amplification takes a 
little longer than one step RT-PCR, cost wise it was significantly cheaper in 
consumables than multiplex one-step RT-PCR reaction. Considering the cost 
effectiveness of RT-Bst amplification and PCR detection additional pathogenic 
viruses such as enterovirus and bocavirus could be screened using this technique. 
Screening a panel of respiratory tract viruses will help control spread and 
intervention of respiratory tract infections (reviewed by Olofsson et al., 2011). 
Taken together, the evidence and findings in this chapter suggests that RT-Bst 
amplification could be a more sensitive and cheaper option for rapid detection of a 
panel of respiratory tract viruses commonly causing human respiratory tract 
infections. RT-Bst amplification is a competitive method for reverse transcription 
and amplification of cDNA directly from an RNA sample. A more detailed study is 
needed for further optimization and validation of the method using different types 
of virus genomes at various temperatures before applying it on clinical samples. 




However, RT-Bst amplification technique has potential to be used as an alternative 




Amplification of genomic RNA of 
viruses using a novel method—
RT-Bst SPA  
 
 




6.1 Introduction and aims 
The detection of currently unknown pathogenic viruses from clinical samples is 
one of the most challenging problems in diagnostic molecular virology. Known 
viruses can be detected using an appropriate primer pair in PCR amplification. 
However, primers specific for known viruses may not bind specifically to nucleic 
acids of currently unknown and new variants of viruses leading to false negative 
results (Zhang et al., 2011; Quan et al., 2007). Therefore a sequence independent 
approach will be required for detection of these new types of viruses. Whole 
genome amplification (Section 1.6) is a sequence independent approach for 
discovery, detection, and characterization of novel pathogenic microorganisms 
from a limited amount of DNA (Hutchison and Venter, 2006; Lasken, 2007; 
Hughes et al., 2005). The entire genome of pathogenic microorganisms can be 
amplified broadly in two ways, using PCR based techniques and non-PCR based 
isothermal amplification techniques (Section 1.6). PCR based whole genome 
amplification uses random or degenerate primers for PCR amplification of the 
whole genomes. In another approach genomic DNA is digested to ligate with the 
adapters for subsequent amplification of the whole genome from the adapter 
sequences. Isothermal amplification of nucleic acids can use phi29 or Bst DNA 
polymerase, random primers and nucleotides to amplify the nucleic acids using 
multiple displacement activity. Random primers bind to different areas of the 
denatured template and the polymerases extend the primers and synthesize the 
complementary strand. Random primers proceed and displace the 5’-end of the 
upstream strands. This reaction is repeated for the displaced strands producing a 
hyper-branched amplification of DNA (Figure 1.4). NASBA is another method used 
for the amplification of an RNA template (Guatelli et al., 1990) (Figure 1.1). 
Many new virus types have been identified with the development of molecular 
techniques in the last two decades (Section 1.1). Sequence independent single 
primer amplification (SISPA) is a PCR based method for the amplification of whole 
genomes and library preparation for sequence based detection of any 




uncharacterized viruses (Section 1.8.1.2). SISPA requires the synthesis of double 
stranded cDNA (from ssRNA genomes) and ligation of adapters at both ends of 
digested double stranded cDNA. Fragments of dsDNA flanked with primer 
sequences are amplified using a single primer (Figure 1.3). Allander et al. (2007) 
discovered new types of human polyomavirus using sequence independent single 
primer amplification (SISPA). The SISPA technique, in combination with 
immunoscreening was also used for characterization of Norwalk virus from faeces 
samples (Matsui et al., 1991) and human astrovirus from tissue culture 
supernatants (Matsui et al., 1993).  DNase-SISPA is a modified version of SISPA 
technique that uses a DNase step to remove contaminating human and other free 
DNA molecules. Virus nucleic acids that remain protected within their capsids are 
subsequently extracted and amplified using the SISPA technique. Allander et al. 
(2001) identified new parvoviruses from serum sample using the DNase-SISPA 
technique.  
Phi29-amplification of the whole genome using multiple displacement amplification 
(MDA) (Section 1.8.2.1) can produce 100 µg of DNA from a few microliters of 
blood (Hosono et al., 2003) or even from fingerprints (Sorensen et al., 2004). It is 
possible to replicate 99.8% of the template genome with low amplification bias 
(less than three-fold) in the representation of different regions of the genome using 
MDA (Dean et al., 2002; Hosono et al., 2003). Amplicons generated in MDA are 
high-molecular-weight DNA (Dean et al., 2002 and 2001) of 2 to 100 kb in length. 
On the contrary, PCR-based whole genome amplification methods are highly 
biased (amplification bias 104-106-fold) and produces shorter products (only a few 
hundred base pairs in length) (Dean et al., 2002). Multiple displacement 
amplification (MDA) products have been used for restriction fragment length 
polymorphism (RFLP) detection (Luthra et al., 2004, Dean et al., 2002), gene 
rearrangement and DNA sequencing (Mai et al., 2004; Paez et al., 2004; Lovmar 
et al., 2003; Detter et al., 2002; Dean et al., 2001). Phi29 DNA polymerase is a 
high fidelity (Nelson et al., 2002; Esteban et al., 1993) enzyme and has been found 
to be useful for genotyping of SNPs and point mutations (Baker et al., 2004; Paez 




et al., 2004; Hosono et al., 2003; Lovmar et al., 2003; Tranah et al., 2003; Dean et 
al., 2002).  
The large fragment of Bst DNA polymerase is another enzyme that amplifies the 
whole genome using multiple displacement amplification technique with less bias 
(less than three-fold) (Lage et al., 2003; Dean et al., 2002; Rook et al., 2004). Bst 
DNA polymerase amplifies the whole genome in a similar mechanism to phi29 
DNA polymerase. Unlike phi29 DNA polymerase Bst DNA polymerase does not 
have 3’ to 5’ exonuclease activity (Aliotta et al., 1996). Bst DNA polymerase was 
also used for the amplification of DNA from formalin-fixed paraffin-embedded 
tissues (Aviel-Ronen et al., 2006). Bst DNA polymerase amplification can be used 
for isothermal nucleic acid amplification of the human genome for comparative 
genomic hybridization array (Aviel-Ronen et al., 2006).  
Whole genome sequencing and microarray analysis require higher concentrations 
of DNA which can be amplified from limiting amounts of clinical samples using any 
of the PCR or non-PCR based whole genome amplification methods (Erlandsson 
et al., 2011; Mejlhede et al., 2009, Pan et al., 2008; Palacios et al., 2007). The 
whole genome amplified DNA can be either cloned to make a library for analysing 
the sequences using the Sanger sequencing method or sequenced directly using 
Next Generation Sequencing (NGS) techniques for example, 454 (Roche), Solexa 
(Illumina) and SOLiD (ABI) (Section 1.8.4). Although the NGS techniques produce 
millions of sequences in a single round of operation (Margulies et al., 2005), they 
can vary in their read lengths based on the type of technology used. Both the 
Sanger and NGS approaches are relatively expensive to determine the whole 
genome sequences and to detect new types of sequences. Microarray analysis 
can be a cheaper approach for detection of known and undescribed viruses from 
clinical samples (Wang et al., 2003; Gardner et al., 2010) (Section 1.5.7). In a 
recent study, Nicholson et al., (2011) successfully demonstrated the utility of a 
panviral microarray (Virochip platform) for detection of swine viruses in both cell 
culture supernatant and clinical samples. This Virochip platform contains highly 




conserved 70 mer sequences from every sequenced viral genome for 
simultaneous detection of many known, novel and emerging viruses (Wang et al., 
2003). Gardner et al. (2010) designed a pan microbial detection array and a novel 
statistical analysis method for detection of all known viruses (including 
bacteriophages), bacteria and plasmids. This array is more robust compared to the 
previous microarray analysis because it uses more family specific probes per 
target, 50 for viruses and 15 for bacteria in spite of 2-10 probes per target in 
previous assay. This array is more up to date than the previous array (Wang et al., 
2003) because the probe sequences are designed using a more recent sequence 
database. Both of these arrays have the potential to detect and characterize 
known and novel sequences of pathogenic microorganisms.   
Subtractive hybridization has also been found to be useful for detection of new 
viruses such as torque teno virus (Muerhoff et al., 1997; Nishizawa et al., 1997) 
but it is relatively lengthy and may take weeks to analyse each sample. Another 
approach for WGA is particle associated nucleic acid PCR (Stang et al., 2005) that 
requires separation of virus particles from large volumes (11 ml) of sample through 
sucrose gradient centrifugation and synthesis of cDNA from viral RNA. In the 
particle associated nucleic acid PCR method virus sequences are amplified using 
tailed random primers to generate different sizes of amplicons. These PCR 
products are subsequently cloned for the preparation of a whole genome library. 
Although SISPA (Lambden et al., 1992 and 1995) and virus-discovery-cDNA-AFLP 
(VIDISCA) (Van der Hoek et al., 2004) are widely used for sequence independent 
amplification and detection of new variants of existing viruses, they are laborious 
and time consuming. In these two techniques RNA is reverse transcribed to single 
stranded cDNA and the second strand is synthesized. Blunt ends of double 
stranded cDNA were generated through the use of T4 DNA polymerase. Prepared 
double stranded cDNA is either ligated directly to blunt end adaptors or digested 
with suitable enzymes to ligate them to suitable adapters. Subsequently, reactions 
are purified to be used for PCR amplification using primer sequences from the 




adapters (Reyes and Kim, 1991). However, an alternative, brief protocol could be 
more useful to save time and money. 
In this chapter a novel protocol (RT-Bst SPA) has been developed to minimize the 
steps, time and cost for whole genome amplification (Figure 6.1; Table 6.5). In this 
approach, cDNA was prepared from RNA using tailed random primers, 5’-
GACCATCTAGCGACCTCCACMNNMNM-3’ (Stang et al., 2005) instead of 
random primers during RT-Bst amplification. Complementary DNA is prepared and 
amplified simultaneously from RNA. In this process 3’ of tailed random primers 
bind initially to RNA and subsequently to the synthesized cDNA and continue 
synthesis of the complementary strands. Consequently all of the hyper-branched 
cDNA contains the tail sequences at the 5’-end after RT-Bst amplification. RT-Bst 
amplified products can be used as a template for PCR based whole genome 
amplification using the tail sequence of random primers (5’-GACCATCTAGCGA 
CCTCCAC-3’) as a single primer (RT-Bst SPA) (Stang et al., 2005). The RT-Bst 
SPA process is explained in the following sections and figure 6.1. Amplified PCR 
products can either be cloned in suitable vectors for making a library or used for 
Next Generation Sequencing (Section 1.8.4). Purified MS2 RNA was used in this 
study as a control RNA to validate this protocol. Consequently, this protocol was 
applied on tissue culture extracts positive for hRSV, parainfluenza 2 and influenza 
B. Two patient samples positive for swine influenza A (sample 23) and hRSV 































Figure 6.1: Basic steps in RT-Bst single primer amplification (RT-Bst-SPA) 
of viral RNA.  1: Viral RNA, 2: Reverse transcription and synthesis of cDNA 
using tailed primer, 3: Degradation of RNA from cDNA:RNA hybrid through 
RNase H activity or heat, 4: Binding and extension of the tailed primers, 5: 
Synthesis of hyper-branched DNA with Bst DNA polymerase activity, 6: Primer 
extension with Bst DNA polymerase, 7: Hybridization of the DNA strands with tail 
primer from step 6, 8:  PCR amplification of different sizes of DNA using tail 
sequence as a primer. 9: TOPO-TA cloning of the amplified PCR products to 
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6.2 Whole genome amplification using RT-Bst single primer 
amplification (RT-Bst SPA) 
6.2.1 Sample processing and DNase treatment  
DNase treatment (Allander et al., 2001 and 2007) is necessary to remove any 
contaminating host DNA before whole genome amplification from clinical samples 
can be performed. It is expected that different samples will contain different 
amounts of host cells, cell free DNA and other cellular materials including microbial 
normal flora. An optimum DNase treatment of any sample containing viruses will 
vary depending on the presence of host and other DNA molecules in different 
samples. 
Commercially available MS2 RNA was used (as control) to evaluate the protocol 
for whole genome amplification using RT-Bst SPA. As the MS2 RNA was already 
purified a DNase treatment was not required for RT-Bst SPA amplification from 
MS2 RNA. Moreover free RNA is more labile than viral RNA protected by a capsid 
and degrades easily. Tissue culture extracts positive for influenza B, parainfluenza 
2 and hRSV were used for whole genome amplification using this protocol. Patient 
samples 23 and 39 previously determined to be positive for swine influenza A virus 
and hRSV, respectively, by multiplex one-step RT-PCR and RT-Bst PCR (Table 
5.2a and 5.2b) were used for whole genome amplification. Initially these samples 
were centrifuged at 14000 g in a bench top centrifuge for 5 minutes to remove 
cellular debris. Then samples were treated with DNase (Baseline Zero, Epicentre 
Biotechnologies, Cambridge, UK) according to the protocol optimized in this study 








Table 6.1: Digestion of extracellular DNA using Baseline Zero 
 Reaction component Reaction volume 
Tissue culture fluid 50.0 µl 
10X baseline zero reaction buffer  6.0 µl 
Baseline Zero (1.0 U µl-1) (Epicentre 
Biotechnology, Cambridge, UK) 2.0 µl 
Nuclease free water 2.0 µl 
Total volume 60.0 µl 
Incubation  37º C for 10 minutes 
 
6.2.2 RNA extraction from tissue culture media and 
nasopharyngeal samples 
Viral RNA was extracted immediately after DNase (Baseline Zero) treatment 
using either QIAamp viral RNA or QIAamp Blood DNA mini kit (QIAGEN, Crawley, 
UK) (Section 2.6.3) following the manufacturer’s guideline with the exclusion of 
carrier RNA in the case of the QIAamp viral RNA mini kit. No carrier RNA was 
added during this extraction process in order to avoid amplification of unwanted 
sequences and to improve amplification of desired viral RNA after WGA.  
 
6.2.3 RT-Bst amplification 
Commercially available MS2 RNA and RNA extracted from tissue culture media 
positive for hRSV and influenza B were immediately amplified by RT-Bst protocol 
using tailed random primers, 5’-GACCATCTAGCGACCTCCACMNNMNM-3’, here 
N represents A, T, G or C and M represents A or C (Section 2.6.6) (Stang et al., 
2005), instead of the pentadecamer random primers (Appendix Table A1) 
(Stangegaard et al., 2006) as described in section 2.6.6. This tailed random primer 




was used instead of the N15 primer so that double stranded cDNA prepared after 
RT-Bst amplification could be primed with the tail sequence added to the 5’-end of 
all of the amplified sequences. These tail sequences would aid in single primer 
amplification of the RT-Bst amplified products as discussed in section (6.2.4).  
 
6.2.4 Single primer amplification of RT-Bst amplified products  
RT-Bst amplified product generated using the tailed random primers (Section 6.2.3) 
was immediately used as a template for PCR reaction as described in section 
2.6.7.2. The tail sequence of the random primers (5’-GACCATCTAGCGACCTC 
CAC-3’, Stang et al., 2005) was used as a primer during PCR amplification (Figure 
6.1). The same primer was used as forward and reverse primers for PCR 
amplification. The total volume of the PCR reaction was scaled up to 60 µl adding 
6.0 µl of the RT-Bst amplified product as template. The PCR conditions were the 
same as described in section 2.6.7.2. 
 
6.2.5 TOPO-TA cloning and preparation of genomic libraries  
RT-Bst SPA product produced after whole genome amplification (Section 6.2.4) 
was resolved on an agarose gel (Section 2.6.1) for visualisation of the amplified 
products (Figure 6.2). RT-Bst SPA products were then purified through a DNA 
purification column (Section 2.6.11) and cloned into TOPO-TA cloning vector 
(Section 2.6.8) to make libraries for MS2, parainfluenza 2, influenza B, hRSV and 





















Subsequently, 10 colonies were picked randomly from the kanamycin (30 µg ml-1) 
containing Luria Bertani agar plates and confirmed for the presence of inserted 
sequence in the vector by colony PCR (Section 2.6.9; Figure, 6.3). Clones positive 
for the inserted sequence by PCR were further propagated in Luria Bertani broth 
containing kanamycin (30 µg ml-1) for the extraction of plasmid (Section 2.6.10). 
After colony PCR, amplified products were separated on an agarose gel (Figure 
6.3).  Different sizes of cloned inserts were present in the whole genome libraries 
generated for different viruses. Smaller bands appeared to be preferably cloned 
over larger bands. This was determined when the sizes of the whole genome 
amplified products (Figure 6.2) were compared with those of the cloned inserts 
 
M     1  M          2              3              4             5               6          7     
 
Figure 6.2: Whole genome amplification of MS2 RNA and virus RNA 
extracted from known positive samples using RT-Bst SPA. M: 100 bp 
DNA ladder (Fermentas, York, UK); Lane 1: bacteriophage MS2 RNA (20 ng); 
Lane 2: patient sample 23 positive for swine influenza A; Lane 3: tissue culture 
fluid positive for Influenza B; Lane 4: tissue culture fluid positive for 
parainfluenza 2; Lane 5: tissue culture fluid positive for hRSV; Lane 6: patient 








(Figure 6.3). However, in some cases PCR products that were amplified to a 
greater extent were cloned more easily over less amplified products (Figure 6.2, 
and 6.3 for MS2). It could be possible to excise different sizes of discrete bands 
after appropriate DNase treatment and clone them to generate a library containing 
different sizes and diversity of DNA sequences instead of column purifying all the 






































6.3 Analysis of sequences from the libraries prepared from RNA 
virus genomes 
Three out of six libraries prepared from the RNA viruses were sequenced (Section 









Sample 39 positive 
for hRSV 
 
Sample 23 positive 
for influenza A 
 
Parainfluenza 2 
Figure 6.3: Colony PCR detection of inserts in 10 clones randomly picked from 
different libraries generated for different virus genomes. M: 100 bp DNA ladder 
(Fermentas, York, UK); Lanes 1 to 10: randomly picked colonies 1 to 10; Lane 11: 












amplification (WGA). Sequences from the clones were compared using the 
BLASTn tools (http://blast.ncbi.nlm.nih.gov/Blast.cgi) to match them with those 
available in the public database (Section 2.8 and Table 6.2, 6.3 and 6.4).  
Sequences of influenza B clones 1 and 2 showed partial similarities with segment 
1 of influenza B when they were aligned with influenza B genomic sequences 
(Table 6.2). However, the sequences of influenza B clones 1 and 2 showed 
similarity with eukaryotic 28S rRNA sequences when aligned with all other 
sequences (Table 6.2). Similarly, sequences from Influenza B clones 3, 4 and 5 
showed partial similarities with segment 8 of influenza B when the sequences were 
aligned with only influenza B genomic sequences; otherwise they did not match 
with any other sequence in the database (Table 6.2). Sequences of influenza B 
clones 6 to 9 showed partial similarity with eukaryotic sequences and clone 10 did 
not match with any other sequence in the database when they were aligned with 















Table 6.2: BLASTn analysis of the cloned sequences from the influenza B 
library for sequence homology in the database 
Clones BLASTn analysis of the cloned sequences of Influenza B  
Matched with all other sequences  
Query coverage (QC, %), E-value (E ), 
Maximum identity (MI, %) 
Matched with influenza B sequences 
Query coverage (QC, %), E-value (E ), 
Maximum identity (MI, %) 
Clone 1 Uncultured-Eukaryotic-28S-rRNA (232 bp) 
 QC= 94, E= 9e-91, MI=90 
Influenza B segment 1 (23 bp) 
QC= 8, E=0.19, MI=91 
Clone 2 Uncultured-Eukaryotic-28S-rRNA (234 bp) 
 QC= 93, E= 1e-95, MI=91 
Influenza B segment 1 (23 bp) 
QC=8, E=0.19, MI=91 
Clone 3 No match (236 bp) Influenza B segment 8 (27 bp) 
QC=9, E=2.3, MI=89 
Clone 4 No match (236 bp) Influenza B segment 8 (27 bp) 
QC=9, E=2.3, MI=89 
Clone 5 No match (236 bp) Influenza B segment 8 (27 bp) 
QC=9, E=2.3, MI=89 
Clone 6 Partially eukaryotic otherwise no match 
(243 bp) 
No match 
Clone 7 Partially eukaryotic otherwise no match 
(243 bp) 
No match 
Clone 8 Partially eukaryotic otherwise no match 
(189 bp) 
No match 





No match (243 bp) No match 
 
The sequence of hRSV clone 1 showed similarity with human chromosome 15 
sequence when it was aligned with other sequences (Table 6.3). However, clone 1 
showed partial similarity with hRSV sequence when aligned with the hRSV 
genomic sequence only. Sequences of clones 2 to 5 showed similarity with human 




chromosome 17 sequence. Sequences of clones 6 to 8 matched with human 
chromosome 14 when aligned with the other sequences and partially matched with 
hRSV when aligned with hRSV genomic sequence only. Sequences of clones 9 
and 10 matched with human chromosome 8 sequence (Table 6.3). 
 
Table 6.3: BLASTn analysis of the cloned sequences from hRSV library for 
sequence homology in the database  
Clones BLASTn analysis of the cloned sequences of hRSV 
Aligned against all available sequences  
Query coverage (QC, %), E-value (E), Maximum 
identity (MI, %) 
Aligned against hRSV 
sequences 
Clone 1 Human chromosome 15 (230 bp) 
QC=84, E=2e-112, MI=100 
Partial hRSV (18 bp) 
QC=6, E=0.052, MI=100 
Clone 2 Human chromosome 17 (246 bp) 
QC=85, E=4e-121, MI=100 
No match 
Clone 3 Human chromosome 17 (287 bp) 
QC=93, E=3e-143, MI=97 
Not match 
Clone 4 Human chromosome 17 (287 bp) 
QC=93, E=3e-143, MI=97 
Not match 
Clone 5 Human chromosome 17 (246 bp) 
QC=85, E=4e-121, MI=100 
Not match 
Clone 6 Human chromosome 14 (262 bp) 
QC= 87, E= 6e-132, MI=100 
Partial hRSV (18 bp) 
QC=7, E=0.21, MI=91 
Clone 7 Human chromosome 14 (262 bp) 
QC= 87, E= 6e-132, MI= 100 
Partly hRSV (18 bp) 
QC=7, E=0.21, MI=91 
Clone 8 Human chromosome 14 (262 bp) 
QC= 87, E= 6e-132, MI= 100 
Partly hRSV (18 bp) 
QC=7, E=0.21, MI=91 
Clone 9 Human chromosome 8 (233 bp) 
QC= 91, E= 2e-111, MI= 97 
Did not match 
Clone 10 Human chromosome 8 (233 bp) 
QC= 91, E= 2e-111, MI=97 
Did not match 
 




The sequencing results from the tissue culture samples positive for hRSV and 
influenza B showed that some of the cloned sequences showed similarities to 
either human genomic sequences or eukaryotic sequences. There was only partial 
similarity to hRSV and influenza B sequences (Table 6.2 and 6.3). The presence 
of such unrelated sequences in the library was possibly due to poor DNase 
treatment (2 U). Some of the sequences did not match with any sequences in the 
database which possibly indicates non-specific amplification during PCR. The rest 
of the samples such as tissue culture samples positive for parainfluenza 2 and 
patient samples 23 and 39, were not analysed through sequencing, although 
libraries were generated from them. After analysis of the sequences from the 
clones prepared from MS2 RNA, it was found that all of the clones (ten) were 
positive for MS2 bacteriophage sequence (Table 6.4). This result indicates that if 
the desired RNA concentration can be increased significantly over the other types 
of nucleic acid sequences in the sample through appropriate DNase treatment, 
RT-Bst SPA can be more useful for cloning and sequencing desired sequences. 
It was found that WGA using RT-Bst SPA was effective for amplification of MS2 
genomic RNA and all of the clones were positive for MS2 genomic sequences. 
Different parts of the MS2 genome was amplified in this technique and all of these 
were within 217-329 bp in sizes (Table 6.4). Four out of ten library sequences 
were partially positive for influenza B and hRSV genomic sequences for libraries 
prepared from influenza B and hRSV, respectively. The lengths of the cloned 
sequences for influenza B and hRSV libraries were found to fall between 190-244 









Table 6.4: BLASTn analysis of the cloned sequences from MS2 library for 
sequence homology in the database  
Clones BLASTn analysis of the cloned sequences of MS2 
Matched with all other sequences 
Query coverage (QC, %), E-value (E), 
Maximum identity (MI, %) 
Matched with MS2 sequences 
Query coverage (QC, %), E-value 
(E), Maximum identity (MI, %) 
Clone 1 MS2 genome 2592-2911 (320 bp) 
QC=89, E=6e-167, MI= 99 
MS2 genome 2592-2911 (320 bp) 
QC=89, E=6e-167, MI= 99 
Clone 2 MS2 genome 2592-2911 (320 bp) 
QC=89, E=2e-163, MI= 99 
MS2 genome 2592-2911(320 bp) 
QC=89, E=5e-168, MI= 99 
Clone 3 MS2 genome 2590-2911 (322 bp) 
QC=89, E=6e-165, MI= 100 
MS2 genome 2590-2911 (322 bp) 
QC=89, E=1e-169, MI= 100 
Clone 4 MS2 genome 2590-2918 (329 bp) 
QC=92, E=3e-168, MI= 99 
MS2 genome 2590-2918 (329 bp) 
QC=92, E=7E-173, MI=99  
Clone 5 MS2 genome 2590-2918 (329 bp) 
QC=92, E=7e-173, MI=99 
MS2 genome 2590-2918 (329 bp) 
QC=92, E=3e-168, MI=99 
Clone 6 MS2 genome 1154-1370 (217 bp) 
QC=83, E=4e-104, MI=98 
MS2 genome 1154-1370 (217 bp) 
QC=83, E=2e-99, MI=98 
Clone 7 MS2 genome 1154-1370 (217 bp) 
QC=83, E=3e-103, MI=99 
MS2 genome 1154-1370 (217 bp) 
QC=83, E=6e-108, MI=99 
Clone 8 MS2 genome 1154-1370 (217 bp) 
 QC=83, E=2e-99, MI=98 
MS2 genome 1154-1370 (217 bp) 
QC=83, E=4e-104, MI=98 
Clone 9 MS2 genome 1154-1370 (217 bp) 
QC=83, E=6e-108, MI=99 
MS2 genome 1154-1370 (217 bp) 
QC=83, E=3e-103, MI=99 
Clone 10 MS2 genome 2590-2918 (329 bp) 
QC=92, E=3e-168, MI=99 
MS2 genome 2590-2918 (329 bp) 








6.4 DNase treatment to improve the performance of whole 
genome amplification (WGA)  
The Baseline Zero (Epicentre Biotechnology, Cambridge, UK), a DNase, was 
used in this study for digestion of cell-free DNA before extraction of viral RNA and 
amplification of the whole genome using RT-Bst SPA.  Baseline Zero DNase was 
used in this study for its improved efficiency over the commonly used pancreatic 
DNase I for digestion of DNA. According to the manufacturer’s information 
Baseline Zero degrades both the ssDNA and dsDNA to mononucleotides 
whereas the DNase I degrades both the ssDNA and dsDNA to short 
oligonucleotides and mononucleotides. The cell-free DNA was digested using 
Baseline Zero after incubating at 37 C for 10 minutes following the 
manufacturer’s instructions in this study. 10 µl of nasopharyngeal sample was 
treated individually with 10, 20, 30, and 40 U of Baseline Zero (Epicentre 
Biotechnology, Cambridge, UK) following the protocol provided by the 
manufacturers (Table 6.1). Subsequently, RNA was extracted from 
nasopharyngeal sample 65 (Section 6.2.2) and amplified by RT-Bst SPA (Sections 
6.2.3 and 6.2.4; Figure 6.1). It was found that more discrete bands appeared at 30 
U and 40 U of Baseline Zero treatments, which indicate that an optimum DNase 
treatment can improve the amplification of the desired sequences (Figure 6.4). A 
similar result of amplification of discrete bands after optimum DNase I treatment 
was reported by other workers (Allander et al., 2001). However cloning of these 
discrete bands could be useful to improve the performance of RT-Bst SPA (Figure 
6.4, L3 and L4). Appropriate optimization of the DNase treatment can be done in 



















This study was designed to develop and evaluate a method for whole genome 
amplification (WGA) and the resulting technique was named RT-Bst SPA. Using 
this method, WGA was found to be effective in the amplification of purified MS2 
RNA, but its performance varied when it was applied to tissue culture samples 
positive for influenza B and hRSV.  
Although different sizes of bands between 200 and 800 bp appeared after WGA 
using RT-Bst SPA, only the smaller sized PCR products (between 200 and 300 bp) 
were preferentially cloned (Section 2.6.8). Consequently, this did not represent the 
range of different sizes of cDNA amplified in RT-Bst SPA. A smear of different 
sizes of PCR products were observed on the gel (Figure 6.2). This could be due to 
inadequate DNase treatment and presence of host DNA in samples before RT-Bst 
SPA amplification. To overcome this problem a DNase treatment was performed 
using 10, 20, 30 and 40 U of Baseline Zero (Epicentre Biotechnology, 
 
Figure 6.4 Effect of DNase (Baseline Zero) treatments before WGA using 
RT-Bst SPA from sample 65. M: 100 bp DNA ladder (Fermentas, York, UK); 
Lane 1: Baseline zero 10 U; Lane 2: Baseline zero 20 U; Lane 3: Baseline zero 
30 U; Lane 4: Baseline zero 40 U; Lane 5: negative control. 
 
500 bp 




Cambridge, UK) to determine its effect on WGA. Nasopharyngeal sample 65, 
which was positive for hRSV by one-step RT-PCR was used in this experiment 
(Table 5.2c). It was found that more discrete bands appeared after treating sample 
65 using 30 U and 40 U of DNase before RT-Bst SPA amplification. It was 
understood that an optimum DNase treatment could eliminate undesired 
sequences for example, host and other DNA present in the sample. Appropriate 
DNase treatment could be helpful to generate a more representative library from 
the whole genome of viruses.  
It was not possible to optimize the DNase treatment on more samples due to 
limited time available for this study. However, RT-Bst SPA of whole genome can 
be used for either high throughput sequencing or microarray analysis. High 
throughput sequencing can be performed from the RT-Bst SPA amplified products 
using the tail sequence of random primers (5’-GACCATCTAGCGACCTCCAC-3’, 
Stang et al., 2005). In this study a Sanger sequencing approach was used for 
sequencing the whole genome library and only 10 clones were randomly selected 
for analysis of the library sequences. However, high throughput sequencing of 
whole genome amplified product using RT-Bst SPA could be more useful for 
determining the whole genome sequences in this study. It is noteworthy that 
sequencing results obtained after random screening of clones from the whole 
genome library of hRSV and influenza B could be further improved if a higher 
number of clones could be selected for sequence analysis.  
In this study, it was found that DNase digestion of the host genomic DNA from any 
sample is a key to success for WGA of virus genome from clinical samples. 
Different strategies have been employed by other workers for preferential isolation 
of virus particles and whole genome amplification. Stang et al. (2005) used low 
speed centrifugation to remove cellular debris and sucrose gradient 
ultracentrifugation to separate virus particles so that only virus sequences were 
amplified in random PCR. These strategies helped them to selectively amplify the 
sequences specific for the desired viruses. Stang et al., (2005) used larger amount 




(11 ml of supernatant from cell culture) of sample which is not suitable for studying 
any nasopharyngeal sample that is usually collected in small volume. 
Nasopharyngeal samples are collected by touching the nasopharynx using a 
sterile swab and dipping it into a transport media. Allander et al., (2007) pooled ten 
respiratory samples and used 200 µl for extraction of nucleic acids. They also 
used filtration, ultracentrifugation, adapter ligation and SISPA techniques to 
recover virus sequences. However, it may not always be possible to pool multiple 
samples to obtain 200 µl of sample. The new approach RT-Bst PCR developed in 
this study requires relatively small amount of nasopharyngeal sample for WGA, 
starting from 10 µl to 50 µl and is therefore suitable in cases where the amount of 
clinical sample available is limiting. Subsequent sequence analysis suggested that 
appropriate DNase treatment was necessary to identify more positive sequences. 
Microfiltration was used by Allander et al., (2001) to sieve out host cells and 
organelles for purifying serum samples. In this study microfiltration was used for a 
minute amount (10 µl to 50 µl) of samples only but this treatment did not work well 
which could be due to the very low abundance of viruses in the sample (data not 
shown).    
A major drawback of the PCR based WGA is that sequences that do not match 
with other sequences in the database cannot be classified (Stang et al., 2005). 
However, a cut off value such as, E <0.001 (Cann et al., 2005) or E <0.0001 was 
considered by other workers (Allander et al., 2007) to determine any significant 
similarity of the sequences when they used BLASTn tools (Section 2.8).  
Other molecular biological techniques have also been used for the identification of 
new types of viruses such as low-stringency PCR for the detection of conserved 
regions of virus genome for discovery of SARS coronavirus (Drosten et al., 2003). 
Differential display was found useful for identification of human metapneumovirus 
and coronavirus (van den Hoogen et al., 2001; van der Hoek et al., 2004). Allander 
et al., (2007) discovered a third human polyomavirus using the DNase SISPA 
technique. 




RT-Bst SPA, developed in the present study is simple and eliminated multiple 
steps involved in other techniques such as SISPA or particle-associated nucleic 
acid PCR for whole genome amplification. In this method viral RNA was amplified 
through RT-Bst amplification in one step followed by a single primer amplification 
to produce amplicons of different sizes. Although RT-Bst SPA is a similar 
approach to random PCR amplification from single stranded cDNA, it did not 
require a separate cDNA synthesis step. RT-Bst amplification not only converts 
RNA to cDNA but also enables the use of primers with tail sequences for 
subsequent PCR amplification (Section 6.2.4). Generally reverse transcription is a 
less efficient process and converts only 40-80% of RNA to cDNA depending on the 
type of random primers used (Stangegaard et al., 2006). In a preliminary phase of 
this study it was found that the cDNA concentration was improved after RT-Bst 
amplification when compared to reverse transcription alone (Section 4.4). Allander 
et al., (2001) discovered parvovirus, a DNA virus, using the SISPA technique with 
a sensitivity of 106 genome equivalent (GE) ml-1. On the contrary RT-Bst was 
found to be useful for WGA of RNA viruses in this study. A summary of the 
different steps, the time spent and the cost involved in SISPA and RT-Bst 












Table 6.5 Comparison of SISPA and RT-Bst SPA for whole genome 
amplification 






Reverse transcription or 
synthesis of first strand 
Yes 0.5 h £ 3.0 Single 
tube 
reaction  
2.5 h £ 3.0 
Second strand synthesis Yes 2.0 h £ 1.0 
Blunting double stranded cDNA Yes 0.1 h £ 0.5 
Column purification Yes 0.5 h £ 2.0 
Phosphorylation of 5’ end of 
adapter  
Yes 0.5 h £ 1.0 
Column purification Yes 0.5 h £ 2.0 
Adapter ligation to double 
stranded cDNA 
Yes 2.0 h £ 2.0 
Column purification Yes 0.5 h £ 2.0 
PCR using single primer Yes 3.0 h £ 1.0 Yes 3.0 h £ 1.0 
Total time and cost required  9.6 h £ 14.5  5.5 h  £ 4.0 
 
In summary, RT-Bst SPA is a shorter and more cost effective technique compared 
to the SISPA technique. According to our calculation the RT-Bst SPA protocol took 
4.1 hours less for amplification of the whole genome and required £10.50 less for 
reagent cost compared to the SISPA technique (Table 6.5). DNase treatment was 
an important step for successful whole genome amplification using RT-Bst SPA 
because of the differences in concentrations of host DNA in different samples. 
Unlike SISPA, RT-Bst SPA technique was a closed tube reaction and reduced the 
possibility of contamination during whole genome amplification. RT-Bst SPA would 
be a suitable, reliable, sensitive and cheaper option for whole genome 
amplification compared to SISPA provided an optimum DNase treatment was 
ascertained. This approach will allow possibilities for easy and low cost 




amplification of whole genomes of RNA viruses. Amplified products can be used 
for different purposes for example, library preparation, next generation sequencing 
and microarray analysis. This technique can also be used for the amplification of 





Application of HRM analysis for rapid 
detection of virus sequences 
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7.1 Introduction and aims 
High resolution melting (HRM) of PCR products is a sensitive, rapid and economic 
method for the detection and characterization of nucleic acid sequences for 
mutation, polymorphism and epigenetic studies (Reed and Wittwer, 2004; De 
Leeneer et al., 2008; Takano et al., 2008). In conventional real-time PCR, melting 
curve analysis is performed to monitor the purity of amplified products using 
double stranded DNA (dsDNA) binding dyes or hybridization probes to monitor the 
amplification of desired sequences (Wittwer and Kusukawa, 2005). In HRM 
analysis DNA saturating dyes such as, EvaGreen are used which specifically bind 
to double stranded DNA (dsDNA) and emits fluorescence. The amount of 
fluorescence is proportional to the amount of DNA present in the sample. With the 
increase in temperature during the melting analysis dsDNA is denatured to single 
stranded DNA (ssDNA) and the DNA intercalating dye is released. Consequently, 
fluorescent intensity will gradually decrease to a basal level with the increase in 
the melting temperature. If the change in the fluorescence intensity is plotted 
against the transition in the temperature it produces a characteristic curve for 
individual DNA molecules based on their base composition and length which can 
be used for analysis of the sequence. With the development of HRM technology it 
is now possible to accurately control temperature transition and fluorescence data 
acquisition using sophisticated instruments during melting analysis (Gundry et al., 
2003). The newest generation fluorescent DNA binding dyes for example, LC-
Green and EvaGreen have improved saturation properties than the previously 
used SYBR Green I dye (Wittwer et al., 2003). These advancements in high 
resolution melting technology will help with accurate assessment of the sequence 
variations based on the melting behaviour of DNA without using expensive 
fluorescent probes for sequence analysis. Different real-time PCR instruments 
have been used for HRM analysis but they have been reported to vary in their 
performances for analysis of different sequences (Herrmann et al., 2006, 2007a, b). 
PCR amplicons can be genotyped in a closed tube reaction using HRM analysis in 
the presence of a saturating DNA binding dye for example; EvaGreen and LC-
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Green dyes (Wittwer et al., 2003). EvaGreen dye selectively binds to dsDNA and 
strongly fluoresces and makes DNA detection easier using a HRM instrument. 
Unlike SYBR Green I, EvaGreen dye can bind with equal affinity to GC-rich and 
AT-rich regions of DNA at higher concentrations which makes it a suitable dye for 
all types of PCR products. Amplicons are gradually denatured by raising the 
temperature of the reaction. The temperature at which 50% of the total DNA in the 
reaction is denatured is considered as the melting temperature (Tm). These 
characteristic melting patterns of different sequences can be used for analysis of 
different sequences in HRM assays. Melting temperature (Tm) can be estimated 
using the formula; Tm = 2°C x (number of [A+T]) + 4°C x (number of [G+C]). It is a 
function of the DNA GC-content (Tm is higher in GC-rich PCR products), length 
and sequence composition. The other factors which can interfere with melting 
curve analysis are quality of genomic DNA (gDNA), impurities in the extracted 
nucleic acids, primer design, dye selection and PCR reagents. The presence of 
salts in the extracted DNA will influence the thermodynamics of the DNA melting 
transition. The presence of any contaminants will complicate the interpretation of 
the DNA melt curve. Nonspecific PCR products can be produced from low-quality 
DNA leading to incorrect scoring of results in HRM analysis. Low copies of 
template can result in the late amplification of PCR products and low-resolution in 
HRM data (von Ahsen et al., 2001). Therefore, it is necessary to use the same 
reagents, buffers, protocols and nucleic acid extraction and purification processes 
for all of the samples including the controls to avoid the chances of variation in the 
experiment and analysis. 
The fluorescence intensity decreases with the denaturation of the double stranded 
DNA and release of intercalating dye (LC Green). If the fluorescence signals are 
plotted against the increase in temperature it produces a unique curve from each 
type of sequence. The separation of the melt curves becomes more apparent after 
normalization of the pre-melt and post-melt fluorescence signals after the HRM 
analysis using a software for example; Rotor-Gene Q software 1.7. During this 
normalization process signal generated from all samples are set to a uniform 
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relative value within a range of 100% to 0%. Normalisation of the pre-melt and 
post-melt fluorescence data using the HRM analysis software brings similar 
sequences together and moves different sequences apart.  
HRM analysis has been used for analysis of sequence variation in both eukaryotic 
and prokaryotic systems. Shorter sized amplicons showed better resolution of 
small sequence variation in a study of single nucleotide polymorphisms (SNPs) 
(Liew et al., 2004) and detection of pandemic influenza A H1N1 virus (Varillas et 
al., 2011) using HRM analysis. HRM analysis has also been found to be useful to 
distinguish between six common beta-globin genotypes using 110 bp amplicons 
whereas the hydroxytryptamine receptor 2A (HTR2A) single nucleotide 
polymorphism was genotyped in a 554 bp fragment (Wittwer et al., 2003). Other 
workers showed point mutation/deletion and qualitative nucleotide change in one 
assay using quantitative PCR and high resolution melting (qPCR-HRM) (Rouleau 
et al., 2009). Dobrowolski et al., (2009) analysed sequence variations in 16.6 kb 
human mitochondrial genome in less than 2 hours and demonstrated the 
sensitivity and speed of HRM analysis.  
Provaznikova et al., (2008) reported that they could avoid more than 85% of the 
unnecessary sequencing of the myosin heavy chain (MYH) 9 gene when they 
used HRM analysis for pre-sequence screening. One of the limitations of HRM 
analysis is that it is usually not possible to apply this technique in multiplex mode 
to type variants in different fragments at the same time. However, Seipp et al., 
(2008) showed a quadruplex genotyping assay which is very sensitive and 
depends on the high quality of DNA and sensitivity of HRM system used. HRM has 
also been reported for assessment of DNA methylation patterns (Dahl and 
Guldberg, 2007). Epigenetic studies are important because DNA methylation 
patterns have been found to be associated with different diseases for example 
cancer and inherited disorders (Egger et al., 2004).  
There are several other methods that are used to screen for mutation differences 
between two DNA sequences. These techniques include single-strand 
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conformational polymorphism (SSCP) (Shin et al., 2010), denaturing gradient gel 
electrophoresis (DGGE) (Lerman and Silverstein, 1987), temperature gradient 
capillary electrophoresis (TGCE) (Li et al., 2002) and mass spectroscopy (Bocker, 
2007). All of these methods require separation of samples either on gels or 
matrices and sometimes needs additional processing such as enzymatic or 
chemical reactions. Sequencing of the amplicons can provide more information on 
similarities and differences between sequences but can be expensive. With the 
development of DNA melting technology it is now possible to track minute changes 
in the melting behaviour of related sequences using HRM analysis (Gundry et al., 
2003). This technology has the potential to ascertain the sequence similarity by 
matching the melting pattern with a positive control. Appropriate use of HRM 
analysis will help reduce unnecessary costs for DNA sequencing. HRM analysis 
has been applied for identification and characterization of different microorganisms 
for example; mycobacterial typing using hsp65 (Odell et al., 2005), identification of 
bacterial species by analysis of 16S rRNA genes (Cheng et al., 2006), detection of 
quinolone resistance (gyrA mutation) in Salmonella species (Slinger et al., 2007), 
detection of pandemic influenza A H1N1 virus (Varillas et al., 2011) and 
identification of Aspergillus species (Erali et al., 2006). However, there are only a 
limited number of publications available on the applications of HRM analysis for 
the detection and characterization of pathogenic viruses of the respiratory tract 
(Varillas et al., 2011). 
One of the aims of this chapter was to demonstrate the application of HRM 
analysis (Erali et al., 2008) for rapid and accurate detection of different types of 
sequences using a newly developed and sensitive instrument, the Rotor-Gene Q 
(QIAGEN, Crawley, UK). HRM analysis was used for pre-sequence screening from 
a whole genome library prepared from RNA virus genomes. The whole genome 
libraries were prepared from RNA viruses in this study using the RT-Bst SPA as 
described in chapter 6 (Figure 6.1). HRM analysis was also applied for the rapid 
and accurate detection of common respiratory tract virus sequences from cloned 
plasmids as an alternate to conventional sequence based detection. 
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7.2 Protocol for real-time PCR high resolution melting (RT-PCR-
HRM) 
7.2.1 Plasmid extraction and preparation of template 
Three different libraries were prepared from MS2 RNA and RNA extracted from 
tissue culture media positive for hRSV and influenza B as described in chapter 6. 
Plasmids were extracted (Section 2.6.10) from ten randomly selected clones from 
each library for each type of virus. Plasmid concentrations were measured using a 
spectrophotometer (Section 2.6.2.1) and diluted to concentrations between 1-10 
ng µl-1 to be used as templates for PCR followed by HRM (Section 7.2.2) using 
Type-iT HRM kit (QIAGEN, Crawley, UK).  
 
7.2.2 Setting up PCR and HRM programmes using the Rotor-Gene 
Q 
PCR reactions were set up using the Type-iT HRM kit (QIAGEN, Crawley, UK) 
according to table 7.1. A master mix was prepared and 8.0 µl was aliquoted in 0.1 
ml PCR tubes. 2.0 µl of template was added to each tube in triplicate and placed in 
the real-time thermal cycler. Water was added to the negative control tubes 
instead of template to check for any nonspecific amplification or nucleic acid 
contamination in the reagents. Template DNA was added in sufficient amounts so 
that the cycle threshold (CT) value for all samples fell below 30 and they did not 
differ by more than three CT values. The cycle threshold (CT) is defined as the 
number of cycles required for the fluorescence signals to exceed the background 
level of fluorescence. The fluorescence generated from the background can be 
determined from the fluorescence in the negative control.  
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Table 7.1: Reaction components using 2X HRM PCR master mix 
Reaction component Reaction volume 
(µl) 
Final concentration 
2X HRM PCR master mix 
(QIAGEN, Crawley, UK) 
5.0  1X 
Forward primer (10 µM)  0.7  0.7 µM  
Reverse primer (10 µM) 0.7  0.7 µM 
RNase-free water 1.6 -- 
Template DNA 2.0  1-20 ng plasmid per 
reaction 
Total volume 10.0  -- 
 
The Rotor-Gene Q machine was set up according to Figures 7.1 and 7.2. The 
initial hold step was set at 95 ºC for 5 minutes to activate Hot Start Taq Plus DNA 
polymerase (not shown in Figure 7.1). The PCR cycling was set at 95 ºC for 10 
seconds, 55 ºC for 30 seconds and 72 ºC for 10 seconds for 40 cycles following 
the manufacturer’s instructions. Fluorescence data was acquired at the 72 ºC step 
through the green channel (source, 470 nm; detector, 510 nm). The High 
Resolution Melting protocol was followed as shown in figure 7.2. The temperature 
ramp (gradual increase in  temperature to facilitate denaturation) was set at 5 ºC 
below the lowest Tm and 5 ºC above the highest Tm of all PCR products having a 
temperature rise by 0.1 ºC in each step following the manufacturer’s instructions. 
Therefore, the melting temperature for the PCR products generated from the 



























Figure 7.2: General configuration for HRM analysis using the Rotor-Gene 
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The ramp for the PCR products generated from the clones for hRSV was set 
between 73 ºC and 93 ºC. The ramp was determined from the melting behaviour 
of all of the sequences during optimisation of the HRM analysis. HRM data was 
analysed at the end of PCR and data acquisition using the Rotor-Gene Q software 
1.7 (QIAGEN, Crawley, UK). 
 
7.3 Pre-sequence screening of genomic libraries prepared from 
viral RNA by HRM analysis 
Whole genome libraries were prepared from MS2 RNA genome and tissue culture 
media positive for hRSV and influenza B using the RT-Bst SPA (Chapter 6, Figure 
6.1). However, screening a whole genome library is tedious, lengthy and 
expensive. Generally whole genome libraries are screened through selection of 
random clones and sequencing or immunoscreening using specific antibodies. In 
previous studies on sequence based analysis of the library sequences it has been 
found that most of the clones contained similar sequences (Provaznikova et al., 
2008). Therefore, random screening of library sequences can be expensive and 
less productive. In this study we validated the application of HRM analysis for pre-
sequence screening of genomic libraries to reduce expanses towards unnecessary 
sequencing which is described in figure 7.3 and in the following sections 7.3.1, 





















7.3.1 Pre-sequence screening of MS2 genomic library 
A whole genome library was prepared from the MS2 RNA as described in the 
previous section 6.2. Clones were randomly selected from the genomic library to 
validate the HRM analysis as an alternate to conventional sequencing to 
determine the similarities and differences among the cloned sequences. Ten 
clones were randomly selected from the whole genome library of MS2 and the 
plasmids containing the inserts were sequenced (Section 2.6.10 and 2.7). 
Sequences corresponding to the 10 clones generated from the MS2 genomic 
library were compared using multiple sequence alignment tools CLUSTALW 
(http://www.ebi.ac.uk/Tools/msa/ clustalw2/). Sequences from clones 1, 2 and 3; 
clones 4, 5 and 10; clones 6, 7, 8 and 9 were found to fall into three different 
clusters after multiple sequence alignment (Figure 7.6, Table 6.4). After HRM 
WGA using RT-Bst SPA
TA cloning to make a 
whole genome library
Random selection of 10 clones 
and extraction of plasmid
Sequence 
analysis using 
the BLASTn and 
CLUSTALW







Figure 7.3: Presequence screening of genomic libraries prepared from viral 
RNA by HRM analysis (sequencing was done using either M13 F or R primer, 
PCR products were amplified using a single primer from the tail of the random 
primer, 5’-GACCATCTAGCGA CCTCCAC-3’, before HRM analysis ) 
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analysis and normalization of curves similar patterns for these three types of 
sequences were also found (Figure 7.5). Melting temperatures for these three 
groups (Table 7.2) were also slightly different which became evident after 
dissociation of the amplicons (Figure 7.5) and analysing the data using Rotor-
Gene Q software 1.7. The average melting temperatures for sequences of clones 
1, 2 and 3; clones 4, 5 and 10; clones 6, 7, 8 and 9 were 82.88 ºC; 82.91 ºC and 
84.03 ºC, respectively (Table 7.2). It was found that similar sequences produced 
similar melting curves and vice versa (Figure 7.4). The similarities and differences 
between different sequences were clearly apparent from the normalized HRM 




































































































































































































































Colour Name Peak 1 Peak 2 Peak 3 
 
MS2-Clone-1 82.88   
 
MS2-Clone-1 82.82   
 
MS2-Clone-2 82.80   
 
MS2-Clone-2 82.87   
 
MS2-Clone-3 82.85   
 
MS2-Clone-3 81.38 82.80  
 
MS2-Clone-4 81.45 82.80  
 
MS2-Clone-4 81.65 82.88  
 
MS2-Clone-5 82.83   
 
MS2-Clone-5 82.83   
 
MS2-Clone-6 83.93   
 
MS2-Clone-6 83.95   
 
MS2-Clone-7 84.03   
 
MS2-Clone-7 84.05   
 
MS2-Clone-8 84.05   
 
MS2-Clone-8 84.08   
 
MS2-Clone-9 84.02   
 
MS2-Clone-9 84.02   
 
MS2-Clone-10 81.55 82.85  
 
MS2-Clone-10 77.30 81.55 82.90 
 
MS2-Clone-1 83.02   
 
MS2-Clone-2 81.95 83.00  
 
MS2-Clone-3 82.90   
 
MS2-Clone-4 83.02   
 
MS2-Clone-5 83.05   
 
MS2-Clone-6 84.10   
 
MS2-Clone-7 84.03   
 
MS2-Clone-8 84.03   
 
MS2-Clone-9 84.15   
 
MS2-Clone-10 81.85 83.10  
 
Table 7.2: Melting 
temperatures of different 
amplicons in triplicate for 
clones generated from MS2 
RNA 
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Figure 7.6: Alignment of the 10 clone sequences from the MS2 library using 





















CLUSTAL 2.1 multiple sequence alignment for MS2 clone 1, 2 and 3 
 
MS2-Clone-2-2592-2911-320bp      GACCATCTAGCGACCTCCACATAAAAGTGCGCGCCGCAGCTCTCGCGAAA 50 
MS2-Clone-3-2590-2911-322bp      GACCATCTAGCGACCTCCACATAAAAGTGCGCGCCGCAGCTCTCGCGAAA 50 
MS2-Clone-1-2592-2911-320bp      GACCATCTAGCGACCTCCACATAAAAGTGCGCGCCGCAGCTCTCGCGAAA 50 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      GAGCCCGGACACGAACGTTTTACGAAGATTCGGTTTAAAACCGTAGTAGG 100 
MS2-Clone-3-2590-2911-322bp      GAGCCCGGACACGAACGTTTTACGAAGATTCGGTTTAAAACCGTAGTAGG 100 
MS2-Clone-1-2592-2911-320bp      GAGCCCGGACACGAACGTTTTACGAAGATTCGGTTTAAAACCGTAGTAGG 100 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      CAAGTGCCTCTAGCACACGGGGTGCAATCTCACTGGGACATATAATATCG 150 
MS2-Clone-3-2590-2911-322bp      CAAGTGCCTCTAGCACACGGGGTGCAATCTCACTGGGACATATAATATCG 150 
MS2-Clone-1-2592-2911-320bp      CAAGTGCCTCTAGCACACGGGGTGCAATCTCACTGGGACATATAATATCG 150 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      TCCCCGTAGATGCCTATGGTTCCGGCGTTACCAAAATGGATTTGGGTCGC 200 
MS2-Clone-3-2590-2911-322bp      TCCCCGTAGATGCCTATGGTTCCGGCGTTACCAAAATGGATTTGGGTCGC 200 
MS2-Clone-1-2592-2911-320bp      TCCCCGTAGATGCCTATGGTTCCGGCGTTACCAAAATGGATTTGGGTCGC 200 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      TTTGACTATTGCCCAGAATATCATGGACTCTAGCTCAAATGTGAACCCAT 250 
MS2-Clone-3-2590-2911-322bp      TTTGACTATTGCCCAGAATATCATGGACTCTAGCTCAAATGTGAACCCAT 250 
MS2-Clone-1-2592-2911-320bp      TTTGACTATTGCCCAGAATATCATGGACTCTAGCTCAAATGTGAACCCAT 250 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      TTCCCATTGTGGAAAATAGTTCCCATCGTATCGTCTCGCCATCTACGATT 300 
MS2-Clone-3-2590-2911-322bp      TTCCCATTGTGGAAAATAGTTCCCATCGTATCGTCTCGCCATCTACGATT 300 
MS2-Clone-1-2592-2911-320bp      TTCCCATTGTGGAAAATAGTTCCCATCGTATCGTCTCGCCATCTACGATT 300 
                                 ************************************************** 
 
MS2-Clone-2-2592-2911-320bp      CCGTAGTGTGAGCGGATACGATCGAGATATGAATATAGCTCCGGTGGAGG 350 
MS2-Clone-3-2590-2911-322bp      CCGTAGTGTGAGCGGATACGATCGAGATATGAATATAGCTCAGGTGGAGG 350 
MS2-Clone-1-2592-2911-320bp      CCGTAGTGTGAGCGGATACGATCGAGATATGAATATAGCTC-GGTGGAGG 349 
                                 ***************************************** ******** 
 
MS2-Clone-2-2592-2911-320bp      TCGCTAGATGGTC 363 
MS2-Clone-3-2590-2911-322bp      TCGCTAGATGGTC 363 
MS2-Clone-1-2592-2911-320bp      TCGCTAGATGGTC 362 
                                 ************* 
 
























CLUSTAL 2.1 multiple sequence alignment for MS2 clones 4, 5 and 10 
 
 
MS2-Clone-4-MS2sequence-2590-2      GACCATCTAGCGACCTCCACCTGAGCTATATTCATATCTCGATCGTATCC 50 
MS2-Clone-10-MS2sequences-2590      GACCATCTAGCGACCTCCACCTGAGCTATATTCATATCTCGATCGTATCC 50 
MS2-Clone-5-MS2sequence-2590-2      GACCATCTAGCGACCTCCACCTGAGCTATATTCATATCTCGATCGTATCC 50 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      GCTCACACTACGGAATCGTAGATGGCGAGACGATACGATGGGAACTATTT 100 
MS2-Clone-10-MS2sequences-2590      GCTCACACTACGGAATCGTAGATGGCGAGACGATACGATGGGAACTATTT 100 
MS2-Clone-5-MS2sequence-2590-2      GCTCACACTACGGAATCGTAGATGGCGAGACGATACGATGGGAACTATTT 100 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      TCCACAATGGGAAATGGGTTCACATTTGAGCTAGAGTCCATGATATTCTG 150 
MS2-Clone-10-MS2sequences-2590      TCCACAATGGGAAATGGGTTCACATTTGAGCTAGAGTCCATGATATTCTG 150 
MS2-Clone-5-MS2sequence-2590-2      TCCACAATGGGAAATGGGTTCACATTTGAGCTAGAGTCCATGATATTCTG 150 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      GGCAATAGTCAAAGCGACCCAAATCCATTTTGGTAACGCCGGAACCATAG 200 
MS2-Clone-10-MS2sequences-2590      GGCAATAGTCAAAGCGACCCAAATCCATTTTGGTAACGCCGGAACCATAG 200 
MS2-Clone-5-MS2sequence-2590-2      GGCAATAGTCAAAGCGACCCAAATCCATTTTGGTAACGCCGGAACCATAG 200 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      GCATCTACGGGGACGATATTATATGTCCCAGTGAGATTGCACCTCGTGTG 250 
MS2-Clone-10-MS2sequences-2590      GCATCTACGGGGACGATATTATATGTCCCAGTGAGATTGCACCTCGTGTG 250 
MS2-Clone-5-MS2sequence-2590-2      GCATCTACGGGGACGATATTATATGTCCCAGTGAGATTGCACCTCGTGTG 250 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      CTAGAGGCACTTGCCTACTACGGTTTTAAACCGAATCTTCGTAAAACGTT 300 
MS2-Clone-10-MS2sequences-2590      CTAGAGGCACTTGCCTACTACGGTTTTAAACCGAATCTTCGTAAAACGTT 300 
MS2-Clone-5-MS2sequence-2590-2      CTAGAGGCACTTGCCTACTACGGTTTTAAACCGAATCTTCGTAAAACGTT 300 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      CGTGTCCGGGCTCTTTCGCGAGAGCTGCGGCGCGCACTTTTACTGTGGTG 350 
MS2-Clone-10-MS2sequences-2590      CGTGTCCGGGCTCTTTCGCGAGAGCTGCGGCGCGCACTTTTACTGTGGTG 350 
MS2-Clone-5-MS2sequence-2590-2      CGTGTCCGGGCTCTTTCGCGAGAGCTGCGGCGCGCACTTTTACTGTGGTG 350 
                                    ************************************************** 
 
MS2-Clone-4-MS2sequence-2590-2      TGGAGGTCGCTAGATGGTC 369 
MS2-Clone-10-MS2sequences-2590      TGGAGGTCGCTAGATGGTC 369 
MS2-Clone-5-MS2sequence-2590-2      TGGAGGTCGCTAGATGGTC 369 
                                    ******************* 
 
















An * (asterisk) represents positions that have a single, fully conserved residue. A : (colon) represents conservation between 







CLUSTAL 2.1 multiple sequence alignment of MS2 clones 6, 7, 8 and 9 
 
 
MS2-Clone-6-MS2sequences-1154-      GACCATCTAGCGACCTCCACCTACGCGAAGTTGCTTGGGGCGACAGTCAC 50 
MS2-Clone-8-MS2sequences-1154-      GACCATCTAGCGACCTCCACCTACGCGAAGTTGCTTGGGGCGACAGTCAC 50 
MS2-Clone-9-MS2sequences-1154-      GACCATCTAGCGACCTCCACCTACGCGAAGTTGCTTGGGGCGACAGTCAC 50 
MS2-Clone-7-MS2sequences-1154-      ---------------------TACGCGAAGTTGCTTGGGGCGACAGTCAC 29 
                                                         ***************************** 
 
MS2-Clone-6-MS2sequences-1154-      GTCG--AGTTCCGCCATTGTCGACGAGAACGAACTGAGTAGAGTTAGAAG 98 
MS2-Clone-8-MS2sequences-1154-      GTCG--AGTTCCGCCATTGTCGACGAGAACGAACTGAGTAGAGTTAGAAG 98 
MS2-Clone-9-MS2sequences-1154-      GTCGCCAGTTCCGCCATTGTCGACGAGAACGAACTGAGTAGAGTTAGAAG 100 
MS2-Clone-7-MS2sequences-1154-      GTCGCCAGTTCCGCCATTGTCGACGAGAACGAACTGAGTAGAGTTAGAAG 79 
                                    ****  ******************************************** 
 
MS2-Clone-6-MS2sequences-1154-      CCATGCTTCAAACTCCGGTTGAGGGCTCTATCTAGAGAGCCGTTGCCTGA 148 
MS2-Clone-8-MS2sequences-1154-      CCATGCTTCAAACTCCGGTTGAGGGCTCTATCTAGAGAGCCGTTGCCTGA 148 
MS2-Clone-9-MS2sequences-1154-      CCATGCTTCAAACTCCGGTTGAGGGCTCTATCTAGAGAGCCGTTGCCTGA 150 
MS2-Clone-7-MS2sequences-1154-      CCATGCTTCAAACTCCGGTTGAGGGCTCTATCTAGAGAGCCGTTGCCTGA 129 
                                    ************************************************** 
 
MS2-Clone-6-MS2sequences-1154-      TTAATGCTAACGCATCTAAGGTATGGACCATCGAGAAAGGGGACTTTACG 198 
MS2-Clone-8-MS2sequences-1154-      TTAATGCTAACGCATCTAAGGTATGGACCATCGAGAAAGGGGACTTTACG 198 
MS2-Clone-9-MS2sequences-1154-      TTAATGCTAACGCATCTAAGGTATGGACCATCGAGAAAGGGGACTTTACG 200 
MS2-Clone-7-MS2sequences-1154-      TTAATGCTAACGCATCTAAGGTATGGACCATCGAGAAAGGGGACTTTACG 179 
                                    ************************************************** 
 
MS2-Clone-6-MS2sequences-1154-      TACGCGCCAGTTGTTGGCCATACGGATTGTACCCCTCGATGGTGGAGGTC 248 
MS2-Clone-8-MS2sequences-1154-      TACGCGCCAGTTGTTGGCCATACGGATTGTACCCCTCGATGGTGGAGGTC 248 
MS2-Clone-9-MS2sequences-1154-      TACGCGCCAGTTGTTGGCCATACGGATTGTACCCCTCGATGGTGGAGGTC 250 
MS2-Clone-7-MS2sequences-1154-      TACGCGCCAGTTGTTGGCCATACGGATTGTACCCCTCGATGGTGGAGGTC 229 
                                    ************************************************** 
 
MS2-Clone-6-MS2sequences-1154-      GCTAGATGG---------------------- 257 
MS2-Clone-8-MS2sequences-1154-      GCTAGATGGTC-------------------- 259 
MS2-Clone-9-MS2sequences-1154-      GCTAGATGGTC-------------------- 261 
MS2-Clone-7-MS2sequences-1154-      GCTAGATGGTCAAGGGCGAATTCCAGCACAC 260 
                                    *********                       
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7.3.2 Application of HRM to screen genomic library prepared from 
tissue culture media positive for influenza B 
A whole genome library was prepared from tissue culture media positive for 
influenza B as described in section 6.2. This whole genome library was used to 
validate the application of HRM analysis for characterization of the cloned 
sequences as an alternate to conventional sequencing. Ten clones were randomly 
picked from the whole genome library prepared from the tissue culture fluid 
positive for influenza B and the plasmids were sequenced (Section 2.6.10 and 2.7). 
The sequences generated from the 10 clones from the influenza B library were 
compared using multiple sequence alignment tools CLUSTALW (http://www.ebi. 
ac.uk/Tools/msa/clustalw2/). Sequences from clones 1 and 2; clones 3, 4 and 5; 
clones 6, 7 and 10 and clones 8 and 9 were found to fall into four different groups 
(Appendix vi, pages l-m) when they were analysed using the multiple sequence 
alignment tool CLUSTALW (Figure 7.9, Table 6.2). After HRM analysis and 
normalisation of the data generated from the sequences of the ten clones of 
influenza B, it was again found that similar sequences produced similar patterns of 
HRM melt curves (Figure 7.8). Figure 7.7 shows the conventional melting pattern 
of the different sequences from the ten clones of influenza B. It was found that 
similar sequences showed similar melting temperatures and they tended to group 
together when they were analysed using the Rotor-Gene Q software 1.7. The 
average melting temperatures for clones 1 and 2; clones 3, 4 and 5; clones 6, 7 
and 10 and clones 8 and 9 were 82.41 ºC, 81.22 ºC, 85.56 ºC and 82.52 ºC, 
respectively (Table 7.3). HRM analyses was found useful for grouping similar 
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Colour Name Peak 1 
   
 
Influenza B-Clone-1 82.52 
 
Influenza B-Clone-1 82.37 
 
Influenza B-Clone-2 82.33 
 
Influenza B-Clone-2 82.35 
 
Influenza B-Clone-3 81.17 
 
Influenza B-Clone-3 81.20 
 
Influenza B-Clone-4 81.20 
 
Influenza B-Clone-4 81.23 
 
Influenza B-Clone-5 81.15 
 
Influenza B-Clone-5 81.22 
 
Influenza B-Clone-6 85.53 
 
Influenza B Clone-6 85.47 
 
Influenza B-Clone-7 85.43 
 
Influenza B-Clone-7 85.45 
 
Influenza B-Clone-8 82.55 
 
Influenza B-Clone-8 82.48 
 
Influenza B-Clone-9 82.42 
 
Influenza B-Clone-9 82.42 
 
Influenza B-Clone-10 85.57 
 
Influenza B-Clone-10 85.58 
 
Influenza B-Clone-1 82.50 
 
Influenza B-Clone-2 82.43 
 
Influenza B-Clone-3 81.27 
 
Influenza B-Clone-4 81.25 
 
Influenza B-Clone-5 81.35 
 
Influenza B-Clone-6 85.65 
 
Influenza B-Clone-7 85.65 
 
Influenza B-Clone-8 82.70 
 
Influenza B-Clone-9 82.57 
 
Influenza B-Clone-10 85.72 
 
Table 7.3: Melting temperatures 
for different clones of influenza B 
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Figure 7.9: Multiple sequence alignment of the whole genome library 
sequences for tissue culture media positive for influenza B virus using the 




















CLUSTAL 2.1 multiple sequence alignment for influenza B clone 1 and 2 
 
 
Influenza-B-Clone-1-InfB-Seg1-      GACCATCTAGCGACCTCCACAGCCCAGGGAGCGG-CTTGGAATAATCAGC 49 
Influenza-B-Clone-2-InfB-Seg1-      GACCATCTAGCGACCTCCACAGCCCAGGGAGCGGGCTTGGAATAATCAGC 50 
                                    ********************************** *************** 
 
Influenza-B-Clone-1-InfB-Seg1-      GGGGAAAGAAGACCCTGTTGAGCTTGACTCTAGTCCGACTTGAAATGACT 99 
Influenza-B-Clone-2-InfB-Seg1-      GGGGAAAGAAGACCCTGTTGAGCTTGACTCTAGTCCGACTTGAAATGACT 100 
                                    ************************************************** 
 
Influenza-B-Clone-1-InfB-Seg1-      TTCGAGATATAGCCTAAGTGGGAGCTAACGCACCG-TGTAAAACCACTGC 148 
Influenza-B-Clone-2-InfB-Seg1-      TTCGAGATATAGCCTAAGTGGGAGCTAACGCACCGCTGTAAAACCACTGC 150 
                                    *********************************** ************** 
 
Influenza-B-Clone-1-InfB-Seg1-      TCGCTTAGCCATTTTACTTACTCCGTGAAGAAGTGGCCAATTTATTGGTT 198 
Influenza-B-Clone-2-InfB-Seg1-      TCGCTTAGCCATTTTACTTACTCCGTGAAGAAGTGGCCAATTTATTGGTT 200 
                                    ************************************************** 
 
Influenza-B-Clone-1-InfB-Seg1-      CTTAGATTTAAACATCTATTTTATAGGTGTGAACTTTGCGGAGGACAAGG 248 
Influenza-B-Clone-2-InfB-Seg1-      CTTAGATTTAAACATCTATTTTATAGGTGTGAACTTTGCGGAGGACAAGG 250 
                                    ************************************************** 
 
Influenza-B-Clone-1-InfB-Seg1-      TGAGGTGGAGGTCGCTAGATG--- 269 
Influenza-B-Clone-2-InfB-Seg1-      TGAGGTGGAGGTCGCTAGATGGTC 274 
                                    *********************    
 
CLUSTAL 2.1 multiple sequence alignment for influenza B clone 3,4 and 5 
 
 
Influenza-B-Clone-3-Partially-      GACCATCTAGCGACCTCCACCCGCAACTTCTCCCATTGCTTCAAAAACTG 50 
Influenza-B-Clone-5-NoMatch-In      GACCATCTAGCGACCTCCACCCGCAACTTCTCCCATTGCTTCAAAAACTG 50 
Influenza-B-Clone-4-InfB-Seg-8      GACCATCTAGCGACCTCCACCCGCAACTTCTCCCATTGCTTCAAAAACTG 50 
                                    ************************************************** 
 
Influenza-B-Clone-3-Partially-      GAAAGTTGCTACCTGCGTTGGTATACATACTACCAACTGTTACCAAAACT 100 
Influenza-B-Clone-5-NoMatch-In      GAAAGTTGCTACCTGCGTTGGTATACATACTACCAACTGTTACCAAAACT 100 
Influenza-B-Clone-4-InfB-Seg-8      GAAAGTTGCTACCTGCGTTGGTATACATACTACCAACTGTTACCAAAACT 100 
                                    ************************************************** 
 
Influenza-B-Clone-3-Partially-      GCATAAGCATACCCTTGGTCAACGGATTGATACATTGTTTATAGAAAGCA 150 
Influenza-B-Clone-5-NoMatch-In      GCATAAGCATACCCTTGGTCAACGGATTGATACATTGTTTATAGAAAGCA 150 
Influenza-B-Clone-4-InfB-Seg-8      GCATAAGCATACCCTTGGTCAACGGATTGATACATTGTTTATAGAAAGCA 150 
                                    ************************************************** 
 
Influenza-B-Clone-3-Partially-      TTGAGGCTATTTCCATCGCAAGCTTTCTCTCTCGCGAGGAAAAGCATCCA 200 
Influenza-B-Clone-5-NoMatch-In      TTGAGGCTATTTCCATCGCAAGCTTTCTCTCTCGCGAGGAAAAGCATCCA 200 
Influenza-B-Clone-4-InfB-Seg-8      TTGAGGCTATTTCCATCGCAAGCTTTCTCTCTCGCGAGGAAAAGCATCCA 200 
                                    ************************************************** 
 
Influenza-B-Clone-3-Partially-      CATGTCCGCTTGGCAATACGAAAAGTGGATACCTTGCGTATACTCCTGAT 250 
Influenza-B-Clone-5-NoMatch-In      CATGTCCGCTTGGCAATACGAAAAGTGGATACCTTGCGTATACTCCTGAT 250 
Influenza-B-Clone-4-InfB-Seg-8      CATGTCCGCTTGGCAATACGAAAAGTGGATACCTTGCGTATACTCCTGAT 250 
                                    ************************************************** 
 
Influenza-B-Clone-3-Partially-      GGTGCTGTGGAGGTCGCTAGATGGTC 276 
Influenza-B-Clone-5-NoMatch-In      GGTGCTGTGGAGGTCGCTAGATGGTC 276 
Influenza-B-Clone-4-InfB-Seg-8      GGTGCTGTGGAGGTCGCTAGATGGTC 276 
                                    ************************** 
 






















An * (asterisk) represents positions that have a single, fully conserved residue. A : (colon) represents conservation between 
groups of strongly similar properties. A . (period) is used for conservation between groups of weakly similar properties. 
 
CLUSTAL 2.1 multiple sequence alignment of influenza B clones 6, 7 and 10 
 
 
Influenza-B-Clone-6-Partly-Euk      GACCATCTAGCGACCTCCACCCGCTCTGATTAATCCAGTTTTCACACCCA 50 
Influenza-B-Clone-10-NoMatch        GACCATCTAGCGACCTCCACCCGCTCTGATTAATCCAGTTTTCACACCCA 50 
Influenza-B-Clone-7-PartlyEuka      GACCATCTAGCGACCTCCACCCGCTCTGATTAATCCAGTTTTCACACCCA 50 
                                    ************************************************** 
 
Influenza-B-Clone-6-Partly-Euk      ATGTCGGTCGATACGATCCAGTTACGCACATCTGGAGCGGACTCAATCTG 100 
Influenza-B-Clone-10-NoMatch        ATGTCGGTCGATACGATCCAGTTACGCACATCTGGAGCGGACTCAATCTG 100 
Influenza-B-Clone-7-PartlyEuka      ATGTCGGTCGATACGATCCAGTTACGCACATCTGGAGCGGACTCAATCTG 100 
                                    ************************************************** 
 
Influenza-B-Clone-6-Partly-Euk      GCAAGTGAGCAAAGCATTTTCATGACGCTCACAGGCACAATCAACTCAAC 150 
Influenza-B-Clone-10-NoMatch        GCAAGTGAGCAAAGCATTTTCATGACGCTCACAGGCACAATCAACTCAAC 150 
Influenza-B-Clone-7-PartlyEuka      GCAAGTGAGCAAAGCATTTTCATGACGCTCACAGGCACAATCAACTCAAC 150 
                                    ************************************************** 
 
Influenza-B-Clone-6-Partly-Euk      GACGACCGGTATTTTGCTGAACACGGTCAGCGTAAGGCCACCTGCGGACA 200 
Influenza-B-Clone-10-NoMatch        GACGACCGGTATTTTGCTGAACACGGTCAGCGTAAGGCCACCTGCGGACA 200 
Influenza-B-Clone-7-PartlyEuka      GACGACCGGTATTTTGCTGAACACGGTCAGCGTAAGGCCACCTGCGGACA 200 
                                    ************************************************** 
 
Influenza-B-Clone-6-Partly-Euk      CCACCGACCCGAACGCATTGGATAACAGCGCTACCGACGCGACCTTGATC 250 
Influenza-B-Clone-10-NoMatch        CCACCGACCCGAACGCATTGGATAACAGCGCTACCGACGCGACCTTGATC 250 
Influenza-B-Clone-7-PartlyEuka      CCACCGACCCGAACGCATTGGATAACAGCGCTACCGACGCGACCTTGATC 250 
                                    ************************************************** 
 
Influenza-B-Clone-6-Partly-Euk      GAAGCTCGGGCCTGTGGAGGTCGCTAGATGGTC 283 
Influenza-B-Clone-10-NoMatch        GAAGCTCGGGCCTGTGGAGGTCGCTAGATGGTC 283 
Influenza-B-Clone-7-PartlyEuka      GAAGCTCGGGCCTGTGGAGGTCGCTAGATGGTC 283 
                                    ********************************* 
 
CLUSTAL 2.1 multiple sequence alignment of influenza B clones 8 and 9 
 
 
Influenza-B-Clone-8-PartlyEuka      GACCATCTAGCGACCTCCACCGTACAGAACCACCATTAGCACCATTACCG 50 
Influenza-B-Clone-9-Partly-Euk      GACCATCTAGCGACCTCCACCGTACAGAACCACCATTAGCACCATTACCG 50 
                                    ************************************************** 
 
Influenza-B-Clone-8-PartlyEuka      CCAGCATAATAAGTACCATAGCCGCCGCCCGTTGCAGTAATTGTATCAAA 100 
Influenza-B-Clone-9-Partly-Euk      CCAGCATAATAAGTACCATAGCCGCCGCCCGTTGCAGTAATTGTATCAAA 100 
                                    ************************************************** 
 
Influenza-B-Clone-8-PartlyEuka      AACAGAATTAGATCCCGATACCCCATTGTTGGTACCAGCCGCAGCACCGT 150 
Influenza-B-Clone-9-Partly-Euk      AACAGAATTAGATCCCGATACCCCATTGTTGGTACCAGCCGCAGCACCGT 150 
                                    ************************************************** 
 
Influenza-B-Clone-8-PartlyEuka      TTCCACCCGCACCAATAGTCACAGTAAATGATCCGGTTGAATAAGTAGCT 200 
Influenza-B-Clone-9-Partly-Euk      TTCCACCCGCACCAATAGTCACAGTAAATGATCCGGTTGAATAAGTAGCT 200 
                                    ************************************************** 
 
Influenza-B-Clone-8-PartlyEuka      CCTGGGGTTGTGGAGGTCGCTAGATGGTC 229 
Influenza-B-Clone-9-Partly-Euk      CCTGGGGTTGTGGAGGTCGCTAGATGGTC 229 
                                    ***************************** 
 
C h a p t e r  7                                                              P a g e  | 178 
 
 
7.3.3 Application of the HRM analysis to screen a genomic library 
prepared from a tissue culture media positive for hRSV 
A whole genome library was prepared from a tissue culture medium positive for 
hRSV as described in section 6.2 (Figure 6.1). Clones were randomly selected and 
screened using HRM analysis to validate its application as an alternative to 
conventional sequencing. As with the MS2 and the Influenza B libraries, ten clones 
were randomly selected from the whole genome library prepared for hRSV and the 
plasmids were sequenced after extraction (Section 2.6.1. and 2.7). Sequences 
generated from the 10 clones of the library prepared from a tissue culture medium 
positive for hRSV were compared using multiple sequence alignment tools 
CLUSTALW (http://www.ebi.ac.uk/ Tools/msa/clustalw2/). Ten sequences were 
found to fall into 5 different types after multiple sequence analysis using 
CLUSTALW tool (Figure 12). The sequence of clone 1 was different from all the 
other sequences. Clones 2 and 5; clones 3 and 4; clones 6, 7 and 8 and clones 9 
and 10 were found to be similar based on the sequence information (Table 6.3). 
After HRM analysis and normalization of the HRM curves of clone 1; clones 2 and 
5; clones 3 and 4; clones 6, 7 and 8 and clones 9 and 10 fell into five types of 
sequences (Figure 7.11). Figure 7.10 shows the conventional melting patterns of 
the different amplicons and they were found to group together when they had 
similar melting temperatures. After analysis of the data using Rotor-Gene Q 
software 1.7 it was found that the average melting temperatures for PCR products 
from clone 1; clones 3 and 4; clones 6, 7 and 8 and clones 9 and 10 were 78.92 ºC, 
79.07 ºC, 81.27 ºC and 84.91 ºC, respectively (Table 7.4). However, each 
sequence from clone 2 and 5 produced two similar peaks at different temperatures 
of 83.18 ºC and 85.06 ºC. After comparing the  sequence information and 
normalized HRM curves it was found that similar sequences produced similar 
melting patterns and vice versa.  
 
 






























































































































































































































































Table 7.4: Colour codes 
and melting temperatures 
for different clones of 
hRSV 
Colour Name Peak 1 Peak 2 
 
hRSV-Clone-1 78.97  
 
hRSV-Clone-1 78.92  
 
hRSV-Clone-1 78.87  
 
hRSV-Clone-2 83.18 85.05 
 
hRSV-Clone-2 83.18 85.05 
 
hRSV-Clone-2 83.20 85.07 
 
hRSV-Clone 3 79.12  
 
hRSV-Clone 3 79.05  
 
hRSV-Clone 3 79.20  
 
hRSV-Clone 4 78.98  
 
hRSV-Clone 4 79.00  
 
hRSV-Clone 4 79.10  
 
hRSV-Clone 5 83.18 85.05 
 
hRSV-Clone 5 83.25 85.10 
 
hRSV-Clone 5 83.20 85.05 
 
hRSV-Clone 6 81.30  
 
hRSV-Clone 6 81.25  
 
hRSV-Clone 6 81.25  
 
hRSV-Clone 7 81.28  
 
hRSV-Clone 7 81.23  
 
hRSV-Clone 7 81.28  
 
hRSV-Clone 8 81.30  
 
hRSV-Clone 8 81.30  
 
hRSV-Clone 8 81.25  
 
hRSV-Clone 9 84.85  
 
hRSV-Clone 9 84.90  
 
hRSV-Clone 9 84.85  
 
hRSV-Clone 10 84.87  
 
hRSV-Clone 10 85.05  
 
hRSV-Clone 10 84.95  
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Figure 7.12: Multiple sequence alignment of the whole genome library 
sequences for tissue culture media positive for hRSV using the CLUSTALW 




















CLUSTAL 2.1 multiple sequence alignment for hRSV clones 2 and 5 
 
 
hRSV-Clone-2-HumanChro-17      GACCATCTAGCGACCTCCACCCACCAAGTTACAGAAGAGGATTAGCACCT 50 
hRSV-Clone-5-HumanChro-17      GACCATCTAGCGACCTCCACCCACCAAGTTACAGAAGAGGATTAGCACCT 50 
                               ************************************************** 
 
hRSV-Clone-2-HumanChro-17      TGCTCTCACTGTGGAGAGAGAGGGAGAATCGCTGGCCCTCACGGGCTGCC 100 
hRSV-Clone-5-HumanChro-17      TGCTCTCACTGTGGAGAGAGAGGGAGAATCGCTGGCCCTCACGGGCTGCC 100 
                               ************************************************** 
 
hRSV-Clone-2-HumanChro-17      AGGCGTGGGGAGGCCGACAGACCCAGTGGATGAGCTAGAAGGGAGAGAAT 150 
hRSV-Clone-5-HumanChro-17      AGGCGTGGGGAGGCCGACAGACCCAGTGGATGAGCTAGAAGGGAGAGAAT 150 
                               ************************************************** 
 
hRSV-Clone-2-HumanChro-17      GACATTTGTTCATATTCCTAAAGGAGCTGCTTTCCTGGGTCAGAGCCTTA 200 
hRSV-Clone-5-HumanChro-17      GACATTTGTTCATATTCCTAAAGGAGCTGCTTTCCTGGGTCAGAGCCTTA 200 
                               ************************************************** 
 
hRSV-Clone-2-HumanChro-17      GCTTCTCTAGTCCCTCTTTCTCTTTGAGCATCTATTAACCACCAATGGGG 250 
hRSV-Clone-5-HumanChro-17      GCTTCTCTAGTCCCTCTTTCTCTTTGAGCATCTATTAACCACCAATGGGG 250 
                               ************************************************** 
 
hRSV-Clone-2-HumanChro-17      GGCCACTAGAGGGCCTGTGGAGGTCGCTAGATGGTC 286 
hRSV-Clone-5-HumanChro-17      GGCCACTAGAGGGCCTGTGGAGGTCGCTAGATGGTC 286 
                               ************************************ 
 
CLUSTAL 2.1 multiple sequence alignment hRSV clones 3 and 4 
 
 
hRSV-Clone-3-HumanChro-17      GACCATCTAGCGACCTCCACATGCGAAACACATTGTAGGAGCTCAGAAGA 50 
hRSV-Clone-4-HumanChro-17      GACCATCTAGCGACCTCCACATGCGAAACACATTGTAGGAGCTCAGAAGA 50 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      TGTCAGCAATAGTTTTTATCTTACCACTATCACTAATGTTACTACCATTG 100 
hRSV-Clone-4-HumanChro-17      TGTCAGCAATAGTTTTTATCTTACCACTATCACTAATGTTACTACCATTG 100 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      ATGTTATTCTCATCATCATTATAATTATCTCTGAGTGCTCAGCATCTAGT 150 
hRSV-Clone-4-HumanChro-17      ATGTTATTCTCATCATCATTATAATTATCTCTGAGTGCTCAGCATCTAGT 150 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      AGATGCTTGGTAAATATCAAATCAGTGGATGAATGACTACCTCTAGAAGC 200 
hRSV-Clone-4-HumanChro-17      AGATGCTTGGTAAATATCAAATCAGTGGATGAATGACTACCTCTAGAAGC 200 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      TCCTTTTATTCCTTCATTACAGGTCCTGGCTCCCTGACTTCATTTCTCCT 250 
hRSV-Clone-4-HumanChro-17      TCCTTTTATTCCTTCATTACAGGTCCTGGCTCCCTGACTTCATTTCTCCT 250 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      ATATATTTTATGCAGGATCTGCTTCATGGCAGAACAGAGTAATGGTTAAG 300 
hRSV-Clone-4-HumanChro-17      ATATATTTTATGCAGGATCTGCTTCATGGCAGAACAGAGTAATGGTTAAG 300 
                               ************************************************** 
 
hRSV-Clone-3-HumanChro-17      AGCTGGGGTGGAGGTCGCTAGATGGTC 327 
hRSV-Clone-4-HumanChro-17      AGCTGGGGTGGAGGTCGCTAGATGGTC 327 
                               *************************** 
 






















An * (asterisk) represents positions that have a single, fully conserved residue. A : (colon) represents conservation between 
groups of strongly similar properties. A . (period) is used for conservation between groups of weakly similar properties. 
CLUSTAL 2.1 multiple sequence alignment for hRSV clones 6, 7 and 8 
 
 
hRSV-Clone-6-Partially-Matched      GACCATCTAGCGACCTCCACCGCCCTTAATCCATTTAACCCTGAGTTGAC 50 
hRSV-Clone-8-PartMatched-hRSV-      GACCATCTAGCGACCTCCACCGCCCTTAATCCATTTAACCCTGAGTTGAC 50 
hRSV-Clone7-PartMatched-hRSV-1      GACCATCTAGCGACCTCCACCGCCCTTAATCCATTTAACCCTGAGTTGAC 50 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      ACAGCACATGTTTCAGAGAGCACGGGCTTGGGGGTAAGGTTATAGATTAA 100 
hRSV-Clone-8-PartMatched-hRSV-      ACAGCACATGTTTCAGAGAGCACGGGCTTGGGGGTAAGGTTATAGATTAA 100 
hRSV-Clone7-PartMatched-hRSV-1      ACAGCACATGTTTCAGAGAGCACGGGCTTGGGGGTAAGGTTATAGATTAA 100 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      CAGCATCCCAAGGCAGAAAAATTTTTCGTAGTACAGAACAAAATGGAGTC 150 
hRSV-Clone-8-PartMatched-hRSV-      CAGCATCCCAAGGCAGAAAAATTTTTCGTAGTACAGAACAAAATGGAGTC 150 
hRSV-Clone7-PartMatched-hRSV-1      CAGCATCCCAAGGCAGAAAAATTTTTCGTAGTACAGAACAAAATGGAGTC 150 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      TCCTATGTTTACTTCTTTCTACCCAGACACAGTAACAATCTGATCTCTCT 200 
hRSV-Clone-8-PartMatched-hRSV-      TCCTATGTTTACTTCTTTCTACCCAGACACAGTAACAATCTGATCTCTCT 200 
hRSV-Clone7-PartMatched-hRSV-1      TCCTATGTTTACTTCTTTCTACCCAGACACAGTAACAATCTGATCTCTCT 200 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      GTCTTTTCCCCACATTCCCCCTTTTCTTTTCGACAAAACCGCCATTGTCA 250 
hRSV-Clone-8-PartMatched-hRSV-      GTCTTTTCCCCACATTCCCCCTTTTCTTTTCGACAAAACCGCCATTGTCA 250 
hRSV-Clone7-PartMatched-hRSV-1      GTCTTTTCCCCACATTCCCCCTTTTCTTTTCGACAAAACCGCCATTGTCA 250 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      TCATGGCCCATTCTCGATGGTCGCTTTCTCTTGTGGAGGTCGCTAGATGG 300 
hRSV-Clone-8-PartMatched-hRSV-      TCATGGCCCATTCTCGATGGTCGCTTTCTCTTGTGGAGGTCGCTAGATGG 300 
hRSV-Clone7-PartMatched-hRSV-1      TCATGGCCCATTCTCGATGGTCGCTTTCTCTTGTGGAGGTCGCTAGATGG 300 
                                    ************************************************** 
 
hRSV-Clone-6-Partially-Matched      TC 302 
hRSV-Clone-8-PartMatched-hRSV-      TC 302 
hRSV-Clone7-PartMatched-hRSV-1      TC 302 
                                    ** 
 
CLUSTAL 2.1 multiple sequence alignment for hRSV clones 9 and 10 
 
 
hRSV-Clone-9-HumanChrom8-Full       GACCATCTAGCGACCTCCACCAGACAAAAACAGGACCGCACGATGGAATG 50 
hRSV-Clone-10-HumanCrhom-8-Ful      GACCATCTAGCGACCTCCACCAGACAAAAACAGGACCGCACGATGGAATG 50 
                                    ************************************************** 
 
hRSV-Clone-9-HumanChrom8-Full       AGAGAGCTGCAGTGACAGGGGGACGTTGAGGCAGGCAGAGGTGAGAAGCA 100 
hRSV-Clone-10-HumanCrhom-8-Ful      AGAGAGCTGCAGTGACAGGGGGACGTTGAGGCAGGCAGAGGTGAGAAGCA 100 
                                    ************************************************** 
 
hRSV-Clone-9-HumanChrom8-Full       GTGAGAACGAAGGGAATGCTGGGTGCATCCTGAGGAAGCCTCTCCCATCT 150 
hRSV-Clone-10-HumanCrhom-8-Ful      GTGAGAACGAAGGGAATGCTGGGTGCATCCTGAGGAAGCCTCTCCCATCT 150 
                                    ************************************************** 
 
hRSV-Clone-9-HumanChrom8-Full       AGAAGCCACCAGGACTATCGCAGGCGGGCTATGAAACACCAGGCTTTGGA 200 
hRSV-Clone-10-HumanCrhom-8-Ful      AGAAGCCACCAGGACTATCGCAGGCGGGCTATGAAACACCAGGCTTTGGA 200 
                                    ************************************************** 
 
hRSV-Clone-9-HumanChrom8-Full       GCAAGATGACTGTGTCTCTCCCAAAAGGCTTACAGAAGCAAAATTGAGTT 250 
hRSV-Clone-10-HumanCrhom-8-Ful      GCAAGATGACTGTGTCTCTCCCAAAAGGCTTACAGAAGCAAAATTGAGTT 250 
                                    ************************************************** 
 
hRSV-Clone-9-HumanChrom8-Full       CGTGTGGAGGTCGCTAGATGGTC 273 
hRSV-Clone-10-HumanCrhom-8-Ful      CGTGTGGAGGTCGCTAGATGGTC 273 
                                    *********************** 
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7.4 Application of HRM for rapid detection of common pathogenic 
viruses of the respiratory tract  
PCR products positive for influenza B, hRSV, hRV and parainfluenza 2 were 
cloned in vector pCR2.1 as described in section 2.6.8. These vectors were 
transformed into chemically competent cells (E coli XL1-Blue, Agilent Technology, 
Edinburgh, UK) and propagated in Luria Bertani broth containing kanamycin (30 
µg µl-1) (Section 2.6.8). Plasmids were extracted (Section 2.6.10) from these 
clones and used as templates after quantitation and appropriate dilution as 
described in section 7.2. Commercially available plasmid (H1N1 Universal Control 
Plasmid V3, 2473 bp) containing the sequences for influenza A and swine 
influenza A was obtained from Integrated DNA Technology (IDT), Leuven, Belgium 
to be used as positive control for the respective viruses. Details of the primers 
used for influenza B, hRSV, hRV and parainfluenza 2 are provided in Table 2.4. 
Primers designed by WHO for the detection of influenza A and swine influenza A 
were obtained from IDT, Leuven, Belgium (Appendices i, Table A1). The PCR 
protocol and analysis was done according to the protocol mentioned in section 7.2 
with some modifications. The PCR cycle was optimized for all of the viruses as 
follows: 95 ºC for 10 seconds, 55 ºC for 30 seconds and 72 ºC for 30 seconds for 
40 cycles. The melting temperature for the PCR products generated from the 
viruses were set to ramp (gradual increase in melting temperature) between 72 ºC 
and 89 ºC. The average melting temperatures for influenza B, hRSV, hRV and 
influenza A were 79.48 C, 78.59 C, 80.34 C and 80.58 C, respectively (Table 
7.5). Two distinct peaks were observed for the melting curves for parainfluenza 2 
at 79.07 C and 81.27 C. Two peaks were also observed in the melting curves of 
swine influenza A at 77.42 C and 77.83 C (Table 7.5). All of the selected viruses 
showed distinct melting temperatures and HRM melting patterns for different 
amplicons when they were analysed using Rotor-Gene Q software 1.7 (Figure 
7.13 and 7.14). 
 
























































































































































































































































































Colour Name Peak 1 Peak 2 
 
Influenza B 79.47  
 
Influenza B 79.43  
 
Influenza B 79.55  
 
N35 hRSV 78.65  
 
N35 hRSV 78.57  
 
N35 hRSV 78.55  
 
N15 hRV 80.35  
 
N15 hRV 80.32  
 
N15 hRV 80.37  
 
Parainfluenza 2 79.15 81.33 
 
Parainfluenza 2 79.10 81.30 
 
Parainfluenza 2 78.98 81.20 
 
Swine influenza A 77.45 77.85 
 
Swine influenza A 77.45 77.80 
 
Swine influenza A 77.37 77.85 
 
Influenza A 80.58  
 
Influenza A 80.57  
 
Influenza A 80.60  
 
Table 7.5: Colour codes and 
melting temperatures for 
common pathogenic viruses 
of the respiratory tract 
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After PCR and HRM analysis of different virus sequences were completed they 
were resolved on an agarose gel (Section 2.6.1) for confirmation of different 
amplicon sizes. It was found that the PCR products for influenza B, hRSV, hRV, 
parainfluenza 2, swine influenza A and influenza A virus sequences were 362 bp, 



















Figure 7.15: Gel electrophoresis of different PCR products of known 
viruses after HRM analysis. M: 100 bp DNA ladder (Fermentas, York, UK); 
Lane 1: influenza B (362 bp); Lane 3: sample 35 positive for hRSV (279 bp); 
Lane 5: sample 15 positive for hRV (549 bp); Lane 7: parainfluenza 2 (507 
bp); Lane 9: swine influenza A (98 bp); Lane 11: influenza A (120 bp); Lanes 
2, 4, 6, 8, 10 and 12 are negative controls for influenza B, hRSV, hRV, 
parainfluenza 2, swine influenza A and influenza A viruses, respectively. 
500 bp 




High resolution melting analysis is a very sensitive technique which can detect 
different types of sequences in a closed tube reaction without the need for 
expensive probes. It has already been reported by other workers that high 
resolution melting (HRM) analysis could be applied for different types of 
applications such as detection of bacteria (Cheng et al., 2006), typing of viruses 
(Dames et al., 2007; Sabol et al., 2009; Varillas et al., 2011) and mutational 
analysis (Krypuy et al., 2007). This study was conducted to evaluate the 
applications of HRM analysis for pre-sequence screening of libraries generated 
after whole genome amplification from samples containing virus genomes. We 
also evaluated HRM for rapid detection of common pathogenic viruses of the 
respiratory tract. 
Three separate libraries were generated from bacteriophage MS2 RNA, tissue 
culture media positive for influenza B and hRSV using the RT-Bst SPA as 
described in chapter 6 (Figure 6.1). Ten clones were picked randomly from each 
library for extraction of plasmids and analysis of sequences by a real-time PCR 
followed by HRM analysis. After matching the sequence information with the 
findings from the HRM analysis it was found that similar sequences produced 
similar melting curves and different sequences produced different melting curves 
from the selected clones from the 3 libraries. Although the melting curves of the 
different sequences of MS2 and influenza B did not produce distinct peaks in their 
conventional melting analyses, the normalised HRM curves produced distinct 
patterns for different groups of sequences after analysing the sequences with 
Rotor-Gene Q software 1.7 (Section 7.3.1 and 7.3.2). Normalization of the HRM 
curves using appropriate software for example, Rotor-Gene Q software 1.7, helps 
to set relative fluorescence values for all of the studied sequences uniformly from 
100% to 0% after collecting them in the pre-melt and post-melt areas for all 
samples (Figure 7.8, 7.11 and 7.14). Normalisation of the HRM melting curves 
brings similar sequences closer and takes different sequences apart and helps to 
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recognise the similarity and differences between the sequences easily (Figure 7.8, 
7.11 and 7.14).  
HRM analysis and normalisation of the melting curves generated from the ten 
clones of MS2 and influenza B produced 3 and 4 different types of melting curves, 
respectively (Figure 7.8 and 7.11). MS2 sequence analysis showed that clones 1, 
2 and 3; clones 6, 7, 8 and 9 and clones 4, 5 and 10 formed three separate groups. 
Influenza B sequence analysis showed clone 1 and 2; clones 8 and 9; clones 3, 4 
and 5 and clones 6, 7 and 10 formed four distinct groups. The melting curves of 
hRSV was analysed using Rotor-Gene Q software 1.7 and it was found that both 
the melting curves and normalized HRM curves showed 5 distinct groups of 
sequences. Clone 1; clones 3 and 4; clones 9 and 10; clones 6, 7 and 8 and 
clones 2 and 3 formed 5 distinct groups (Figure 7.11). It was not possible to 
determine the sequence variations from conventional melting curves. However, it 
was possible to clearly determine the similarities and differences between different 
sequences using normalized HRM curves.  
Generally, a large number of clones need to be sequenced randomly from a whole 
genome library to determine the sequence of any new type of virus (Allander et al., 
2005). Stang et al. (2005) screened the WGA library based on the different sizes 
of the PCR products being cloned. Application of HRM analysis for pre-sequence 
screening of WGA library was found to be useful in this study. This approach will 
enable researchers to screen different types of sequences based on the patterns 
of normalised HRM curves. Thereby, application of HRM for screening WGA 
libraries will reduce the cost for screening clones containing different types of 
sequences. Provaznikova et al., (2008) adapted HRM analysis for pre-sequence 
screening of myosin heavy chain (MYH) 9 gene and could reduce more than 85% 
of the unnecessary sequencing of MYH 9 gene.  
In another part of this study cloned plasmid sequences of common pathogenic 
viruses of the respiratory tract, for example, hRSV, hRV, influenza B, 
parainfluenza 2, influenza A and swine influenza A were used to determine the 
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validity of HRM for rapid detection of common pathogenic viruses. After HRM 
analysis using Rotor-Gene Q software 1.7, it was found that each virus sequence 
produced distinct melting curve and HRM curve subsequent to normalization. 
Individual viruses also showed separate melting temperature after such analysis. 
Having matched the melting temperatures and normalized HRM curve of a known 
virus with an unknown one, it is possible to confirm the presence of a particular 
type of virus after HRM analysis. Fluorescence intensity generated from swine 
influenza A was found to be the lowest, possibly because of the shorter size (98 bp) 
of the amplicon and lowest melting temperature. It was also difficult to observe the 
small amplicon (98 bp) of swine influenza A after PCR and agarose gel 
electrophoresis. However, HRM analysis of the PCR product of swine influenza A 
virus produced a separate curve and it was not difficult to distinguish it from other 
viruses. A point worth mentioning in this study is that all of the above mentioned 
viruses were successfully amplified using the same PCR cycle, same reagent and 
same software. This is a new dimension of rapid and accurate detection of 
respiratory viruses using HRM analysis. This new approach will therefore be useful 
for rapid detection of any particular type of virus or a group of viruses. Appropriate 
positive control will be required for each type of virus to match the similarities of 
sequences. Any variation in the detected sequences can be further investigated by 
sequencing to determine any new type of the known virus. Similar results of HRM 
analysis have been reported by other workers for typing variants of influenza A 
(Lin et al., 2008; Varillas et al., 2011), human metapneumovirus (Sabol et al., 2009) 
and analysing the genetic diversity of HIV without sequencing (Towler et al., 2010). 
A single base variation can be determined easily by HRM analysis when the 
amplicon size is small as was demonstrated by Liew et al., (2004) for SNP 
genotyping using a product length from 38 to 50 bp. Differences in the Tm value 
among the genotypes increased with the decrease in the amplicon size. It also 
took a short period of time for amplification of such small amplicons. Nevertheless, 
it was also possible to distinguish sequence variations in heterozygotes when 
HRM was performed for small amplicons (Graham et al., 2005). HRM analysis also 
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carried out successfully for SNP genotyping by other scientists with relatively 
larger sizes of amplicons such as 160 to 218 bp (Liew et al., 2006 and 2007). 
HRM analysis was also used for the detection and identification of 25 clinically 
important bacteria based on the ribosomal RNA real time PCR (Cheng et al., 
2006). Different sets of primers were used to differentiate between the amplicons 
from closely related species. HRM analysis of heteroduplex sequences is another 
way to differentiate between similar sequences (Sabol et al., 2009). However, such 
an approach was not used in this study. It was possible to detect and differentiate 
among three species of Aspergillus sequences having very similar Tms by 
introducing tailed primers in a multiplex assay (Erali et al., 2006). HRM was also 
applied for analysing pathogenic microorganisms such as genotyping 
Staphylococcus aureus (Stephens et al., 2008), typing variants of influenza A (Lin 
et al., 2008; Varillas et al., 2011) and detecting strains of Bacillus anthracis (Fortini 
et al., 2007). In recent studies it was also possible to determine oseltamivir drug-
resistance using HRM analysis for some isolates of the influenza A/H1N1 2009 
viruses (Lee et al., 2011; Tong et al., 2011). 
HRM analysis of amplicons was also found to be useful for determining mutation in 
the DNA sequences. It was possible to detect 91% of gastrointestinal stroma 
tumours with abnormal melting curves after HRM analysis (Holden et al., 2007). 
Other workers also reported the application of HRM analysis for determining the 
DNA methylation patterns (Dahl and Guldberg, 2007). However, data analysis of 
curves generated after HRM analysis is still criticized due to the lack of statistical 
interrogation and arbitrary interpretation. Recently, a software program called 
‘ScreenCLust’ has been developed for improved statistical analysis of HRM data 
(Reja et al., 2010). Samples can be analysed based on the likelihood of the 
sequences in both supervised and unsupervised modes in the presence of known 
and unknown controls, respectively. It is possible to analyse data without known 
controls using this new algorithms hence it has the potential for de novo HRM 
applications such as mutation discovery. This new software could be further 
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applied for detailed analysis of insertions, deletions, pathogen detection and 
methylation analysis (Reja et al., 2010). 
The HRM analysis was suitable for determining variations in the nucleotide 
sequences in a library generated after WGA in this study. It was also possible to 
determine variations in the nucleotide sequences of known viruses. Although the 
amplicon sizes varied between 90 bp and 507 bp for PCR amplification and HRM 
analysis of pathogenic viruses, it was possible to differentiate the sequences of 
known viruses using this technique. HRM is a closed tube reaction which reduces 
the possibility of carry over contamination and unnecessary expenses for 
sequencing the amplified products. A panel of known viruses can be used to 
further optimize this technique for rapid screening of a panel of common 
pathogenic viruses of the respiratory tract. Further optimisation of HRM analysis 
will aid rapid detection of pathogenic viruses of the respiratory tract leading to 
control of the spread and intervention of infectious diseases, as well as cost-



























Discussion and future work 





This study evaluates the application of isothermal amplification of nucleic acids 
for the detection and characterization of pathogenic viruses of the respiratory 
tract. In the preliminary study on phi29-amplification of four different structural 
conformations of DNA it was found that linear and circular forms of double 
stranded DNA were amplified whereas single stranded DNA (ssDNA) was not 
amplified. This was reflected when single stranded DNA was synthesized from 
single stranded bacteriophage MS2 RNA chosen as the representative genome 
of single stranded RNA viruses. Since recognised pathogenic viruses of the 
respiratory tract are generally RNA viruses, with the exception of adenoviruses, 
the inability of phi29 to amplify ssDNA was a disadvantage. This indicates that 
alternative protocols are necessary for amplification of sscDNA reverse 
transcribed from single stranded viral RNA. Therefore, we evaluated alternative 
protocols for isothermal amplification of single stranded cDNA (prepared from a 
RNA template) to enhance the sensitivity of detection by PCR. Ligation-
mediated phi29-amplification was found to be helpful for the amplification of 
ssDNA but was dependent on the reverse transcription of cDNA from viral 
RNA. A novel protocol designated RT-Bst was developed for the simultaneous 
reverse transcription of RNA and amplification of cDNA to enhance the 
sensitivity of PCR detection of pathogenic viruses of the respiratory tract. This 
RT-Bst amplification was applied for the amplification of RNA extracted from 
bacteriophage MS2 and tissue culture media extracts positive for hRSV which 
showed significant amplification in qualitative PCR assays (discussed in 
Chapter 4). The performance of RT-Bst amplification varied when it was used 
for the amplification of RNA extracted from nasopharyngeal samples 
(discussed in Chapter 5). An alternative and shorter protocol for amplification of 
viral RNA was also developed in this study and named RT-Bst SPA to aid 
nucleic acid based detection of pathogenic viruses of the respiratory tract 
(Chapter 6; Table 6.5). RT-Bst SPA amplified products were subcloned to make 
whole genome libraries. The cloned sequences were analysed using the 
BLASTn tool to determine the utility of RT-Bst SPA for whole genome 
amplification. In sequence based analysis, a large number of clones are 
randomly selected to determine the whole genome sequences which is tedious, 




lengthy and expensive. Therefore, an alternative approach of High Resolution 
Melting (HRM) analysis was used to evaluate its application for pre-sequence 
screening of a whole genome library to avoid unnecessary sequencing. PCR 
based detection of pathogenic microorganisms requires sequencing or use of 
nucleic acid probes for confirmation of the amplified nucleic acid sequences 
which can be lengthy and/or expensive. In this study we demonstrated the 
applications of HRM analysis as an alternative approach to sequencing for 
detection and characterization of common pathogenic viruses of the respiratory 
tract. 
 
 8.2 Approaches for cell-free isothermal amplification of nucleic 
acids and their applications for enrichment of viral genomes 
Different approaches of isothermal amplification of nucleic acids were 
evaluated in this study to aid PCR detection of pathogenic viruses of the 
respiratory tract (Chapter 4 and 6). Isothermal amplification of nucleic acids 
was used in this study because it is less biased over the PCR based 
amplification of the template DNA. These approaches can also be used for 
amplification of nucleic acids from environmental, biological and clinical 
samples. As the aim of our study was to amplify viral RNA, we developed a 
modified protocol (ligation-mediated phi29-amplification) for amplification of 
single stranded DNA (prepared from RNA). We used T4 RNA ligase, T4 DNA 
ligase and CircLigase II ssDNA ligase for ligation mediated phi29-amplification 
using MS2 RNA as substrate. Based on our findings, ligation-mediate phi29-
amplification was found to be useful for the amplification of ssDNA. Further 
studies will be required for the application of the ligation-mediated phi29-
amplification protocol for detection of viral RNA in clinical, biological and 
environmental samples.  
Phi29 DNA polymerase amplifies low copy number templates to elevate the 
concentration of DNA above the normal detection limit of PCR. This is expected 
to enhance the sensitivity of PCR detection and reduce the number of false 
negative results. Sequence independent isothermal amplification of nucleic 




acids in clinical samples using similar approaches is expected to improve 
sensitivity of molecular detection of pathogenic viruses of the respiratory tract. 
As in the present study, phi29-amplifiction has also been found to be useful by 
other workers for amplification of DNA and RNA viruses in clinical samples for 
subsequent microarray analysis (Erlandsson et al., 2011 and 2010).  
Erlandsson et al., (2011) used phi29 amplification for amplification of DNA (for 
example, herpes simplex virus) and RNA viruses (for example, rotavirus, 
hepatitis C virus, hRSV and enterovirus) from a diverse set of clinical samples 
such as, cerebrospinal fluid, urine, serum, faeces, lesion and tracheal aspirate 
for successful amplification and identification by microarray analysis.  
In this study we developed a novel method named RT-Bst for the simultaneous 
reverse transcription of RNA and Bst DNA polymerase amplification of cDNA in 
the same reaction (Section 4.4). In this study, amplification of cDNA copy using 
RT-Bst reaction was found to be useful to improve the sensitivity of PCR 
detection of RNA viruses. In a qualitative PCR based assay on bacteriophage 
MS2 RNA it was found that cDNA molecules at nanogram levels could be 
amplified more efficiently using the RT-Bst protocol than the QuantiTect 
reverse transcription kit (QIAGEN, Crawley, UK) (Section 4.4). A more detailed 
quantitative real-time PCR assay will be required for accurate determination of 
RT-Bst amplification from limiting concentrations of RNA alone and in the 
presence of carrier RNA to determine the sensitivity of the RT-Bst amplification. 
The RevertAid Premium (thermostable form) reverse transcriptase 
(Fermentas, York, UK) was used for RT-Bst amplification of cDNA from RNA 
extracted from nasopharyngeal samples (Chapter 5). In this study the 
performance of RT-Bst PCR was found to be comparable to that of one-step 
RT-PCR detection and more efficient than the immunofluorescence detection of 
common pathogenic viruses of the respiratory tract by the Chelsea and 
Westminster Hospital (Tables 5.1, 5.2, 5.3 and 5.4). The performance of RT-Bst 
amplification could be further improved by optimising the reaction temperature 
(50-60 ºC) and designing appropriate primers (preferably in the central portion 
of the genome) for detection of virus sequences by PCR. In this study we 
determined the RT-Bst amplification of hRSV genomic RNA using eight pairs of 
primers in a qualitative PCR and we found that the central portion of the hRSV 




genome was amplified more efficiently than the terminal parts (Section 4.4.2). 
In future studies RT-Bst amplification could also be improved through 
modification of the reaction conditions for example, allowing only reverse 
transcription in the first 15-30 minutes at 50-60 ºC using genetically modified 
RNase H deficient thermostable RevertAid premium reverse transcriptase 
(Fermentas, York, UK). Subsequently RNase H and Bst DNA polymerase could 
be added for simultaneous degradation of RNA from cDNA:RNA hybrid and 
amplification of cDNA at 60-65 ºC for 1-2 hours. These controlled reaction 
conditions will increase the stability of RNA in the first 30 minutes for efficient 
reverse transcription and degradation of RNA afterwards from the cDNA:RNA 
hybrid for efficient Bst DNA polymerase amplification of cDNA. If such a 
modified protocol is adopted, it could be used for the development of an 
alternative reverse transcription kit to those available in the market. In 
commercially available reverse transcription kits only a fraction of RNA (40-
80%) is converted to cDNA whereas the RT-Bst reaction not only converts 
cDNA from RNA but also amplifies the concentration of cDNA in the reaction 
(Stangegaard et al., 2006). RT-Bst amplification of RNA from minute amounts 
will enable scientists to further study any type of RNA sample such as from 
virus, bacteria or even eukaryotic RNA. This approach can be applicable for 
amplification of nucleic acids from both the culturable and unculturable forms of 
bacteria using molecular detection techniques for example, PCR, hybridization, 
microarray analysis. RT-Bst and RT-Bst SPA amplification can be useful for 
amplification of nucleic acids from laser captured microdissected tissues 
(Aaltonen et al., 2011).  
A significantly large amount of DNA could be prepared using RT-Bst and RT-
Bst SPA from a small amount of clinical sample for detection of pathogenic 
viruses using the multiplex detection techniques for example, ResPlex 
technology (Brunstein et al., 2008) and Infinity system  (Raymond et al., 
2009). Recently, Erlandsson et al., (2010) used a similar strategy for pre-
amplification of circular and linear dsDNA genomes of viruses using phi29 DNA 
polymerase to increase the sensitivity of real-time PCR detection. Erlandsson 
et al., (2011) also demonstrated phi29-amplification for enrichment of RNA and 
DNA viruses for subsequent detection by microarray analysis. In our study we 




demonstrated a unique application of the RT-Bst method for the amplification of 
nucleic acids directly from RNA in a single tube reaction (Erlandsson et al., 
2011 and 2010) (Chapter 4). Erlandsson et al., (2011, 2010) used the  Whole 
Transcriptome Amplification (WTA) kit (QIAGEN, Crawley, UK) for phi29-
amplification of viral RNA which may not be useful for diagnostic laboratories in 
terms of cost and time. The WTA kit requires multiple steps for ligation of RNA 
and amplification of cDNA which is prone to contamination from any template 
DNA from the laboratory. On the contrary, the RT-Bst reaction is a closed tube 
reaction and, as a result, is less prone to contamination from external sources. 
In routine laboratory diagnosis, nested-PCR (Perrott et al., 2009) may be used 
to increase the sensitivity of PCR detection of samples containing very low 
copies of the template (Schloss et al., 2003). However, nested-PCR 
amplification represents high risk of amplicon contamination leading to 
potentially false positive results (Templeton et al., 2004; Bellau-Pujol et al., 
2005). 
 
8.3 RT-Bst SPA—a novel approach for sequence independent 
nucleic acid amplification 
A sequence independent approach can be used for the amplification of both 
known and unknown virus sequences. Although PCR-based methods are 
considered to be more biased than non-PCR based isothermal amplification 
methods, the former is more suitable for cloning and preparation of libraries 
than the latter. Isothermal amplification of nucleic acids produces hyper-
branched structures of DNA which require additional steps for converting them 
to dsDNA before cloning to make a genomic library (Zhang et al., 2006). In this 
study we designed a novel method by combining RT-Bst amplification of cDNA 
from RNA samples followed by Single Primer Amplification (RT-Bst SPA) 
(Chapter 6, Figure 6.1). The RT-Bst SPA designed in this study involves fewer 
steps and is less costly compared to the SISPA technique for amplification of 
whole genomes of RNA viruses which has been adopted in many studies 
(Table 6.5). Our method for the amplification of whole genome requires a 
relatively lower volume of sample (50 µl) compared to other methods, for 




example, SISPA (200 µl) (Allander et al., 2001 and 2005) and particle 
associated nucleic acid PCR (10 ml) (Stang et al., 2005) (Section 6.5). 
However, for virus amplification a pre-treatment with DNase was found to be 
critical for the appropriate digestion and removal of host DNA and other 
unwanted sequences. Further studies will be required to optimise DNase 
treatment for digestion of cell-free DNA before whole genome amplification. 
Allander et al., (2001) optimised DNase SISPA technique on hepatitis B virus, 
bacteriophage M13 and GBV-B viruses for amplification of whole genome 
sequences. They found a smear of different sizes of PCR products after SISPA 
without any DNase treatment which was resolved to discrete PCR bands after 
optimum DNase treatment of the samples. A similar approach of DNase 
treatment can be optimised for whole genome amplification from 
nasopharyngeal samples as a future direction of this study. 
In the present study (Chapter 4) we used the RT-Bst amplified products as 
templates for subsequent PCR amplification. It was found that the RT-Bst 
amplified products can be used directly at 10% of the PCR reaction volume for 
amplification of cDNA sequences (Chapter 4 and 5). Addition of RT-Bst 
amplified product at 10% of a real-time PCR reaction showed inhibition in PCR 
amplification. A further dilution (1:10) of the RT-Bst amplified products before 
PCR amplification showed no inhibition in real-time PCR amplification (data not 
shown). However, further studies will be required to determine the optimum 
dilution for real-time PCR amplification of RT-Bst amplified products.  
RT-Bst SPA has been used in this study for successful amplification of genomic 
RNA of bacteriophage MS2. Both the strategies of whole genome amplification 
(RT-Bst SPA) using random and sequence specific primers (including tail 
sequences) could be useful for microarray analysis and multiplex PCR based 
detection technology for example, ResPlex and Infinity system for detection 
of pathogenic viruses of the respiratory tract. Most of the microarray analysis is 
not sensitive enough for detection of pathogenic microorganisms present in low 
concentration and usually requires pre-amplification of nucleic acids such as, 
using PCR or virus culture. Both RT-Bst and RT-Bst SPA amplified nucleic 
acids can also be used for Next Generation Sequencing (Section 1.8.4) and 
detection of previously uncharacterized virus sequences. RT-Bst SPA can also 




be used for pre-enrichment of genomic sequences for efficient multiplex 
detection of pathogenic viruses using conventional PCR and real-time PCR. 
 
8.4 Application of HRM analysis for rapid detection of virus 
sequences 
In this study (Chapter 7) we investigated the applications of HRM analysis for 
screening sequences from whole genome libraries and rapid detection of 
common pathogenic viruses of the respiratory tract. After PCR amplification of 
the inserts in randomly selected clones and HRM analysis it was found that the 
normalised HRM curves showed reproducible and predictable shapes for 
related sequences allowing the differentiation of sequences into different 
groups based on their similarity (Figures 7.4, 7.6 and 7.8). In the present 
investigation 30 cloned sequences were screened from MS2, influenza B and 
hRSV libraries using HRM analysis. These 30 clone sequences produced 12 
different types of melting curves which means that there were 12 types of 
sequences within the 30 clones. Based on the results of this study, it may be 
possible to save 60% of the unnecessary sequencing of these 30 clones from 
three libraries in this study if they were screened by HRM analysis. Other 
workers also reported the possibility of avoiding unnecessary sequencing of 
more than 85% of the MHY9 gene using HRM analysis for pre-sequence 
screening (Provaznikova et al., 2008). The combined application of RT-Bst SPA 
for whole genome amplification and HRM analysis for pre-sequencing will be a 
potentially useful combination for sequence based analysis and detection of 
new types of viruses. 
HRM analysis has been used in previous studies for detection of bacteria  
(Cheng et al., 2006), typing viruses (Dames et al., 2007; Sabol et al., 2009; 
Varillas et al., 2011) and mutational analysis (Krypuy et al., 2006). In this study 
(Chapter 7) we used HRM analysis for rapid and accurate detection of common 
pathogenic viruses of the respiratory tract. It was found that influenza A, swine 
influenza A, influenza B, hRSV, parainfluenza 2 and hRV produced distinct 
curves after HRM analysis. It was also possible to run all samples using the 




same cycling program. Further optimisation of HRM analysis would be useful 
for detection of a panel of viruses from the same sample using the same 
cycling conditions. Including positive controls for virus types of interest can help 
to interpret the HRM curves generated from unknown samples. Additionally, 
template concentrations below the optimum concentration for PCR amplification 
followed by the HRM analysis (CT value less than 30) can be enriched by our 
developed methods, RT-Bst (Chapter 4) or RT-Bst SPA (Chapter 6). In this 
study purified plasmid constructs of known concentrations were used for PCR 
amplification followed by HRM analysis. In the future, a more detailed study will 
be required for validation of HRM analysis on nasopharyngeal samples for the 
detection and characterization of a panel of pathogenic viruses of the 
respiratory tract. RT-Bst and RT-Bst SPA could be used for enrichment of low 
copy number of viral sequences from clinical and environmental samples. It 
may be suggested that HRM analysis in combination with our developed 
methods RT-Bst and RT-Bst SPA could be a potentially rapid and sensitive 




This study was designed to evaluate the applications of isothermal nucleic acid 
amplification methods using phi29 and Bst DNA polymerases to enrich 
template DNA and RNA from low copy to enhance the detection level of 
different types of nucleic acids. Phi29 amplification alone was found to be 
useful in this study and by other workers (Hosono et al., 2003; Lasken et al., 
2004) for amplification of double stranded DNA. Alternative protocols of 
ligation-mediated phi29-amplification were found to be suitable for amplification 
of single stranded DNA. Two novel protocols, RT-Bst and RT-Bst SPA were 
developed during this study for sequence independent amplification of viral 
nucleic acid sequences. The RT-Bst and RT-Bst SPA methods can be used for 
isothermal amplification of cDNA from RNA genomes to increase the sensitivity 
of PCR, microarray and hybridisation based detection and characterization of 
pathogenic viruses (Figure 8.1). Amplified whole genome using RT-Bst SPA 




can be used for Next Generation Sequencing (Section 1.8.4) for the detection 
of currently undescribed viruses. A summary of the different approaches and 
their applications are shown in figure 8.1. Although the RT-Bst and RT-Bst SPA 
approaches were used on RNA virus genomes in this study, these could be 
adapted for detection and categorization of different types of viral nucleic acids 
for example, circular DNA and double stranded RNA. Development of a 
miniature version of these isothermal amplification approaches will be a step 
forward for on-site rapid detection of viral nucleic acids. Highly specific 
amplification is crucial for accurate detection from limiting number of nucleic 
acid molecules. Most of the existing miniaturised nucleic acid analysis systems 
use PCR amplification. The application and potential of miniaturised isothermal 
nucleic acid amplification methods for example, NASBA, LAMP, HAD, RCA and 
SDA have recently been demonstrated by other workers (reviewed by Asiello 
and Baeumner, 2011). The next step in the development of miniaturised 
systems may be the development of ready-to-use disposable µTAS (micro total 
analysis system) where reagents and primers can be pre-stored on the chip 
(reviewed by Asiello and Baeumner, 2011).  
A quantitative real-time PCR assay can be performed to determine the 
magnitude of isothermal amplification of nucleic acid sequences using these 
novel methods. RT-Bst and RT-Bst SPA protocols can be further improved 
through optimisation of the reaction conditions and modification of enzymes. A 
more elaborate study including a larger number of clinical samples will be 
required to validate the applications of RT-Bst and RT-Bst SPA for multiplex 
detection of pathogenic viruses of the respiratory tract. Further optimisation of 
DNase treatment will be required for enhanced whole genome amplification 
using RT-Bst SPA for the detection and characterization of undescribed 
viruses. The novel methods RT-Bst and RT-Bst SPA developed in this study 
are competitive to other kits in the market used for reverse transcription and 
whole genome amplification in terms of their performances. However, further 
validation of the protocols on a larger number of clinical samples will be 
required for appropriate commercialisation of the approaches developed in this 
study. 
 














Figure 8.1: Flow chart for the application of existing and novel protocols 
(*RT-Bst and *RT-Bst SPA) developed in this study for detection and 
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Appendices 





Table A1: Primer sequences used for detection influenza A virus detection 
Primer name Primer sequence (5’-3’) Source 
SW InfA Forward 5’-GCACGGTCAGCACTTATYCTRAG-3’ WHO, IDT 
SW InfA Reverse  5’-GTGRGCTGGGTTTTCATTTGGTC-3’ WHO, IDT 
SW H1 Forward 5’-GTGCTATAAACACCAGCCTYCCA-3’ WHO, IDT 
SW H1 Reverse 5’-CGGGATATTCCTTAATCCTGTRGC-3’ WHO, IDT 
InfA Forward 5’-GAC CRA TCC TGTCACCTCTGAC-3’ WHO, IDT 
InfA Reverse 5’-AGGGCATTYTGGACAAAKCGTCTA WHO, IDT 




Lambda-F 5’-GATGAGTTCGTGTCCGTACAACTGG-3’ IDT 
Lambda-R 5’-GGTTATCGAAATCAGCCACAGCGCC-3’ IDT 
 
  





Whole genome library sequences: 
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